{"meta":{"query_hash":"f9114deedd5b","filters":{"venue":"Nature Reviews Clinical Oncology"},"cohort_total":128,"direct_labels_cover":0,"predictions_cover":128,"exported":128,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/f9114deedd5b","api":"https://metacan.xera.ac/api/v1/cohort?venue=Nature+Reviews+Clinical+Oncology"},"results":[{"id":"W1275532855","doi":"10.1038/nrclinonc.2015.146","title":"HPV-FASTER: broadening the scope for prevention of HPV-related cancer","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"Sanofi Pasteur; European Commission; World Health Organization; Cancer Research UK; GlaxoSmithKline","keywords":"Medicine; Scope (computer science); Oncology; MEDLINE; HPV vaccines; Internal medicine; Virology; Cervical cancer; Cancer; HPV infection","score_opus":0.40482748180218875,"score_gpt":0.6393141744777583,"score_spread":0.23448669267556954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1275532855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.684647e-7,0.96285486,0.000025018056,0.0012603871,0.001868619,0.008259046,0.00006192339,0.000026320093,0.025643483],"genre_scores_gemma":[0.0000037320006,0.9896445,0.00058497157,0.0008669713,0.0022582617,0.0014366126,0.00025358715,0.00008345966,0.004867902],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913284,0.002480312,0.0041861045,0.00084582355,0.0006012766,0.00055804075],"domain_scores_gemma":[0.9919117,0.0035308283,0.0022343262,0.00096287264,0.0009392139,0.00042104648],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0094896285,0.0005210369,0.008357013,0.00016480991,0.00008006109,0.0000149152975,0.00073768443,0.0038025249,0.0043802275],"category_scores_gemma":[0.006741405,0.00026704915,0.003368172,0.00083059596,0.00042494352,0.00005070555,0.00028795234,0.0058994107,0.0001416806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024298955,0.00028824765,0.0000063294824,0.032688264,0.0004949299,0.0000073860956,0.000012515957,6.34155e-8,5.0080487e-8,0.00015354643,0.046034504,0.9200712],"study_design_scores_gemma":[0.0021824362,0.0023225108,0.0000978168,0.008006658,0.004745445,0.00005588493,0.0000043155974,0.0000052135933,2.5700325e-7,0.00017107371,0.98218054,0.00022786847],"about_ca_topic_score_codex":0.000017486693,"about_ca_topic_score_gemma":0.000102016784,"teacher_disagreement_score":0.936146,"about_ca_system_score_codex":0.0006017035,"about_ca_system_score_gemma":0.004330905,"threshold_uncertainty_score":0.9999782},"labels":[],"label_agreement":null},{"id":"W1556819620","doi":"10.1038/nrclinonc.2015.89","title":"Rationale for metronomic chemotherapy in phase III trials","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Capecitabine; Bevacizumab; Chemotherapy; Oncology; Internal medicine; Colorectal cancer; Maximum tolerated dose; Cancer","score_opus":0.48883996569624805,"score_gpt":0.645525693405134,"score_spread":0.15668572770888595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1556819620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000045980955,0.9800625,0.000016625912,0.0012985595,0.00168802,0.014456537,0.00010336915,0.000020337182,0.002349443],"genre_scores_gemma":[0.0000012316851,0.9867235,0.0023107165,0.001928661,0.0026152665,0.0041925386,0.0005708303,0.000052003226,0.0016052771],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919368,0.0017898184,0.004976715,0.00078244664,0.00017555412,0.00033866827],"domain_scores_gemma":[0.990183,0.0066428566,0.0022930899,0.00044996745,0.00019777386,0.00023333362],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.013603588,0.0005525756,0.018472157,0.00021015515,0.00004000141,0.0000091542215,0.00020643254,0.002169154,0.00021438487],"category_scores_gemma":[0.009280699,0.00031460557,0.0033441677,0.00034169544,0.00012175875,0.00003333044,0.000056252993,0.0017057945,0.000069447284],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013736739,0.0013648277,0.000004195331,0.0038683733,0.0008354383,0.0000143751295,0.000016166327,7.677791e-9,1.9464881e-8,0.00009596265,0.068041615,0.92438537],"study_design_scores_gemma":[0.023780366,0.0041508316,0.000004798018,0.004208202,0.0046691885,0.000021717584,0.0000058675328,0.0000014649117,4.8852538e-8,0.00009416021,0.9628317,0.00023165958],"about_ca_topic_score_codex":0.000004316674,"about_ca_topic_score_gemma":0.000078436846,"teacher_disagreement_score":0.9241537,"about_ca_system_score_codex":0.0013979544,"about_ca_system_score_gemma":0.0029072524,"threshold_uncertainty_score":0.9999306},"labels":[],"label_agreement":null},{"id":"W1968260891","doi":"10.1038/nrclinonc.2013.87","title":"Maintenance therapy in breast cancer—many questions remain","year":2013,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canada Research Chairs","keywords":"Medicine; Breast cancer; Oncology; Chemotherapy; Internal medicine; Clinical trial; Disease; Maintenance therapy; Cancer","score_opus":0.19734653868178328,"score_gpt":0.5794666941963679,"score_spread":0.38212015551458456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968260891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007228629,0.9780833,0.0000019698634,0.008237027,0.003302649,0.006500468,0.000112951966,0.00006459528,0.0036898188],"genre_scores_gemma":[0.0000028126094,0.978651,0.0006260754,0.008907355,0.0032143542,0.0036303229,0.0001884373,0.000096765856,0.004682882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99152464,0.0028122682,0.0035276113,0.0011755617,0.00022181467,0.0007381141],"domain_scores_gemma":[0.99469215,0.002087632,0.0016948533,0.0008433072,0.00021596927,0.00046609645],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0026936657,0.0008553781,0.009956214,0.0003175208,0.000057948462,0.000013581514,0.00047931212,0.0043663387,0.0028663664],"category_scores_gemma":[0.0006549647,0.00051626464,0.0022809973,0.0009011139,0.0003474304,0.00007140205,0.00011531162,0.006861486,0.0009310038],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012405247,0.0013980819,0.0002864315,0.004490207,0.0003550498,0.00020486036,0.0000071456,2.1391722e-8,2.5383926e-7,0.00022171119,0.14878577,0.8441264],"study_design_scores_gemma":[0.0030380092,0.0012127869,0.00080328865,0.022548191,0.001982606,0.0006342533,0.0000015005826,0.0000015370423,3.166487e-8,0.000064566484,0.9693168,0.00039642828],"about_ca_topic_score_codex":0.0001626737,"about_ca_topic_score_gemma":0.0003043852,"teacher_disagreement_score":0.84373,"about_ca_system_score_codex":0.0016182571,"about_ca_system_score_gemma":0.0030486714,"threshold_uncertainty_score":0.9998469},"labels":[],"label_agreement":null},{"id":"W1972098018","doi":"10.1038/nrclinonc.2012.102","title":"Breast cancer in young women","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":249,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Cancer; Young adult; Oncology; Internal medicine; Male breast cancer; Gynecology","score_opus":0.17904000779884738,"score_gpt":0.5603095753350166,"score_spread":0.3812695675361692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972098018","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010571457,0.9876692,5.761926e-7,0.0004897705,0.004877103,0.0026258957,0.00015725433,0.000035176632,0.004134405],"genre_scores_gemma":[0.00002828433,0.9907649,0.00009398468,0.001357798,0.0053028725,0.0010547023,0.00007989836,0.00009131203,0.0012262588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99323344,0.0012754775,0.0035087722,0.0008374813,0.00027399763,0.00087082136],"domain_scores_gemma":[0.99594235,0.0009198938,0.0015514736,0.0008047277,0.00009307829,0.0006884736],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.004291684,0.0006715697,0.01104565,0.00025280847,0.00003011973,0.000009682113,0.00037391216,0.0051041013,0.0027039177],"category_scores_gemma":[0.000547977,0.0004098497,0.001920565,0.0007524348,0.00019028195,0.00006663095,0.00016345092,0.008146995,0.0005586455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007006209,0.00047031516,0.003111638,0.015362624,0.00019487408,0.000054610915,0.000029646306,4.408174e-9,1.0605168e-8,0.000030400965,0.0052429475,0.9754329],"study_design_scores_gemma":[0.0008965671,0.00026049768,0.0044051986,0.018755578,0.0022118513,0.00062573486,0.0000043011482,1.6957125e-7,2.28208e-9,0.0000066679113,0.9724699,0.00036349148],"about_ca_topic_score_codex":0.000111680536,"about_ca_topic_score_gemma":0.0007405773,"teacher_disagreement_score":0.9750694,"about_ca_system_score_codex":0.0025718636,"about_ca_system_score_gemma":0.0022473708,"threshold_uncertainty_score":0.9998353},"labels":[],"label_agreement":null},{"id":"W1973767788","doi":"10.1038/nrclinonc.2012.209","title":"Understanding the mechanisms and treatment options in cancer cachexia","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":941,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cachexia; Medicine; Anorexia; Wasting; Weight loss; Cancer; Quality of life (healthcare); Palliative care; Wasting Syndrome; Systemic inflammation; Intensive care medicine; Bioinformatics; Inflammation; Internal medicine; Oncology; Obesity","score_opus":0.766349811132346,"score_gpt":0.6383445516646545,"score_spread":0.12800525946769148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973767788","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.771835e-7,0.9871125,0.000083999184,0.006447657,0.0014742643,0.0034158812,0.000017500402,0.000022264448,0.0014255415],"genre_scores_gemma":[0.000010371194,0.99114245,0.0019738846,0.004317297,0.0012503752,0.000819885,0.00005135451,0.000036062105,0.0003983108],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953311,0.0016983406,0.0019421628,0.00047284694,0.00013850692,0.00041704616],"domain_scores_gemma":[0.99640596,0.0020417469,0.0007738883,0.0004088222,0.00003272851,0.00033684075],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.003784332,0.0003732826,0.004412538,0.00016414057,0.00011748988,0.00000991972,0.00012814759,0.0020613153,0.00023075995],"category_scores_gemma":[0.00041749372,0.00018653419,0.00070650125,0.00036346712,0.00016267518,0.00002998615,0.00006192907,0.0033469484,0.00006321747],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015321013,0.00033598134,0.000058145284,0.007162593,0.00009201526,0.000021553305,0.000024356508,8.856982e-9,2.216729e-8,0.009934746,0.0012179608,0.9811373],"study_design_scores_gemma":[0.0009853694,0.00044864573,0.000073455834,0.0148189375,0.0026420928,0.00015580426,0.000018372031,0.000001953817,6.38056e-9,0.000583133,0.98012215,0.00015007018],"about_ca_topic_score_codex":0.000019072462,"about_ca_topic_score_gemma":0.00039954478,"teacher_disagreement_score":0.98098725,"about_ca_system_score_codex":0.00219136,"about_ca_system_score_gemma":0.0009454371,"threshold_uncertainty_score":0.9992342},"labels":[],"label_agreement":null},{"id":"W1975769848","doi":"10.1038/nrclinonc.2011.75","title":"The role of local therapy in the management of lung and liver oligometastases","year":2011,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ablative case; Radiation therapy; Systemic therapy; Radiofrequency ablation; Metastasis; Lung cancer; Oncology; Lung; Ablation Therapy; Radiology; Cancer; Ablation; Internal medicine; Breast cancer; Prostate cancer","score_opus":0.17468940798963412,"score_gpt":0.5128772309702628,"score_spread":0.3381878229806287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975769848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009213591,0.992816,0.00001027095,0.00034253512,0.00030340967,0.001875682,0.000008162173,0.0000052165924,0.0046295268],"genre_scores_gemma":[0.00007630032,0.9978258,0.00058696396,0.0010507039,0.00015782776,0.00017592018,0.000013115751,0.000015509138,0.00009782954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99406654,0.0029193012,0.0021824872,0.0003798932,0.00020057443,0.00025119763],"domain_scores_gemma":[0.993299,0.0047559226,0.0011343654,0.0006501942,0.000078374855,0.00008212573],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008326513,0.00030691712,0.0043178718,0.00007997067,0.000047897316,0.000002377943,0.00043211837,0.0009395837,0.00002620138],"category_scores_gemma":[0.0008029642,0.00011598716,0.0007790686,0.00032221712,0.0015998133,0.000011649215,0.00017031589,0.0025686617,0.000010257597],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048801357,0.00034739252,0.00022028477,0.009482693,0.0005458343,0.00008623129,0.00006206257,8.827418e-10,1.0665395e-8,0.0016023552,0.002419094,0.98518527],"study_design_scores_gemma":[0.00056641526,0.0008968091,0.00059502944,0.010727607,0.0025204578,0.00012788297,0.00007573812,7.868611e-7,1.00124076e-7,0.00011728944,0.98428404,0.000087850065],"about_ca_topic_score_codex":0.000008344463,"about_ca_topic_score_gemma":0.000010721756,"teacher_disagreement_score":0.9850974,"about_ca_system_score_codex":0.000030312247,"about_ca_system_score_gemma":0.00015631987,"threshold_uncertainty_score":0.99973243},"labels":[],"label_agreement":null},{"id":"W1978293462","doi":"10.1038/nrclinonc.2014.126","title":"Vessel calibre—a potential MRI biomarker of tumour response in clinical trials","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Cancer Institute; Cancer Research Society; Suomen Lääketieteen Säätiö; Massachusetts Institute of Technology; American Association for Cancer Research","keywords":"Medicine; Clinical trial; Biomarker; Angiogenesis; In vivo; Imaging biomarker; Radiology; Magnetic resonance imaging; Medical physics; Pathology; Internal medicine","score_opus":0.3696068064717427,"score_gpt":0.6259125676573805,"score_spread":0.25630576118563775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978293462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021168187,0.97556806,0.000073783965,0.007438405,0.00813371,0.007672534,0.00015788237,0.000057024172,0.00087743055],"genre_scores_gemma":[0.000018985631,0.98593277,0.0034410974,0.0044222265,0.004618634,0.0007350905,0.00025015036,0.00018623733,0.0003948145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8640814,0.10018418,0.031147081,0.002575587,0.0009641836,0.0010475942],"domain_scores_gemma":[0.84457374,0.1309697,0.0187624,0.0036431996,0.0006278955,0.0014230489],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch","metaepi_broad","research_integrity"],"category_scores_codex":[0.17965905,0.0012357001,0.04102258,0.00082326535,0.000041460866,0.000018325005,0.0012900492,0.013385023,0.0008931823],"category_scores_gemma":[0.14871018,0.0008097151,0.01169122,0.0015008751,0.0009634374,0.00007196071,0.0004919333,0.01168005,0.0005992711],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034532915,0.0015385727,0.00020539782,0.022421397,0.00060271693,0.0003784478,0.0000035037904,7.278415e-8,7.885111e-7,0.000043113054,0.22792068,0.743432],"study_design_scores_gemma":[0.0049918233,0.003624204,0.0014515824,0.052426934,0.0092072245,0.00025300818,0.0000020492862,0.0000085226,3.0510475e-7,0.00004526396,0.927422,0.000567092],"about_ca_topic_score_codex":0.00001771628,"about_ca_topic_score_gemma":0.00003231072,"teacher_disagreement_score":0.7428649,"about_ca_system_score_codex":0.0006911998,"about_ca_system_score_gemma":0.0064534247,"threshold_uncertainty_score":0.99943537},"labels":[],"label_agreement":null},{"id":"W1980246989","doi":"10.1038/nrclinonc.2009.116","title":"Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer","year":2009,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Male Breast Health Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University; University of Toronto","funders":"University of Toronto","keywords":"Medicine; Breast cancer; Gynecomastia; Prostate cancer; Oncology; Internal medicine; Hormonal therapy; BRCA mutation; Cancer; Family history; Male breast cancer; Androgen deprivation therapy; Radiation therapy; Gynecology","score_opus":0.11593446981234697,"score_gpt":0.524147513450953,"score_spread":0.40821304363860605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980246989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000075892253,0.9878032,4.603697e-7,0.0023715207,0.0011887302,0.0058117583,0.00022095157,0.000027603566,0.0025681646],"genre_scores_gemma":[0.0000074360555,0.99116915,0.00040040715,0.0028090398,0.0010670603,0.0017116333,0.00006808604,0.000061697276,0.0027054846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922188,0.0016530337,0.0041653244,0.0009887521,0.00041186187,0.00056220696],"domain_scores_gemma":[0.99393725,0.001012587,0.0035770105,0.0006329831,0.00049345574,0.00034671652],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0028479802,0.000683505,0.011119294,0.00033181076,0.00002277531,0.0000020950051,0.00024875742,0.0024881035,0.00034766633],"category_scores_gemma":[0.00087307143,0.0004106641,0.00094497483,0.0007048409,0.00043458428,0.000051295712,0.00006931594,0.0049314164,0.000018195466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0004569159,0.00041389844,0.0012205405,0.06761913,0.00026997383,0.00022680966,0.00009286195,1.8613883e-7,1.5138752e-8,0.00002160485,0.016648361,0.9130297],"study_design_scores_gemma":[0.0018059516,0.0009263391,0.0051553776,0.07588304,0.0033904414,0.0007166295,0.0000046215646,0.0000014311934,4.570764e-9,0.0000041167914,0.9118139,0.00029811953],"about_ca_topic_score_codex":0.00039284027,"about_ca_topic_score_gemma":0.002864797,"teacher_disagreement_score":0.9127316,"about_ca_system_score_codex":0.0046821954,"about_ca_system_score_gemma":0.0145952,"threshold_uncertainty_score":0.99983454},"labels":[],"label_agreement":null},{"id":"W1982291583","doi":"10.1038/nrclinonc.2013.158","title":"Drug rechallenge and treatment beyond progression—implications for drug resistance","year":2013,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Drug resistance; Disease; Drug; Intensive care medicine; Cancer; Chemotherapy; Pharmacotherapy; Oncology; Internal medicine; Pharmacology; Biology","score_opus":0.19520676732876532,"score_gpt":0.5925349983358467,"score_spread":0.39732823100708137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982291583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.8100455e-7,0.9610145,0.000011245527,0.014841999,0.00078519655,0.014890016,0.0001840925,0.000063890584,0.008208148],"genre_scores_gemma":[6.21763e-7,0.93782055,0.023886375,0.00094282447,0.0010730551,0.01343084,0.0008859881,0.0000831114,0.021876615],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952732,0.0007358662,0.0023156623,0.0011334546,0.0001309183,0.00041094015],"domain_scores_gemma":[0.9936004,0.003153679,0.0015348964,0.00097098364,0.0002643573,0.00047567455],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011637362,0.0006561058,0.0056759324,0.00013248989,0.00019968224,0.000024570438,0.00021410179,0.0016086547,0.000059929753],"category_scores_gemma":[0.0011144434,0.00036396112,0.0015052019,0.00026624658,0.00021846873,0.000063852785,0.000070411676,0.0012770649,0.00010479757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029480892,0.00079460535,0.00001727366,0.008180963,0.0005843521,0.0000071571403,0.000038403352,9.902925e-10,2.4016552e-8,0.0013769298,0.10063233,0.88833845],"study_design_scores_gemma":[0.0018617779,0.00068331434,0.000033680666,0.010931687,0.009799196,0.00004751674,0.000006761469,1.362426e-7,5.7466885e-8,0.00056748703,0.9757857,0.00028272677],"about_ca_topic_score_codex":0.000003004404,"about_ca_topic_score_gemma":0.00014561221,"teacher_disagreement_score":0.88805574,"about_ca_system_score_codex":0.0009146635,"about_ca_system_score_gemma":0.0017740715,"threshold_uncertainty_score":0.9998812},"labels":[],"label_agreement":null},{"id":"W1983138070","doi":"10.1038/nrclinonc.2013.88","title":"Secobarbital in Seattle—why lose sleep?","year":2013,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"Canada Research Chairs","keywords":"Medicine; Alliance; Secobarbital; New england; Sleep (system call); Psychiatry; Family medicine; Gerontology; Internal medicine","score_opus":0.5067369171827889,"score_gpt":0.6360649559348964,"score_spread":0.12932803875210752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983138070","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012727796,0.9783971,0.0000072135704,0.0005404607,0.0019899704,0.0034599593,0.000040815237,0.000035529578,0.015516275],"genre_scores_gemma":[0.0000016464131,0.9884722,0.0042694593,0.003740574,0.0018749707,0.00033951655,0.00031690512,0.00008075904,0.00090392464],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907689,0.0024234871,0.0048740595,0.0009942836,0.00036069695,0.0005785845],"domain_scores_gemma":[0.99031657,0.0057914644,0.002118759,0.0010329527,0.00027870474,0.00046153672],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.003460162,0.00077652343,0.013584163,0.00035711183,0.000021605754,0.000008445001,0.0005510909,0.0057862247,0.0008772012],"category_scores_gemma":[0.012588155,0.0004909018,0.0030559208,0.00082993717,0.00035846193,0.00007687715,0.0002319458,0.007155541,0.0015528743],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002925222,0.0005578875,0.0006233797,0.024712026,0.0002842441,0.00023677477,0.000019786114,1.06760885e-8,6.756793e-8,0.00013985354,0.058243148,0.91515356],"study_design_scores_gemma":[0.0011072452,0.0010265408,0.00006348809,0.060775444,0.002050702,0.00008689676,0.000007749948,0.0000012110719,2.051439e-7,0.000053327847,0.9344646,0.00036264106],"about_ca_topic_score_codex":0.000020761085,"about_ca_topic_score_gemma":0.00006851161,"teacher_disagreement_score":0.9147909,"about_ca_system_score_codex":0.00049143675,"about_ca_system_score_gemma":0.0011488713,"threshold_uncertainty_score":0.99975425},"labels":[],"label_agreement":null},{"id":"W1984628012","doi":"10.1038/ncponc1323","title":"Effect of bisphosphonates on pain and quality of life in patients with bone metastases","year":2009,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Spinal cord compression; Bone pain; Zoledronic acid; Bone resorption; Bone remodeling; Bisphosphonate; Palliative care; Osteolysis; Bone Density Conservation Agents; Prostate cancer; Bone metastasis; Pathologic fracture; Osteoporosis; Oncology; Surgery; Internal medicine; Cancer; Bone density; Spinal cord","score_opus":0.10682037539149301,"score_gpt":0.5208671530690386,"score_spread":0.4140467776775456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984628012","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026991602,0.9921017,3.2370372e-7,0.00009100495,0.00014556224,0.0047202418,0.000073956726,0.000008989072,0.00015900521],"genre_scores_gemma":[0.00086794246,0.99677527,0.0005210397,0.0013274797,0.000036937396,0.00011605239,0.00029397706,0.000029169463,0.00003214771],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98552513,0.00896185,0.0042463127,0.0006214793,0.00033994138,0.00030525756],"domain_scores_gemma":[0.98277897,0.012936144,0.003200461,0.0005776043,0.0001227681,0.00038404946],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.012800318,0.00052887516,0.014009879,0.00020521735,0.000016197655,0.0000016035677,0.000112821195,0.0018300773,0.000022598892],"category_scores_gemma":[0.015064267,0.00026289,0.0008578033,0.00047969352,0.00021578377,0.000021196662,0.00003970257,0.0022284547,0.000009923864],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002292114,0.0020140668,0.036069293,0.054781687,0.0002376528,0.00001576345,0.000001936965,4.4168287e-9,2.5106492e-9,0.000024051129,0.00034491104,0.9042185],"study_design_scores_gemma":[0.0073517114,0.045172438,0.023002943,0.033056132,0.0021959036,0.0000029445741,2.8240447e-7,8.5712486e-8,1.643183e-7,0.000004247363,0.88905257,0.00016055426],"about_ca_topic_score_codex":0.00005948196,"about_ca_topic_score_gemma":0.000081572354,"teacher_disagreement_score":0.904058,"about_ca_system_score_codex":0.00013776758,"about_ca_system_score_gemma":0.00075134076,"threshold_uncertainty_score":0.99998236},"labels":[],"label_agreement":null},{"id":"W1991900845","doi":"10.1038/nrclinonc.2014.3","title":"Bilateral breast cancers","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; Mastectomy; Cancer; Oncology; Prophylactic Mastectomy; Internal medicine; Gynecology; Surgery","score_opus":0.08416437266293572,"score_gpt":0.5034406087044148,"score_spread":0.419276236041479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991900845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000015679724,0.9895544,0.00007484019,0.00024788213,0.004761672,0.0013955843,0.00011974039,0.000022946375,0.0038213332],"genre_scores_gemma":[0.0000041911167,0.9849613,0.0020132563,0.0031893656,0.0067257397,0.0004900255,0.0008907663,0.000113799084,0.0016115634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929698,0.0023039712,0.002663502,0.0013586592,0.00018817277,0.0005158966],"domain_scores_gemma":[0.9960661,0.00037400943,0.0017187423,0.0013837538,0.00017203207,0.00028539496],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0029367872,0.00070032483,0.0046769073,0.0001053568,0.000080122394,0.000023819126,0.0010153535,0.005799585,0.00018351249],"category_scores_gemma":[0.001372021,0.0005029474,0.0023422395,0.00032521808,0.0003425733,0.0000031619334,0.00035009524,0.0027979934,0.0005511627],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015867226,0.000052662,0.000007768734,0.002975133,0.00025087417,0.00000672931,0.0000014835377,4.977805e-7,7.823935e-7,0.000039903192,0.12940046,0.8672478],"study_design_scores_gemma":[0.00036290585,0.00048121344,0.0000071002123,0.002684287,0.0009956403,0.00034967478,7.1820034e-7,0.0000010159239,5.882535e-7,0.00001979852,0.99456763,0.0005294467],"about_ca_topic_score_codex":0.0000064443802,"about_ca_topic_score_gemma":0.00010090626,"teacher_disagreement_score":0.8667184,"about_ca_system_score_codex":0.0006557672,"about_ca_system_score_gemma":0.003832266,"threshold_uncertainty_score":0.9997422},"labels":[],"label_agreement":null},{"id":"W1996301092","doi":"10.1038/nrclinonc.2009.90","title":"Eleven years disease-free: role of chemotherapy in metastatic BRCA2-related breast cancer","year":2009,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"University of California, Irvine","keywords":"Medicine; Breast cancer; Oncology; Tamoxifen; Context (archaeology); Internal medicine; Chemotherapy; Anthracycline; Radiation therapy; Cancer; Surgery","score_opus":0.0449411934382233,"score_gpt":0.45789371921362554,"score_spread":0.41295252577540226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996301092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000651612,0.99620146,0.0000041399285,0.0005321151,0.00063284754,0.0017463433,0.00040849877,0.000010731474,0.00039871808],"genre_scores_gemma":[0.00006406509,0.9956322,0.0012794249,0.0011902195,0.00059546955,0.00035495794,0.0004461677,0.00008611581,0.0003513913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937725,0.0017232931,0.002856307,0.0010097045,0.0002285743,0.00040958947],"domain_scores_gemma":[0.9961656,0.00028904053,0.0018155399,0.0013689947,0.00013673406,0.00022410079],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002015027,0.0005420967,0.003937739,0.00016720907,0.000021698752,0.000008564439,0.0011337126,0.0022101528,0.00022834136],"category_scores_gemma":[0.0011116515,0.00044065894,0.0015116209,0.00062426453,0.00025375167,0.000005558668,0.00020245583,0.0018776525,0.00003666225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075644806,0.0003906988,0.000074001546,0.0017078232,0.00036684412,0.000015994325,0.0000072184007,0.0000025592897,0.0000059049835,0.000054097083,0.010763412,0.9865358],"study_design_scores_gemma":[0.0010906525,0.0002521888,0.0010225012,0.003709163,0.0010570625,0.00004209851,0.000002727751,0.0000025331053,0.0000018600869,0.00034852853,0.99207634,0.0003943206],"about_ca_topic_score_codex":0.000013777235,"about_ca_topic_score_gemma":0.00012392529,"teacher_disagreement_score":0.9861415,"about_ca_system_score_codex":0.00034408044,"about_ca_system_score_gemma":0.0032174534,"threshold_uncertainty_score":0.9998045},"labels":[],"label_agreement":null},{"id":"W1998048991","doi":"10.1038/nrclinonc.2010.194","title":"Preclinical development of molecular-targeted agents for cancer","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cancer; Drug development; Computational biology; Clinical trial; Pharmacology; Bioinformatics; Drug; Internal medicine; Biology","score_opus":0.23838387864681165,"score_gpt":0.5689647708044061,"score_spread":0.33058089215759445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998048991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012671643,0.9827167,0.00040480914,0.00032277522,0.005638431,0.009776451,0.0001296898,0.000059700826,0.0009387984],"genre_scores_gemma":[0.0000017073952,0.94532555,0.047809213,0.0018885464,0.0011749398,0.002371315,0.00070742663,0.00018753963,0.0005337752],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9883406,0.0012751953,0.0076527186,0.0015021007,0.0005213103,0.0007080548],"domain_scores_gemma":[0.9903926,0.002489312,0.0044264593,0.0014215835,0.00060099945,0.000669032],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0056364094,0.00093515514,0.0123305665,0.00026807946,0.000067761335,0.000008076709,0.00074817624,0.0107958745,0.00036355728],"category_scores_gemma":[0.01290673,0.00066742074,0.005092659,0.00059847144,0.00034623605,0.000028505352,0.0002824469,0.00900004,0.00014302456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016255729,0.00086759677,0.00000842828,0.026904084,0.0010562168,0.00004894625,0.000012765762,6.375901e-8,0.000016654527,0.00007517923,0.009162718,0.96168476],"study_design_scores_gemma":[0.0022549154,0.000987172,0.00002227247,0.026012933,0.007622873,0.000071245835,7.337266e-7,0.0000022914983,0.000031655032,0.000019719088,0.96245396,0.0005202309],"about_ca_topic_score_codex":0.0000023372238,"about_ca_topic_score_gemma":0.000072172916,"teacher_disagreement_score":0.96116453,"about_ca_system_score_codex":0.0006267513,"about_ca_system_score_gemma":0.010630363,"threshold_uncertainty_score":0.9995777},"labels":[],"label_agreement":null},{"id":"W2000110198","doi":"10.1038/nrclinonc.2010.21","title":"mTOR signaling and drug development in cancer","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":415,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Drug development; Discovery and development of mTOR inhibitors; Drug; PI3K/AKT/mTOR pathway; Cancer drugs; Cancer; Oncology; Cancer research; Pharmacology; Internal medicine; Signal transduction; Genetics","score_opus":0.10817719052914442,"score_gpt":0.4996171613394671,"score_spread":0.39143997081032267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000110198","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002887309,0.9948112,0.0000112381085,0.00017236389,0.0028065932,0.001473428,0.000025386755,0.000014177333,0.0003969316],"genre_scores_gemma":[0.000017123572,0.9886043,0.0057081375,0.0014640377,0.0026102955,0.000744697,0.00018174376,0.00009214798,0.00057750306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936923,0.0013544365,0.0028128903,0.0013845756,0.00020512796,0.0005507135],"domain_scores_gemma":[0.99677116,0.000615167,0.0014094936,0.0007948978,0.00012216691,0.0002871],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.004765332,0.00070502446,0.004101038,0.00013247001,0.000069335474,0.000023347227,0.00089235883,0.0051840586,0.000101237754],"category_scores_gemma":[0.0029877408,0.0005299294,0.00075197814,0.0002682081,0.00025023852,0.000004581311,0.0005879205,0.0047929725,0.000053335323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021193428,0.0001280963,0.00009711362,0.0036323662,0.00011379435,0.000017962233,0.000009713889,1.3608647e-7,0.00005315728,0.000011329875,0.0076021426,0.988313],"study_design_scores_gemma":[0.00047268625,0.00018553222,0.000013483176,0.0066429903,0.0003513215,0.000030151214,0.000001284095,3.6997903e-7,0.00004138202,0.000012032451,0.9916707,0.00057803537],"about_ca_topic_score_codex":0.000009547551,"about_ca_topic_score_gemma":0.00053916615,"teacher_disagreement_score":0.987735,"about_ca_system_score_codex":0.00022320783,"about_ca_system_score_gemma":0.0027873465,"threshold_uncertainty_score":0.9997152},"labels":[],"label_agreement":null},{"id":"W2000803692","doi":"10.1038/nrclinonc.2011.5","title":"Hypoxia modification with radiotherapy for bladder cancer","year":2011,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Bladder cancer; Hypoxia (environmental); Context (archaeology); Oncology; Cancer; Cancer therapy; Internal medicine","score_opus":0.30217606434239314,"score_gpt":0.5572233347455076,"score_spread":0.2550472704031144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000803692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.2390505e-7,0.9851236,0.00029623287,0.0005376533,0.0014338981,0.009435823,0.00012601673,0.00006364691,0.0029827314],"genre_scores_gemma":[5.502262e-7,0.9737203,0.010464133,0.0038931097,0.0030511136,0.0053879553,0.00030735062,0.00016350539,0.003011962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953198,0.00071621937,0.0021881827,0.0011081009,0.00019426052,0.0004734674],"domain_scores_gemma":[0.9957833,0.0009982587,0.0016139569,0.00096912263,0.00026289068,0.0003724216],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0013111448,0.0007495284,0.007526949,0.00014020714,0.000072824674,0.000011396095,0.00035295982,0.0033839687,0.0005734996],"category_scores_gemma":[0.00042176328,0.00040471146,0.002017359,0.00035689137,0.00022635369,0.000051404888,0.00002815637,0.0023855227,0.000114639086],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004317741,0.0006687257,0.000024398012,0.009190242,0.0017788989,0.000014108855,0.000015209947,1.2407085e-8,9.281655e-8,0.0002236578,0.026083367,0.9615695],"study_design_scores_gemma":[0.0031130102,0.0036402761,0.000051125557,0.009252479,0.011832877,0.000121384386,0.0000011130079,0.0000011595199,2.0634175e-7,0.00003736787,0.9715643,0.0003847218],"about_ca_topic_score_codex":0.000021870337,"about_ca_topic_score_gemma":0.00004948775,"teacher_disagreement_score":0.9611848,"about_ca_system_score_codex":0.00062078907,"about_ca_system_score_gemma":0.002984232,"threshold_uncertainty_score":0.999916},"labels":[],"label_agreement":null},{"id":"W2002193164","doi":"10.1038/nrclinonc.2012.27","title":"Exercise rehabilitation in patients with cancer","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Rehabilitation; Physical therapy; MEDLINE; Cancer; Oncology; Physical medicine and rehabilitation; Internal medicine","score_opus":0.10050910908960778,"score_gpt":0.5026674209300335,"score_spread":0.4021583118404257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002193164","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026279387,0.99047023,6.5056605e-7,0.00030850782,0.002988952,0.0048771733,0.000036759906,0.000027553537,0.0012638872],"genre_scores_gemma":[0.000020984302,0.99541503,0.00047712837,0.001009175,0.0010504896,0.0012529138,0.00035484755,0.00007533889,0.00034410946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945705,0.0013741803,0.0024978074,0.000753902,0.00035252448,0.0004511126],"domain_scores_gemma":[0.995629,0.0017238432,0.0012704942,0.00078010367,0.00024754414,0.00034903173],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0026977495,0.0005315131,0.007524479,0.00022236504,0.000024208253,0.0000061677565,0.00023591955,0.0033189722,0.0004207961],"category_scores_gemma":[0.0012649198,0.00030821393,0.0012132806,0.00079513824,0.00017295915,0.00007588151,0.00007720991,0.0044785826,0.00018829945],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023696954,0.00078418135,0.012826952,0.02733099,0.00007305217,0.00000724882,0.00003838747,6.5778356e-9,3.9342365e-10,0.00002187031,0.0035265232,0.9551538],"study_design_scores_gemma":[0.0014481115,0.0012718303,0.008158804,0.058392845,0.0039052088,0.0000031795275,0.0000039108313,3.6670485e-8,2.1328685e-9,0.0000046560212,0.92651963,0.0002918122],"about_ca_topic_score_codex":0.00006206934,"about_ca_topic_score_gemma":0.0013062276,"teacher_disagreement_score":0.954862,"about_ca_system_score_codex":0.0008866861,"about_ca_system_score_gemma":0.001263212,"threshold_uncertainty_score":0.999937},"labels":[],"label_agreement":null},{"id":"W2004554659","doi":"10.1038/nrclinonc.2011.88","title":"Local treatment of metastatic cancer—killing the seed or disturbing the soil?","year":2011,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Marsden Fund; Elekta; National Institute for Health and Care Research; Canadian Association of Radiation Oncology","keywords":"Medicine; Primary tumor; Prostate cancer; Disease; Clinical trial; Cancer; Metastasis; Randomized controlled trial; Breast cancer; Oncology; Metastatic breast cancer; Internal medicine","score_opus":0.36689963617980204,"score_gpt":0.5629204825720135,"score_spread":0.1960208463922115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004554659","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007347724,0.98991406,0.000020348602,0.0021450976,0.0016940492,0.0055831745,0.00006939443,0.00002037614,0.0005461562],"genre_scores_gemma":[0.00007485745,0.993476,0.00026284103,0.0014645149,0.0011801623,0.002791897,0.00007999353,0.000069341135,0.0006003926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930884,0.002050736,0.0033681411,0.00077359425,0.00027277527,0.00044635776],"domain_scores_gemma":[0.9879659,0.0078338,0.002537043,0.0012874827,0.00014596834,0.00022983205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002172387,0.0007496611,0.008929932,0.0000614986,0.00013515333,0.000011467983,0.00046804326,0.0011415932,0.00039952065],"category_scores_gemma":[0.0008478803,0.00023467898,0.0037183592,0.0005185919,0.0006238232,0.000022794597,0.00010956012,0.0019310131,0.000082029124],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014945379,0.0014469184,0.0000997469,0.0066741784,0.0024372567,0.0001231221,0.00008033195,2.0040936e-7,8.503435e-9,0.00014486047,0.002896684,0.98594725],"study_design_scores_gemma":[0.001372668,0.0033941998,0.00014766757,0.016134795,0.028926399,0.00021115261,0.000026039073,0.0000033531435,4.0884333e-7,0.000020672032,0.9495594,0.00020327317],"about_ca_topic_score_codex":0.0002929839,"about_ca_topic_score_gemma":0.0015415848,"teacher_disagreement_score":0.98574394,"about_ca_system_score_codex":0.0010715292,"about_ca_system_score_gemma":0.0024775767,"threshold_uncertainty_score":0.9569931},"labels":[],"label_agreement":null},{"id":"W2005616606","doi":"10.1038/nrclinonc.2010.173","title":"Metastamirs: a stepping stone towards improved cancer management","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":186,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"microRNA; Metastasis; Cancer research; Angiogenesis; Biomarker; Suppressor; Context (archaeology); Oncomir; Cancer; Medicine; Epithelial–mesenchymal transition; Computational biology; Bioinformatics; Biology; Gene; Internal medicine; Genetics","score_opus":0.09099727883105213,"score_gpt":0.4983215491465548,"score_spread":0.40732427031550267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005616606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010366335,0.9910109,0.00016575826,0.00015023861,0.0030059118,0.0037734823,0.00011845642,0.000030095785,0.0017347672],"genre_scores_gemma":[0.00000265152,0.9862779,0.0062061353,0.0010739175,0.0027551295,0.0012080128,0.0009352344,0.00011901097,0.0014220391],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99315435,0.0017289575,0.0028014618,0.0015130421,0.00023015363,0.0005720133],"domain_scores_gemma":[0.99557984,0.00015426123,0.0022068261,0.0015204148,0.00018835336,0.0003502792],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.003259465,0.00081900187,0.0043967464,0.00014268374,0.00008291481,0.00003232136,0.0009967339,0.0053468137,0.00017476747],"category_scores_gemma":[0.001045413,0.00060246483,0.0025313154,0.0003408811,0.0002422964,0.000006107234,0.0006861827,0.0031960856,0.00011679099],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003182258,0.00022996377,0.0000014934848,0.009257352,0.0007582049,0.000016777098,0.0000013490911,8.341084e-8,0.00006494127,0.000060418246,0.008806767,0.9807708],"study_design_scores_gemma":[0.0006044913,0.00027909066,0.000017337483,0.0040684748,0.0036249987,0.000033568504,0.0000014492365,0.0000019771815,0.000007441729,0.000011911345,0.990756,0.000593301],"about_ca_topic_score_codex":0.0000059308363,"about_ca_topic_score_gemma":0.00008596852,"teacher_disagreement_score":0.9819492,"about_ca_system_score_codex":0.00021662557,"about_ca_system_score_gemma":0.0011806495,"threshold_uncertainty_score":0.99964267},"labels":[],"label_agreement":null},{"id":"W2008243627","doi":"10.1038/nrclinonc.2009.83","title":"Cetuximab, chemotherapy and KRAS status in mCRC","year":2009,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cetuximab; Medicine; Bevacizumab; KRAS; Colorectal cancer; Chemotherapy; Oncology; Internal medicine; Panitumumab; Monoclonal antibody; Cancer; Antibody; Immunology","score_opus":0.15783667549239647,"score_gpt":0.553432103833239,"score_spread":0.3955954283408426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008243627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014266455,0.9821415,4.062666e-7,0.0013071669,0.0006356194,0.003269216,0.000017596283,0.00003196342,0.012582243],"genre_scores_gemma":[0.0000051527873,0.9916033,0.0010180564,0.0053516473,0.0008457644,0.00026198057,0.00007650122,0.000046905672,0.0007906632],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99492586,0.00087777275,0.002492491,0.00094765035,0.000201068,0.0005551649],"domain_scores_gemma":[0.9967184,0.0014724968,0.00090187107,0.0005026756,0.00007542003,0.00032914162],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0016675665,0.00066552265,0.010484044,0.00019289447,0.000046865454,0.000011481586,0.00015448016,0.0026757002,0.00013061856],"category_scores_gemma":[0.001599572,0.00039105018,0.0012539042,0.0004951458,0.00022613285,0.00003240698,0.00009414922,0.00369398,0.00007229507],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001438279,0.0007549687,0.00034219338,0.0055872966,0.00027508754,0.00020561612,0.000020884341,9.616886e-10,8.720791e-9,0.000051883348,0.009080171,0.9835381],"study_design_scores_gemma":[0.0029733127,0.0033117335,0.0021135279,0.011788472,0.0018164807,0.00013218394,0.0000036105282,2.1336174e-7,1.15625065e-8,0.00006177652,0.9775057,0.000293],"about_ca_topic_score_codex":0.000014598025,"about_ca_topic_score_gemma":0.00020359461,"teacher_disagreement_score":0.9832451,"about_ca_system_score_codex":0.00073167967,"about_ca_system_score_gemma":0.0010022932,"threshold_uncertainty_score":0.99985415},"labels":[],"label_agreement":null},{"id":"W2012946235","doi":"10.1038/nrclinonc.2010.166","title":"BRCA mutations in the management of breast cancer: the state of the art","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":161,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Olaparib; BRCA mutation; Genetic testing; Oncology; Ovarian cancer; Cancer; Internal medicine; Genetic counseling; Gynecology; Genetics; Gene","score_opus":0.06094619099305645,"score_gpt":0.4737882625077883,"score_spread":0.4128420715147319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012946235","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004916131,0.99203223,0.000011783263,0.0021758904,0.0014142923,0.0023804528,0.00024346265,0.0000020342466,0.0016906941],"genre_scores_gemma":[0.00011592513,0.99642926,0.000491956,0.0011903751,0.00038916673,0.0007315024,0.000092831106,0.000027387694,0.00053156994],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99495494,0.002103536,0.0020206645,0.00046349608,0.00023358862,0.00022378041],"domain_scores_gemma":[0.99594474,0.0005762664,0.0018629007,0.0014258951,0.00015522972,0.000034944056],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00364665,0.00029711126,0.001568591,0.000042003307,0.00006309152,0.0000074146114,0.0016841566,0.0010971702,0.000039110513],"category_scores_gemma":[0.0003170828,0.0001263655,0.0011233806,0.0005750093,0.00064431556,0.000002345165,0.0003303855,0.0023119824,0.000014265793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010516925,0.00014848303,0.000023273642,0.0022724376,0.00023518977,0.0000017046555,0.00002132293,0.0000043900027,0.0000027334984,0.0001491061,0.010925738,0.9862051],"study_design_scores_gemma":[0.00022837322,0.00008547718,0.00063178566,0.0021540106,0.0010120684,0.00004188087,0.000011756761,7.071148e-7,0.0000032160945,0.00011955185,0.99558634,0.00012486266],"about_ca_topic_score_codex":0.000008725877,"about_ca_topic_score_gemma":0.00054751907,"teacher_disagreement_score":0.9860802,"about_ca_system_score_codex":0.00008815742,"about_ca_system_score_gemma":0.0011304627,"threshold_uncertainty_score":0.99998975},"labels":[],"label_agreement":null},{"id":"W2013581577","doi":"10.1038/nrclinonc.2010.207","title":"Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Prostate cancer; Randomized controlled trial; Clinical trial; Oncology; Cancer; Brachytherapy; Internal medicine; Surgery","score_opus":0.06985595778117436,"score_gpt":0.5036500943469786,"score_spread":0.43379413656580423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013581577","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018034074,0.97911286,0.000040695988,0.0021746191,0.0034482665,0.014495918,0.0005660145,0.000056905817,0.000086704276],"genre_scores_gemma":[9.4384717e-7,0.9670861,0.01762924,0.0038437012,0.0022345034,0.0080776,0.00039822326,0.00015179063,0.00057790795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99371433,0.00076398265,0.0032319825,0.0014391837,0.00021788826,0.0006326294],"domain_scores_gemma":[0.99160904,0.003875278,0.0027619863,0.0008784854,0.00027145905,0.00060377724],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0025688217,0.0009031046,0.010098312,0.00012698601,0.00011404676,0.000024178738,0.00026390218,0.0037359414,0.0001024313],"category_scores_gemma":[0.0025360053,0.00052550156,0.0018715734,0.00026902359,0.0003466967,0.00005921056,0.00008575491,0.0049506146,0.000027526658],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003468642,0.0005613306,0.0002167408,0.013742921,0.0007703658,0.00006116334,0.000012475822,7.4905564e-8,2.2396827e-7,0.00011793622,0.008997415,0.97517246],"study_design_scores_gemma":[0.0059460877,0.005435336,0.00011709561,0.022350064,0.0067473296,0.00008536346,0.0000011616787,0.0000031636182,5.5087696e-7,0.00009068973,0.95876265,0.0004604924],"about_ca_topic_score_codex":0.000023351204,"about_ca_topic_score_gemma":0.00015036919,"teacher_disagreement_score":0.974712,"about_ca_system_score_codex":0.00063218403,"about_ca_system_score_gemma":0.002345503,"threshold_uncertainty_score":0.9997197},"labels":[],"label_agreement":null},{"id":"W2016004402","doi":"10.1038/nrclinonc.2012.3","title":"The potential of exploiting DNA-repair defects for optimizing lung cancer treatment","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; European Society for Medical Oncology; Institut National Du Cancer","keywords":"ERCC1; DNA repair; Medicine; Gemcitabine; Lung cancer; Synthetic lethality; DNA mismatch repair; Oncology; DNA damage; Cancer research; Chemotherapy; Cancer; Bioinformatics; DNA; Internal medicine; Nucleotide excision repair; Biology; Genetics","score_opus":0.09933348595744591,"score_gpt":0.47432545535902126,"score_spread":0.37499196940157536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016004402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000037550326,0.9918721,0.00030808416,0.000056714784,0.0032981413,0.0040711258,0.00007663924,0.000029457313,0.00025024288],"genre_scores_gemma":[0.000022869175,0.98484933,0.008050831,0.00023231897,0.0035450705,0.0023945612,0.00024813795,0.00010733722,0.0005495238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99400157,0.0017198729,0.002551446,0.00087963097,0.00017229105,0.0006751693],"domain_scores_gemma":[0.99488163,0.0012171812,0.002476929,0.001006742,0.00019376822,0.00022374462],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0038002592,0.0006581704,0.0038386006,0.00005122488,0.00017598359,0.000014259264,0.00064314675,0.003252993,0.000017762215],"category_scores_gemma":[0.0017778195,0.0003760334,0.0048932284,0.00013970314,0.00018096207,0.000005230451,0.00029868606,0.00091789104,0.000009155136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006068958,0.000219611,0.0000056094086,0.0053374344,0.0008853157,0.000003355769,0.0000036962997,8.662605e-7,0.00010417314,0.00013525851,0.002649782,0.9905942],"study_design_scores_gemma":[0.0006106402,0.0012457846,9.923558e-7,0.0025420212,0.0052172565,0.000029817973,0.000005538697,0.000012493599,0.00012623583,0.00001168876,0.98984826,0.0003492633],"about_ca_topic_score_codex":0.0000037162197,"about_ca_topic_score_gemma":0.000044142696,"teacher_disagreement_score":0.9902449,"about_ca_system_score_codex":0.00024789665,"about_ca_system_score_gemma":0.0010562139,"threshold_uncertainty_score":0.99986917},"labels":[],"label_agreement":null},{"id":"W2016370944","doi":"10.1038/ncponc1320","title":"Unintended pregnancy during radiotherapy for cancer","year":2009,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Radiation therapy; Pregnancy; Cancer; Unintended pregnancy; MEDLINE; Oncology; Obstetrics; Gynecology; Medical physics; Internal medicine; Family planning; Environmental health; Research methodology","score_opus":0.24699852706825695,"score_gpt":0.5984097964357625,"score_spread":0.35141126936750555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016370944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.4927397e-7,0.9868426,0.000030719824,0.0012966063,0.0030570345,0.007706298,0.00008831321,0.00007951525,0.00089819514],"genre_scores_gemma":[4.0891115e-7,0.98513097,0.0024606048,0.0025858744,0.0045180814,0.0013770174,0.00016314533,0.00012240936,0.003641468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939876,0.0006869743,0.0033527687,0.0011253936,0.00022150174,0.0006257323],"domain_scores_gemma":[0.9952881,0.0011147712,0.002030967,0.0009220609,0.00019897253,0.0004451408],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0012567183,0.0007789245,0.01148493,0.00019261432,0.000081493774,0.000014100759,0.00042809968,0.004650446,0.0003761885],"category_scores_gemma":[0.00162604,0.00048241555,0.0047015515,0.0004413005,0.00022165838,0.000043695105,0.000049353694,0.004629601,0.000038522703],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001457997,0.00032625365,0.000020270352,0.02646261,0.0005401087,0.00005182516,0.000007810297,1.7583837e-8,1.8897109e-7,0.00011253292,0.015968557,0.95636404],"study_design_scores_gemma":[0.002260038,0.0014836211,0.000085383,0.07237675,0.004145372,0.00012572198,8.615171e-7,8.499033e-7,1.53847e-7,0.000029834802,0.91907835,0.00041306173],"about_ca_topic_score_codex":0.000011044674,"about_ca_topic_score_gemma":0.00006842185,"teacher_disagreement_score":0.955951,"about_ca_system_score_codex":0.0011893881,"about_ca_system_score_gemma":0.0021621606,"threshold_uncertainty_score":0.9997628},"labels":[],"label_agreement":null},{"id":"W2018652183","doi":"10.1038/nrclinonc.2013.153","title":"The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma","year":2013,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Ipilimumab; Immunotherapy; Melanoma; Intensive care medicine; Clinical trial; Oncology; Cancer; Internal medicine; Cancer research","score_opus":0.1545630070054307,"score_gpt":0.5229324565085092,"score_spread":0.3683694495030785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018652183","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003841184,0.9722426,0.00002723118,0.0037180032,0.0025032733,0.020892818,0.00048949907,0.000016386031,0.00007178791],"genre_scores_gemma":[0.0000048824195,0.9862137,0.0015824004,0.0017688356,0.0009318324,0.0073723337,0.00009712556,0.00011485847,0.0019140377],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928637,0.0007795048,0.0048488737,0.0006569255,0.0003153735,0.0005356309],"domain_scores_gemma":[0.9734431,0.020070108,0.0047177863,0.0012236384,0.00045183147,0.00009351677],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0033529606,0.00077013177,0.0066468082,0.00005782386,0.00023295078,0.00001621339,0.000608732,0.0016945822,0.00013614354],"category_scores_gemma":[0.0003905714,0.000309343,0.011239315,0.00026213194,0.0008296306,0.000011429676,0.000022501816,0.0009539586,0.000006709123],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005447401,0.0011326752,0.0000042101483,0.0051143994,0.009964572,0.000002125833,0.000077016,1.5772164e-7,0.000029072904,0.00011704489,0.033142973,0.94496834],"study_design_scores_gemma":[0.0068297465,0.018013913,0.000012562871,0.005057579,0.004241005,0.000040334435,0.000036750756,0.000007490382,0.00002493169,0.000038523445,0.96543044,0.00026669662],"about_ca_topic_score_codex":0.00009475034,"about_ca_topic_score_gemma":0.00009370643,"teacher_disagreement_score":0.9447017,"about_ca_system_score_codex":0.0009923978,"about_ca_system_score_gemma":0.0023493238,"threshold_uncertainty_score":0.99993587},"labels":[],"label_agreement":null},{"id":"W2030665986","doi":"10.1038/nrclinonc.2011.19","title":"Can some patients avoid adjuvant chemotherapy for early-stage breast cancer?","year":2011,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Oncology; Breast cancer; Chemotherapy; Adjuvant; Internal medicine; Stage (stratigraphy); Adjuvant chemotherapy; Cancer","score_opus":0.08632046898964518,"score_gpt":0.4584442888768769,"score_spread":0.3721238198872317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030665986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043519907,0.9896751,0.000005346141,0.0005205045,0.0027207234,0.003895892,0.0028771048,0.000027142942,0.00023465122],"genre_scores_gemma":[0.00003176909,0.9874431,0.00053389656,0.0034515848,0.0036764378,0.002594652,0.001230474,0.00017459287,0.0008634811],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943086,0.0009072982,0.0022951735,0.0015720698,0.00016918541,0.0007476649],"domain_scores_gemma":[0.99577975,0.0003587479,0.0021497305,0.0010703311,0.00031958983,0.00032184293],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010602588,0.0010459478,0.0057189115,0.00008631269,0.00014253956,0.000015469584,0.0008616062,0.003857094,0.000095099924],"category_scores_gemma":[0.0005498273,0.00071891356,0.0026988725,0.00018232269,0.0003194324,0.0000069886187,0.00031015443,0.001550507,0.000058043286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020855186,0.0006413519,0.00097381667,0.0045126756,0.0010253977,0.0000031924537,0.000012049969,1.4953587e-8,1.6293919e-7,0.00006622763,0.021328485,0.97122806],"study_design_scores_gemma":[0.0023587262,0.000976819,0.0020866874,0.0030190372,0.0017401365,0.000014233128,0.0000015221423,6.410075e-8,0.000001265674,0.000033388278,0.98908615,0.00068197073],"about_ca_topic_score_codex":0.00007591277,"about_ca_topic_score_gemma":0.0003003243,"teacher_disagreement_score":0.9705461,"about_ca_system_score_codex":0.00034897155,"about_ca_system_score_gemma":0.0011580783,"threshold_uncertainty_score":0.9995262},"labels":[],"label_agreement":null},{"id":"W2047080566","doi":"10.1038/nrclinonc.2014.169","title":"Management of familial cancer: sequencing, surveillance and society","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Izaak Walton Killam Health Centre; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Context (archaeology); Cancer; Genetic counseling; Medicine; Personalized medicine; Genetic testing; Proband; DNA sequencing; Genetics; Computational biology; Bioinformatics; Biology; Mutation; Gene","score_opus":0.08380407246663417,"score_gpt":0.4848599894130483,"score_spread":0.4010559169464141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047080566","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017266308,0.9951906,0.00011284611,0.00008317157,0.001632588,0.0011895663,0.00008771944,0.000008824365,0.0016774238],"genre_scores_gemma":[0.000018502535,0.9906417,0.006092173,0.0007041632,0.0013540608,0.000333865,0.00021276993,0.000050862654,0.0005918791],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955216,0.0011056999,0.0019827422,0.0009420037,0.00015824905,0.00028968262],"domain_scores_gemma":[0.99706155,0.00027797252,0.0016128366,0.0007901189,0.00013588359,0.00012165802],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0029734042,0.00043752007,0.0034204957,0.00003198219,0.000048502436,0.00000723765,0.00051300426,0.0027574059,0.000025256919],"category_scores_gemma":[0.00032996797,0.0003328554,0.0013683917,0.00020583188,0.00038576443,0.0000019588072,0.00038386325,0.0012049159,0.000012846496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000876325,0.000037045782,0.00003139579,0.0153598515,0.0005414594,0.000002856443,0.000004337168,4.5000658e-7,0.0000021787298,0.000091844406,0.025951054,0.9579688],"study_design_scores_gemma":[0.00037377473,0.00029846554,0.00003966667,0.0034270808,0.0007831874,0.000018740126,0.000005179577,0.0000021450246,0.0000021225733,0.000017057999,0.9947293,0.00030327676],"about_ca_topic_score_codex":0.000006425935,"about_ca_topic_score_gemma":0.000041906686,"teacher_disagreement_score":0.96877825,"about_ca_system_score_codex":0.00026879067,"about_ca_system_score_gemma":0.0010658184,"threshold_uncertainty_score":0.9999123},"labels":[],"label_agreement":null},{"id":"W2047409231","doi":"10.1038/nrclinonc.2014.172","title":"Advances in biology and therapy","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Medical physics; Engineering ethics; Intensive care medicine; Engineering","score_opus":0.0960430805836337,"score_gpt":0.5209912276319424,"score_spread":0.4249481470483087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047409231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000074704853,0.99199986,0.000025962076,0.00008323949,0.00089361874,0.0015171552,0.000020405036,0.0000107327505,0.0054415544],"genre_scores_gemma":[0.0000088576235,0.9948232,0.00086039415,0.0017484236,0.0017377901,0.00035041414,0.00029589096,0.000047886217,0.00012709986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931166,0.003454416,0.0019077325,0.0010551582,0.00006530146,0.00040078175],"domain_scores_gemma":[0.9974439,0.00068792136,0.0010160238,0.0006317659,0.000047589503,0.000172803],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0038882531,0.0005278859,0.0042946544,0.00010347877,0.000037990412,0.000010046633,0.0005083543,0.004868428,0.000037308644],"category_scores_gemma":[0.0022736543,0.00034819933,0.00083033135,0.00018309748,0.0003145305,0.0000036406602,0.00023708648,0.0021893766,0.00007170749],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026859618,0.00009428357,0.00007025948,0.002405948,0.00003196896,0.000004100603,0.000001400389,6.7096955e-9,0.0000034502254,0.00038380505,0.0009867324,0.9959912],"study_design_scores_gemma":[0.0005872335,0.0014306082,0.0000060753214,0.002019791,0.0000843551,0.00004745559,5.586207e-7,2.2046073e-7,0.0000026326716,0.00030657247,0.99514806,0.0003664477],"about_ca_topic_score_codex":0.0000012621545,"about_ca_topic_score_gemma":0.000037295835,"teacher_disagreement_score":0.9956247,"about_ca_system_score_codex":0.000029458719,"about_ca_system_score_gemma":0.00036780673,"threshold_uncertainty_score":0.999897},"labels":[],"label_agreement":null},{"id":"W2051410494","doi":"10.1038/nrclinonc.2010.136","title":"Drug resistance in metastatic castration-resistant prostate cancer","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":340,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Vedecká Grantová Agentúra MŠVVaŠ SR a SAV","keywords":"Prostate cancer; Medicine; Docetaxel; Androgen receptor; Drug resistance; Cancer; Cabazitaxel; Oncology; Cancer research; Internal medicine; Enzalutamide; Tumor microenvironment; Metastasis; Androgen deprivation therapy; Biology","score_opus":0.1910857334701918,"score_gpt":0.5670317297040429,"score_spread":0.3759459962338511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051410494","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016158643,0.9833615,4.0100076e-7,0.0031322045,0.0016044802,0.007782455,0.00014570051,0.000040976676,0.003916133],"genre_scores_gemma":[0.000003281584,0.9727679,0.003030131,0.0008038546,0.00084107625,0.0026371677,0.000457091,0.00010248659,0.019357026],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.990773,0.0023765953,0.0041287676,0.0013311293,0.00055136485,0.0008391252],"domain_scores_gemma":[0.99397534,0.0024253735,0.0017199576,0.0010473208,0.0002919603,0.00054007536],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.005367069,0.0008126416,0.008795571,0.00038477912,0.000090345675,0.000034019005,0.00047986032,0.0022407155,0.0003774124],"category_scores_gemma":[0.0028260853,0.0004829644,0.0016984267,0.001168379,0.0004678117,0.000092811744,0.0001286598,0.010670192,0.00027373226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004437179,0.0006556089,0.00007187291,0.029252829,0.000272431,0.0010159918,0.000040322597,1.0828252e-8,8.4584315e-7,0.00019624531,0.018865936,0.9491842],"study_design_scores_gemma":[0.0023877653,0.00032135652,0.00009594218,0.031649545,0.0024347177,0.00004226901,0.0000053847384,3.3702398e-7,4.6334068e-7,0.00014406373,0.9625342,0.00038397784],"about_ca_topic_score_codex":0.00003950959,"about_ca_topic_score_gemma":0.0062356754,"teacher_disagreement_score":0.9488002,"about_ca_system_score_codex":0.0011203709,"about_ca_system_score_gemma":0.007597372,"threshold_uncertainty_score":0.9997622},"labels":[],"label_agreement":null},{"id":"W2058374643","doi":"10.1038/nrclinonc.2010.19","title":"Zoledronic acid for breast cancer therapy-induced bone loss","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Zoledronic acid; Medicine; Breast cancer; Oncology; Internal medicine; Cancer","score_opus":0.22815931231604225,"score_gpt":0.5823688584877984,"score_spread":0.35420954617175615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058374643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016092341,0.9783466,0.0000023668708,0.004334041,0.0053536594,0.01087556,0.0003498217,0.00007963437,0.0006422456],"genre_scores_gemma":[0.000013157352,0.9802802,0.0011678085,0.009214842,0.0037095402,0.0037772479,0.0004012515,0.00017041985,0.0012655093],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921463,0.0011290044,0.0041043907,0.0013268016,0.00030439926,0.0009891127],"domain_scores_gemma":[0.9928006,0.0019353663,0.0026316852,0.0012992506,0.00033163885,0.0010014477],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.003419469,0.0009915542,0.012512994,0.00018059388,0.0001370427,0.000013224151,0.00040791134,0.00932327,0.0005316483],"category_scores_gemma":[0.0014314918,0.000575197,0.0040307585,0.00044612942,0.00020579019,0.000053039592,0.00009089346,0.009231289,0.00054166804],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036345044,0.001191978,0.000087090724,0.016390296,0.0005137129,0.00008759398,0.0000033222252,4.1322828e-10,3.7763425e-7,0.000061701125,0.009184008,0.9721165],"study_design_scores_gemma":[0.0050329873,0.0019461247,0.00023279329,0.013665192,0.0045156917,0.0012165748,3.5717065e-7,2.9523093e-7,3.113617e-7,0.00003336041,0.97294056,0.00041577546],"about_ca_topic_score_codex":0.000023135426,"about_ca_topic_score_gemma":0.0002315408,"teacher_disagreement_score":0.97170067,"about_ca_system_score_codex":0.00068413053,"about_ca_system_score_gemma":0.006538418,"threshold_uncertainty_score":0.99966997},"labels":[],"label_agreement":null},{"id":"W2059075557","doi":"10.1038/nrclinonc.2014.200","title":"Current treatment landscape for relapsed and/or refractory multiple myeloma","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Pomalidomide; Medicine; Multiple myeloma; Carfilzomib; Refractory (planetary science); Lenalidomide; Bortezomib; Oncology; Internal medicine; Regimen; Ixazomib; Disease; Thalidomide; Clinical trial","score_opus":0.2542302185574246,"score_gpt":0.5603429840524028,"score_spread":0.3061127654949782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059075557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000080402,0.9860203,0.000030384621,0.00032896906,0.0016577216,0.011131211,0.00018804817,0.00007870339,0.0005565787],"genre_scores_gemma":[0.000008336415,0.98625004,0.004053332,0.00034117833,0.0028326104,0.003255548,0.0013741626,0.00013099592,0.0017537742],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.991831,0.0021544164,0.003282143,0.0015311693,0.00035219354,0.00084909337],"domain_scores_gemma":[0.9829309,0.012904932,0.0016249783,0.0012076756,0.00022366704,0.0011078394],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0028363545,0.0010426366,0.011277598,0.00029620115,0.0001471555,0.000025746565,0.00032701093,0.0034954925,0.00017857066],"category_scores_gemma":[0.014615855,0.00052388204,0.003068074,0.0003119757,0.00024641736,0.00005021519,0.00015818019,0.00311655,0.00041085688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011423407,0.0019461394,0.00031676513,0.030007979,0.0008418986,0.00012997932,0.0000068665154,2.6326854e-9,4.493798e-8,0.000030562267,0.017015599,0.94856185],"study_design_scores_gemma":[0.010370071,0.012918352,0.00020686454,0.017672349,0.0050765383,0.00021562111,0.0000017789416,0.000023249699,8.647896e-8,0.00000999577,0.9530908,0.00041432882],"about_ca_topic_score_codex":0.0000038166463,"about_ca_topic_score_gemma":0.000082885526,"teacher_disagreement_score":0.9481475,"about_ca_system_score_codex":0.0007192547,"about_ca_system_score_gemma":0.002097644,"threshold_uncertainty_score":0.9997213},"labels":[],"label_agreement":null},{"id":"W2061859480","doi":"10.1038/nrclinonc.2014.147","title":"Delirium in patients with cancer: assessment, impact, mechanisms and management","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bruyère","funders":"","keywords":"Delirium; Medicine; Intensive care medicine; Distress; Dementia; Neurocognitive; Sedation; Midazolam; Cancer; Palliative care; Intervention (counseling); Psychiatry; Disease; Internal medicine; Cognition; Nursing; Anesthesia; Clinical psychology","score_opus":0.06240061580795696,"score_gpt":0.5148131530139222,"score_spread":0.4524125372059652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061859480","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007194073,0.9861941,0.00013756484,0.00082580367,0.00086390995,0.006990337,0.00005362805,0.00002568169,0.0049018273],"genre_scores_gemma":[0.000008231864,0.96449924,0.0026861057,0.031023694,0.0002161753,0.00066070474,0.0005915771,0.00009703267,0.00021721897],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939206,0.0017841257,0.0023045198,0.0010764593,0.00036541666,0.00054888375],"domain_scores_gemma":[0.9931082,0.0012612295,0.0015660624,0.000641411,0.003061081,0.0003620128],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0022563091,0.0007928077,0.008166194,0.00042134215,0.00004008163,0.000014272412,0.00026048298,0.002277759,0.00015238907],"category_scores_gemma":[0.005003351,0.00046018136,0.0010622675,0.000555251,0.00023041316,0.000046714187,0.00021284778,0.004702004,0.000054779666],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001367944,0.00042887352,0.001816863,0.018058809,0.0006611803,0.00008748053,0.0000023930527,1.9012301e-8,3.3798295e-9,0.0003494738,0.018244859,0.96021324],"study_design_scores_gemma":[0.003700033,0.003201041,0.006144904,0.038262818,0.0050935764,0.00002217964,0.0000096492,0.0000012212944,4.3170014e-9,0.000034433593,0.943112,0.00041809463],"about_ca_topic_score_codex":0.000012442066,"about_ca_topic_score_gemma":0.000095089745,"teacher_disagreement_score":0.9597952,"about_ca_system_score_codex":0.0008380701,"about_ca_system_score_gemma":0.00085013016,"threshold_uncertainty_score":0.999785},"labels":[],"label_agreement":null},{"id":"W2075647502","doi":"10.1038/nrclinonc.2012.203","title":"Past, present, and future of radiotherapy for the benefit of patients","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":445,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Radiation therapy; Medicine; Timeline; Medical physics; Surgery","score_opus":0.07865278484667142,"score_gpt":0.48457258811811893,"score_spread":0.4059198032714475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075647502","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.797291e-7,0.99090916,0.003127534,0.0002085585,0.0008930348,0.004375524,0.0002553611,0.000011046381,0.00021920228],"genre_scores_gemma":[0.0000010319767,0.96852255,0.02151641,0.00012728969,0.009033551,0.0005329285,0.0001088826,0.00006234735,0.00009499703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963455,0.0005585725,0.0022572598,0.00041087632,0.00013989776,0.00028790245],"domain_scores_gemma":[0.9920129,0.0037668191,0.0032486196,0.0006998071,0.0001703193,0.00010150381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015251297,0.0004435922,0.004746541,0.000062451145,0.000048466663,0.000004582729,0.00058710505,0.0012088085,0.00013263151],"category_scores_gemma":[0.00003138361,0.00023154863,0.0016153557,0.00019441907,0.00028214484,0.000059682334,0.000082206774,0.0014320709,6.1662524e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028066592,0.00034944224,0.00060160697,0.0036084848,0.0005095551,4.312339e-8,0.000012207338,2.5625418e-8,4.9875105e-8,0.0030341314,0.0053509837,0.9865054],"study_design_scores_gemma":[0.00053738616,0.0005062845,0.000083818544,0.0010403888,0.0012072315,6.3566773e-7,0.0000016236373,0.0000010886955,3.5167258e-7,0.00027088486,0.9961558,0.00019452003],"about_ca_topic_score_codex":0.000002430749,"about_ca_topic_score_gemma":4.380327e-7,"teacher_disagreement_score":0.9908048,"about_ca_system_score_codex":0.000048264323,"about_ca_system_score_gemma":0.0001226967,"threshold_uncertainty_score":0.94422793},"labels":[],"label_agreement":null},{"id":"W2076764562","doi":"10.1038/nrclinonc.2013.101","title":"Biopsies: next-generation biospecimens for tailoring therapy","year":2013,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé","keywords":"Biobank; Medicine; Procurement; Medical physics; Biorepository; Data science; Disease; Computer science; Bioinformatics; Pathology; Biology; Business","score_opus":0.33398476079712514,"score_gpt":0.5006813748694565,"score_spread":0.16669661407233138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076764562","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021573791,0.9906503,0.0001538322,0.00019312953,0.0041779736,0.0041339016,0.00013264437,0.000014307911,0.0005223126],"genre_scores_gemma":[0.000002410491,0.9770023,0.0054475986,0.0022243834,0.011127134,0.0015652176,0.0018337393,0.00010519228,0.000692012],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955296,0.0005583217,0.0022276463,0.0011105622,0.000111821784,0.00046204697],"domain_scores_gemma":[0.9964231,0.0007727652,0.0014083778,0.00093539257,0.00023053387,0.00022978017],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017678172,0.00063051446,0.0033436087,0.00008378975,0.00010770143,0.0000691292,0.0006122144,0.0039892653,0.00008089348],"category_scores_gemma":[0.0026938538,0.00045467704,0.002048932,0.00017375321,0.00014816594,0.0000060056786,0.00019634028,0.0011446904,0.00016776472],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016273863,0.00013932622,0.0000019208362,0.0011557903,0.00019995218,0.0000014810627,0.0000018204972,2.0475753e-7,0.00013205646,0.00016791126,0.105112605,0.89307064],"study_design_scores_gemma":[0.00062944845,0.0014860678,9.008082e-7,0.00076805765,0.00043264826,0.000015655703,0.0000017769937,0.0000048178244,0.000032047083,0.000029854842,0.99610114,0.0004975895],"about_ca_topic_score_codex":0.0000037922248,"about_ca_topic_score_gemma":0.00003095823,"teacher_disagreement_score":0.89257306,"about_ca_system_score_codex":0.00013581838,"about_ca_system_score_gemma":0.0009475733,"threshold_uncertainty_score":0.9997905},"labels":[],"label_agreement":null},{"id":"W2078922516","doi":"10.1038/nrclinonc.2011.110","title":"Hormone replacement therapy and the risk of breast cancer","year":2011,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Menopause; Hormone replacement therapy (female-to-male); Estrogen; Climacteric; Oncology; Internal medicine; Cancer; Gynecology; Risk factors for breast cancer; Hormone; Hormone therapy; Obstetrics; Testosterone (patch)","score_opus":0.06146250601322517,"score_gpt":0.4354960011655808,"score_spread":0.3740334951523556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078922516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000119005264,0.9959701,0.0000034193963,0.00012709094,0.00063508586,0.0022502483,0.00008282084,0.0000064676724,0.00080580753],"genre_scores_gemma":[0.000020572159,0.9977117,0.000210874,0.00048685443,0.0008068301,0.00034732843,0.00007676755,0.000046963483,0.00029211128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929608,0.0041378452,0.0018165655,0.0006978919,0.00011048132,0.00027638205],"domain_scores_gemma":[0.99595314,0.0006298699,0.0022989751,0.0008673023,0.00010542488,0.00014529556],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0048518367,0.00048657556,0.0036968063,0.000042230695,0.000071799026,0.0000066594453,0.0005030767,0.0035314525,0.00003381837],"category_scores_gemma":[0.0007230412,0.00022034453,0.0016720203,0.00016239,0.00074295024,0.0000020804523,0.0002592473,0.0025605022,0.000018465189],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008693406,0.00016570363,0.000036906215,0.000936438,0.0011841024,0.000002133555,0.0000071154573,1.6875777e-8,0.0000030219426,0.00016027143,0.009796814,0.98683816],"study_design_scores_gemma":[0.002513156,0.001174818,0.000089743655,0.0013136824,0.0020682705,0.00010671369,0.0000012959139,4.2826912e-7,0.000002283256,0.00002704888,0.992467,0.00023555705],"about_ca_topic_score_codex":0.000024318813,"about_ca_topic_score_gemma":0.0000083872155,"teacher_disagreement_score":0.9866026,"about_ca_system_score_codex":0.000027831924,"about_ca_system_score_gemma":0.00045986616,"threshold_uncertainty_score":0.99974066},"labels":[],"label_agreement":null},{"id":"W2088071966","doi":"10.1038/nrclinonc.2010.39","title":"Tumor size and survival in breast cancer—a reappraisal","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":128,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; McGill University","funders":"","keywords":"Breast cancer; Medicine; Cancer; Oncology; Lymph node; CA15-3; Internal medicine; Pathology","score_opus":0.06137663211828988,"score_gpt":0.48711788209049506,"score_spread":0.4257412499722052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088071966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006010034,0.99343437,6.344813e-7,0.0009320157,0.0027725515,0.0011708161,0.0003031428,0.000014897654,0.0013114463],"genre_scores_gemma":[0.000032897227,0.9941869,0.000506758,0.0012110228,0.0030535057,0.0006496752,0.00015870055,0.000080142345,0.0001203934],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943648,0.0015727122,0.0020082218,0.0013679708,0.00016269104,0.00052357855],"domain_scores_gemma":[0.9962826,0.0014296956,0.0011721349,0.0007637093,0.000105095445,0.0002467895],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0021071094,0.0007722665,0.005336259,0.000069933165,0.000063783,0.00001630253,0.00050491357,0.0036563068,0.00006132846],"category_scores_gemma":[0.0025057734,0.0005364189,0.00097182917,0.0002708061,0.00046441657,0.000004557805,0.00049117184,0.0035254154,0.000035273217],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008235031,0.0002662396,0.00150674,0.0023920038,0.00021254977,0.000044523393,0.0000032092073,8.349309e-9,0.0000018722612,0.000060348928,0.0031691156,0.99226105],"study_design_scores_gemma":[0.0010158024,0.00019235049,0.005960254,0.0031011577,0.00086253876,0.0003261663,0.0000022887843,6.1165984e-8,2.4180582e-7,0.000009141071,0.9880559,0.00047412261],"about_ca_topic_score_codex":0.00007175858,"about_ca_topic_score_gemma":0.0017039466,"teacher_disagreement_score":0.9917869,"about_ca_system_score_codex":0.00008330658,"about_ca_system_score_gemma":0.0011307173,"threshold_uncertainty_score":0.9997087},"labels":[],"label_agreement":null},{"id":"W2091749101","doi":"10.1038/nrclinonc.2014.70","title":"Managing bone metastases and reducing skeletal related events in prostate cancer","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Denosumab; Prostate cancer; Cabozantinib; Enzalutamide; Zoledronic acid; Oncology; Internal medicine; Androgen deprivation therapy; Bisphosphonate; Osteoclast; Cancer; Bone mineral; Osteoporosis; Androgen receptor","score_opus":0.1038734455543476,"score_gpt":0.53018600332383,"score_spread":0.4263125577694824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091749101","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000080821315,0.9909078,4.8423374e-7,0.001817427,0.0013151972,0.0050456394,0.000028201248,0.000040212213,0.00076422794],"genre_scores_gemma":[0.00004435549,0.9947098,0.000892959,0.0016761008,0.00027777647,0.0006978884,0.00030894854,0.0000829567,0.0013092483],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907951,0.0028330097,0.004310412,0.0011553022,0.00024043309,0.00066578615],"domain_scores_gemma":[0.99508005,0.001561565,0.0021085213,0.00060937717,0.00007251953,0.00056794233],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.005364747,0.0006713268,0.010179685,0.00033292646,0.000068824396,0.000005747786,0.0001436602,0.0021704321,0.00007946296],"category_scores_gemma":[0.0027279435,0.0004301784,0.0010616772,0.0006124491,0.00015495205,0.000058924124,0.00014667117,0.00539685,0.00014316813],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062972154,0.00038732434,0.0006426022,0.036419846,0.0003187208,0.00037175996,0.000010207719,3.2991817e-8,1.1268214e-8,0.000034654888,0.0013799911,0.96037185],"study_design_scores_gemma":[0.0026316338,0.00079416105,0.00051081134,0.057885226,0.0042593507,0.0005173296,0.0000013127946,0.0000034060802,1.2476395e-8,0.00008871347,0.93303263,0.00027539016],"about_ca_topic_score_codex":0.000112269896,"about_ca_topic_score_gemma":0.00016211969,"teacher_disagreement_score":0.9600965,"about_ca_system_score_codex":0.000536026,"about_ca_system_score_gemma":0.0012488835,"threshold_uncertainty_score":0.999815},"labels":[],"label_agreement":null},{"id":"W2096210342","doi":"10.1038/nrclinonc.2012.194","title":"Image-guided radiotherapy: from current concept to future perspectives","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":499,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation","keywords":"Radiation therapy; Medicine; Medical physics; Context (archaeology); Radiation oncology; Image-guided radiation therapy; Precision medicine; Personalized medicine; Radiology; Bioinformatics; Pathology","score_opus":0.10728901813918192,"score_gpt":0.5314880463345762,"score_spread":0.42419902819539435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096210342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.7800089e-7,0.9531285,0.035747103,0.00042298014,0.0047449656,0.0041908184,0.00033480846,0.00016550488,0.001265137],"genre_scores_gemma":[1.8874968e-7,0.8271695,0.14108878,0.0006895779,0.029595487,0.00077577063,0.0003485793,0.00017406451,0.00015809647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9909822,0.0031142181,0.0032164308,0.0015555198,0.0003038145,0.00082784175],"domain_scores_gemma":[0.9933908,0.0018069766,0.002398928,0.0015268257,0.00022086487,0.00065561105],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0015117691,0.0012698342,0.009026353,0.0001834689,0.00011790828,0.000059471506,0.0013946656,0.0022617523,0.0033197675],"category_scores_gemma":[0.00019315381,0.0008768604,0.0034771797,0.0005991204,0.00032547786,0.0002516272,0.00021510804,0.0070952983,0.00025965716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012269786,0.0005353795,0.000018217137,0.00075756834,0.00049309916,0.0000030205676,0.00017278612,2.6641812e-8,6.0396127e-7,0.0023760805,0.06599043,0.92964053],"study_design_scores_gemma":[0.0004714644,0.0002713298,0.0000062325034,0.0032917345,0.0012561902,0.0000055621435,0.000040289993,6.350574e-7,2.661878e-7,0.00027137232,0.99350107,0.00088386907],"about_ca_topic_score_codex":0.000014071287,"about_ca_topic_score_gemma":0.0000027238386,"teacher_disagreement_score":0.92875665,"about_ca_system_score_codex":0.0007128418,"about_ca_system_score_gemma":0.00089441374,"threshold_uncertainty_score":0.9993682},"labels":[],"label_agreement":null},{"id":"W2112474929","doi":"10.1038/nrclinonc.2009.236","title":"Advanced pancreatic carcinoma: current treatment and future challenges","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":791,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Vedecká Grantová Agentúra MŠVVaŠ SR a SAV","keywords":"Medicine; Pancreatic carcinoma; Current (fluid); Oncology; Carcinoma; Internal medicine; General surgery; Medical physics; Intensive care medicine; Pancreatic cancer; Cancer","score_opus":0.2586644263938099,"score_gpt":0.5656768351710881,"score_spread":0.30701240877727826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112474929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000064087726,0.9796567,0.0000010590727,0.0027330185,0.00291279,0.006207335,0.000034808578,0.00006244493,0.008327769],"genre_scores_gemma":[0.0000026149855,0.9868899,0.0025722566,0.00038410732,0.0074949623,0.0014075774,0.0002207866,0.00009825155,0.0009295216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99134916,0.002764258,0.003189168,0.0015479155,0.00032414641,0.00082534],"domain_scores_gemma":[0.9912366,0.0045874813,0.0014876715,0.0014460606,0.00021730059,0.001024843],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0033567543,0.001090981,0.016060617,0.00028043723,0.00013437594,0.000014265757,0.0003839578,0.0066801794,0.0002384555],"category_scores_gemma":[0.0025671115,0.00061076146,0.002096934,0.00032503478,0.00063904683,0.00005349973,0.00020776049,0.009004716,0.00039104288],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011920932,0.0011515234,0.00039432803,0.022732401,0.00041835403,0.00018437469,0.000032665404,2.3676716e-10,6.2952346e-8,0.00057058036,0.0013671645,0.9730293],"study_design_scores_gemma":[0.002794104,0.005072096,0.00085579243,0.008531133,0.011885828,0.00087822776,0.000015272333,0.0000010585494,2.4479688e-8,0.00005768947,0.96946806,0.00044070487],"about_ca_topic_score_codex":0.000003475189,"about_ca_topic_score_gemma":0.00005136085,"teacher_disagreement_score":0.97258866,"about_ca_system_score_codex":0.0006607245,"about_ca_system_score_gemma":0.003411668,"threshold_uncertainty_score":0.9996344},"labels":[],"label_agreement":null},{"id":"W2128625986","doi":"10.1038/nrclinonc.2012.196","title":"Predicting outcomes in radiation oncology—multifactorial decision support systems","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":395,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Interreg; National Cancer Institute; KWF Kankerbestrijding; Center for Translational Molecular Medicine; European Commission","keywords":"Medicine; Radiation oncology; Predictive modelling; Outcome (game theory); Decision support system; Medical physics; Clinical decision support system; Clinical Oncology; Population; Precision medicine; Oncology; Radiation therapy; Intensive care medicine; Internal medicine; Data mining; Pathology; Computer science; Machine learning; Cancer","score_opus":0.1317209994531531,"score_gpt":0.5501465579063007,"score_spread":0.41842555845314766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128625986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033229164,0.9651482,0.00010582439,0.0005049234,0.02710715,0.004314504,0.000020272018,0.0000951619,0.0026707212],"genre_scores_gemma":[0.00004411971,0.98358613,0.0038821273,0.0012490007,0.009877093,0.00034502987,0.00047544306,0.00012671844,0.00041432554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98608404,0.004223312,0.006921728,0.0011620797,0.0006830237,0.0009257977],"domain_scores_gemma":[0.9806278,0.013625143,0.0037148613,0.00097554584,0.0001512276,0.0009054305],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.018430943,0.00086888386,0.013412498,0.000551164,0.000090321395,0.000035124318,0.00059766206,0.007532115,0.00021176579],"category_scores_gemma":[0.0350837,0.00054889603,0.002320226,0.00061668555,0.00022901203,0.00014188579,0.0002552753,0.014275424,0.0005720609],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007664805,0.0008324715,0.013302328,0.007846587,0.00024549698,0.0002133069,0.00002588396,4.885273e-7,5.9309922e-8,0.00006365402,0.00618862,0.97120446],"study_design_scores_gemma":[0.0030838943,0.0010595362,0.0009970727,0.012324572,0.0034949335,0.0004349205,0.000005900073,0.00014464058,7.1397985e-9,0.0000073146757,0.9780357,0.00041152953],"about_ca_topic_score_codex":0.000038858878,"about_ca_topic_score_gemma":0.000020614127,"teacher_disagreement_score":0.97184706,"about_ca_system_score_codex":0.0018909308,"about_ca_system_score_gemma":0.0024933466,"threshold_uncertainty_score":0.99969625},"labels":[],"label_agreement":null},{"id":"W2142138307","doi":"10.1038/nrclinonc.2014.96","title":"The oligometastatic state—separating truth from wishful thinking","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":280,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Ontario Institute for Cancer Research","keywords":"Medicine; Radiosurgery; Ablative case; Radiation therapy; Wishful thinking; Disease; Oncology; Intensive care medicine; Internal medicine","score_opus":0.16479687837889093,"score_gpt":0.5457368453934333,"score_spread":0.38093996701454236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142138307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000030583512,0.98134696,0.0003132525,0.0011412547,0.0039323564,0.005298966,0.00007234575,0.0001162885,0.007775526],"genre_scores_gemma":[0.0000021235576,0.975854,0.012069096,0.007050818,0.0019209358,0.00052394776,0.00063420384,0.00015454626,0.0017903637],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98066336,0.008589421,0.0072360244,0.0015667261,0.0010356843,0.00090877205],"domain_scores_gemma":[0.95805097,0.032396212,0.005905213,0.0026111486,0.0002424672,0.0007939804],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.018246753,0.0011231682,0.012681568,0.00021049396,0.00031623375,0.00013299321,0.001375259,0.0018009064,0.00040088984],"category_scores_gemma":[0.039446644,0.00059155526,0.003924264,0.0007161344,0.0004940232,0.00008390012,0.0005403969,0.0075149173,0.0018699425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007427062,0.0003314695,0.0000096910735,0.016438216,0.0012494292,0.00018532675,0.000022115895,5.913405e-8,7.2475794e-9,0.0010050482,0.03495816,0.9457262],"study_design_scores_gemma":[0.0013759151,0.0006727942,0.000034884564,0.020510884,0.014479025,0.00003565736,0.0000155635,0.000023742166,1.1919382e-8,0.0020857817,0.9602801,0.0004856483],"about_ca_topic_score_codex":0.000008274618,"about_ca_topic_score_gemma":0.00002521931,"teacher_disagreement_score":0.94524056,"about_ca_system_score_codex":0.0003611445,"about_ca_system_score_gemma":0.0014660404,"threshold_uncertainty_score":0.9996536},"labels":[],"label_agreement":null},{"id":"W2143852804","doi":"10.1038/nrclinonc.2011.21","title":"Antiangiogenic therapy: impact on invasion, disease progression, and metastasis","year":2011,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":676,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Antiangiogenic therapy; Oncology; Disease; Clinical trial; Internal medicine; Adjuvant therapy; Adjuvant; Drug; Angiogenesis; Cancer; Pharmacology","score_opus":0.16187340228044506,"score_gpt":0.5144781344395424,"score_spread":0.3526047321590973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143852804","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006510461,0.99649245,0.000007924819,0.000089324276,0.0007864613,0.0019156893,0.00013627633,0.00001670822,0.0004900631],"genre_scores_gemma":[0.000062599305,0.9944017,0.00046831064,0.002058339,0.0017280038,0.00039133147,0.00054193387,0.00010836743,0.00023942758],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99405694,0.0021404754,0.0017797423,0.0013703476,0.00017365509,0.0004788679],"domain_scores_gemma":[0.99636626,0.0003100659,0.0013822849,0.0011869177,0.00013108627,0.0006233994],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0023556813,0.00085467653,0.0038081277,0.00011946243,0.00010692145,0.000022938608,0.0006227661,0.0028869582,0.00020779711],"category_scores_gemma":[0.0010720261,0.00046121542,0.0037523317,0.00026264047,0.00030511295,0.0000050299304,0.0003112677,0.0012031479,0.00012165078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022266501,0.00037061,0.00016229616,0.0012955407,0.0006596995,0.00002041769,0.0000018287046,1.723221e-8,0.0000014863637,0.00005301352,0.043028496,0.95418394],"study_design_scores_gemma":[0.0004515094,0.0020089417,0.00025509187,0.0030628196,0.0013592667,0.000037018715,5.474778e-7,1.204339e-7,0.000003427978,0.000026243577,0.99228555,0.0005094662],"about_ca_topic_score_codex":0.0000026504154,"about_ca_topic_score_gemma":0.0000046328523,"teacher_disagreement_score":0.95367444,"about_ca_system_score_codex":0.000062707506,"about_ca_system_score_gemma":0.0011631036,"threshold_uncertainty_score":0.99978393},"labels":[],"label_agreement":null},{"id":"W2165952695","doi":"10.1038/nrclinonc.2014.73","title":"Management of low risk prostate cancer—active surveillance and focal therapy","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"National Institutes of Health; Prostate Cancer UK; University College London Hospitals NHS Foundation Trust; National Institute for Health and Care Research","keywords":"Medicine; Prostate cancer; Disease; Radiation therapy; Cancer; Prostate; Internal medicine; Oncology; Biopsy; Risk assessment; Intensive care medicine; Gynecology","score_opus":0.08557453831440603,"score_gpt":0.504704247737107,"score_spread":0.41912970942270095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165952695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052053023,0.99069065,0.000004255599,0.00047195464,0.0010317077,0.006505988,0.00026193995,0.000028336053,0.0009531083],"genre_scores_gemma":[0.000037267197,0.99566185,0.00078288116,0.0007096156,0.0005487274,0.0017740657,0.00017265302,0.00006800137,0.00024495847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99357504,0.0018052927,0.0028903594,0.0010549267,0.0002662223,0.00040814467],"domain_scores_gemma":[0.9932084,0.0023154942,0.0032083637,0.0007670528,0.00018197569,0.00031867804],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0029095379,0.00066474994,0.0090549635,0.000098727985,0.000051066418,0.000008470235,0.0002252414,0.00161604,0.00007210942],"category_scores_gemma":[0.0005208192,0.00038522333,0.0014478163,0.0003378573,0.00034611535,0.000029348834,0.00014398385,0.0023940885,0.000034778757],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025157907,0.00070986984,0.0014308277,0.035098486,0.0018183489,0.00009648642,0.000012020096,3.9604426e-8,7.858636e-9,0.0000846151,0.003148795,0.95734894],"study_design_scores_gemma":[0.0027446589,0.0027850028,0.0025479528,0.035821583,0.0026473894,0.00002769827,0.0000027231965,9.800717e-7,4.3880883e-7,0.000044416847,0.9530926,0.000284584],"about_ca_topic_score_codex":0.000022275002,"about_ca_topic_score_gemma":0.00003573524,"teacher_disagreement_score":0.95706433,"about_ca_system_score_codex":0.0004284642,"about_ca_system_score_gemma":0.00057819166,"threshold_uncertainty_score":0.99990743},"labels":[],"label_agreement":null},{"id":"W2173653020","doi":"10.1038/nrclinonc.2015.203","title":"The importance of overdiagnosis in breast-cancer screening","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Overdiagnosis; Medicine; Breast cancer; Mammography; Breast cancer screening; Cancer; Population; Mammography screening; Gynecology; Oncology; Medical physics; Intensive care medicine; Internal medicine; Environmental health","score_opus":0.3845793694743051,"score_gpt":0.5979906439529697,"score_spread":0.21341127447866465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173653020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000070287383,0.9910957,0.0000033659874,0.0028323247,0.0011170001,0.0022417514,0.00006214055,0.000018477143,0.0026221962],"genre_scores_gemma":[0.0000070440537,0.99321604,0.0010382045,0.0035376705,0.0014832118,0.00047168977,0.0000405228,0.000047891714,0.0001577111],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917303,0.0016971047,0.004611008,0.0007889429,0.0006040742,0.000568592],"domain_scores_gemma":[0.99126977,0.0037809827,0.0031503397,0.0010179032,0.00041747128,0.00036354756],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.010990023,0.0005389495,0.008501107,0.00013215987,0.00005736633,0.000012422036,0.00073125167,0.0028967962,0.00012471089],"category_scores_gemma":[0.005051221,0.00028744197,0.0021163563,0.0010922116,0.00037974544,0.000079757214,0.00026794864,0.005466926,0.00005161452],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013304186,0.000118274715,0.012807253,0.0042936285,0.0001800577,0.000095889634,0.0000042705396,1.1916314e-7,7.713905e-9,0.00012554027,0.056389317,0.9258526],"study_design_scores_gemma":[0.00076294836,0.00036784261,0.0023593996,0.04328709,0.0018178427,0.00022477205,0.0000092494265,0.0000021368564,1.4621527e-8,0.000053115953,0.9508828,0.00023278182],"about_ca_topic_score_codex":0.00004660574,"about_ca_topic_score_gemma":0.00032546118,"teacher_disagreement_score":0.92561984,"about_ca_system_score_codex":0.0006500669,"about_ca_system_score_gemma":0.0029129146,"threshold_uncertainty_score":0.9999578},"labels":[],"label_agreement":null},{"id":"W2204191358","doi":"10.1038/nrclinonc.2015.173","title":"Population genetic testing for cancer susceptibility: founder mutations to genomes","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill University","funders":"National Human Genome Research Institute; National Institutes of Health; National Society of Genetic Counselors","keywords":"Genetic testing; Population; Medicine; Cancer; Genetics; Genetic predisposition; Mutation; Exome; Genetic counseling; Disease; Exome sequencing; Bioinformatics; Biology; Gene; Environmental health; Internal medicine","score_opus":0.2628726937656278,"score_gpt":0.5534412217413754,"score_spread":0.29056852797574767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2204191358","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003783181,0.990164,0.00077181956,0.000319634,0.00280375,0.005313609,0.00024833973,0.000027660752,0.00031336708],"genre_scores_gemma":[0.000016360973,0.9257054,0.06281682,0.0016384361,0.0042339913,0.0034052762,0.0014362421,0.00012125298,0.0006262267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940487,0.0012004675,0.0026060618,0.0014348015,0.00021413929,0.0004958043],"domain_scores_gemma":[0.99549955,0.00096215383,0.0013635515,0.0010319205,0.0007925879,0.0003502069],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0030529317,0.00058914867,0.0032281582,0.00014843061,0.00013530963,0.00003478931,0.00064332323,0.0029839773,0.0000420605],"category_scores_gemma":[0.00832569,0.00048239532,0.0011245658,0.00058924226,0.00013362445,0.0000055458345,0.0002596892,0.0010618703,0.00008625389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017729802,0.00009547777,0.00024676413,0.0027965056,0.00019781447,0.0000014476078,0.000008444544,0.000025753252,0.00000426866,0.00001798055,0.02103323,0.9755546],"study_design_scores_gemma":[0.00037873333,0.00092680746,0.00013748767,0.0012143208,0.0014589055,0.000025751417,0.0000051067273,0.000007852864,5.286842e-7,0.00025601516,0.99507654,0.00051195716],"about_ca_topic_score_codex":0.000020935013,"about_ca_topic_score_gemma":0.00080190244,"teacher_disagreement_score":0.97504264,"about_ca_system_score_codex":0.0009846853,"about_ca_system_score_gemma":0.0037404527,"threshold_uncertainty_score":0.9997628},"labels":[],"label_agreement":null},{"id":"W2268138802","doi":"10.1038/nrclinonc.2015.236","title":"Academic research sheds light on issues that matter to patients","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Breast cancer; Adjuvant; Oncology; Adjuvant chemotherapy; Disease; Stage (stratigraphy); Clinical trial; Intensive care medicine; Internal medicine; Cancer","score_opus":0.34109635688056944,"score_gpt":0.6409072574456448,"score_spread":0.29981090056507537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2268138802","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004345879,0.96356773,0.0000054637385,0.017810242,0.0029641811,0.0064479304,0.000051862142,0.00006678044,0.009081445],"genre_scores_gemma":[0.0000016351116,0.96304727,0.0009875519,0.019619687,0.0058391457,0.0011223292,0.00009040044,0.00020308465,0.0090888785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9877718,0.0047167707,0.0033896985,0.001829904,0.0011250069,0.001166795],"domain_scores_gemma":[0.9899773,0.0053522736,0.0013292471,0.0019151438,0.0005254794,0.000900552],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.007272292,0.00094407535,0.009605443,0.00064920617,0.00011243537,0.000015496556,0.0011954486,0.0068376716,0.0025094158],"category_scores_gemma":[0.0068620606,0.0004953885,0.0018877763,0.0008924757,0.00037799607,0.00009618589,0.0005401394,0.014560132,0.03022259],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028337757,0.00032949992,0.00036101034,0.006689002,0.00018865983,0.000037048554,0.000016472728,1.6309795e-9,1.5577122e-7,0.00009704879,0.13431317,0.85768455],"study_design_scores_gemma":[0.0011771967,0.0022450394,0.00037584017,0.074613556,0.0005589182,0.000044745248,0.0000016648546,6.792653e-9,7.4311123e-7,0.00015879086,0.9203862,0.00043727693],"about_ca_topic_score_codex":0.0000020403131,"about_ca_topic_score_gemma":0.0000038650055,"teacher_disagreement_score":0.8572473,"about_ca_system_score_codex":0.0015408475,"about_ca_system_score_gemma":0.0009692609,"threshold_uncertainty_score":0.9997498},"labels":[],"label_agreement":null},{"id":"W2269087069","doi":"10.1038/nrclinonc.2015.224","title":"Can advanced-stage ovarian cancer be cured?","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":401,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.19827072950754132,"score_gpt":0.5608637098340041,"score_spread":0.3625929803264628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269087069","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.1885174e-7,0.95643604,0.0000047518297,0.020582546,0.00565914,0.0054393047,0.0007713271,0.000092696384,0.011013976],"genre_scores_gemma":[0.0000014622476,0.9689215,0.0016812435,0.011894155,0.004910096,0.0029605173,0.00034956535,0.0001767283,0.009104728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99097705,0.0016774194,0.004110759,0.0018837086,0.0004627078,0.00088833034],"domain_scores_gemma":[0.9914303,0.0027574487,0.0028132505,0.001815211,0.00024200155,0.0009417787],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0024192545,0.001193196,0.012949674,0.00022126925,0.00010537106,0.000021679758,0.00058725505,0.005223753,0.003726963],"category_scores_gemma":[0.0023463673,0.0006425045,0.0041169673,0.0005940022,0.00031748923,0.000065848944,0.00022951172,0.0048801904,0.0006296742],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005879872,0.0007629114,0.000082886196,0.012972096,0.0010958563,0.00045100483,0.000005476938,1.2346756e-8,2.975733e-8,0.0016911711,0.063371435,0.91950834],"study_design_scores_gemma":[0.0029746278,0.0013103695,0.00006963136,0.057263747,0.006838508,0.000113970935,0.0000014170906,1.1222642e-7,1.4879964e-7,0.000040895335,0.93081594,0.00057064823],"about_ca_topic_score_codex":0.000045243796,"about_ca_topic_score_gemma":0.00033196076,"teacher_disagreement_score":0.9189377,"about_ca_system_score_codex":0.0022348326,"about_ca_system_score_gemma":0.0070688887,"threshold_uncertainty_score":0.9996026},"labels":[],"label_agreement":null},{"id":"W2396078839","doi":"10.1038/nrclinonc.2016.64","title":"Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pharmacokinetics; Chemotherapy; Oncology; Clinical trial; Pharmacology; Drug; Colorectal cancer; Intensive care medicine; Cancer; Internal medicine","score_opus":0.1640822111862569,"score_gpt":0.5620383089072559,"score_spread":0.39795609772099905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396078839","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019222205,0.98450696,0.000011496786,0.0009875871,0.0037914705,0.0041882163,0.00012414917,0.00006121908,0.006309667],"genre_scores_gemma":[0.000008555236,0.98706335,0.001220044,0.002578655,0.006028188,0.0003293157,0.00016625183,0.00012245162,0.002483188],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919489,0.0020644427,0.004153437,0.0010146138,0.0002462659,0.0005723362],"domain_scores_gemma":[0.9921026,0.0034073608,0.0030807056,0.00077241653,0.00021353757,0.00042333064],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0013993497,0.00084761664,0.012429378,0.0003528265,0.00003905435,0.00000570754,0.0005286415,0.0037387954,0.004080292],"category_scores_gemma":[0.001254841,0.00049804663,0.0040073763,0.0006028771,0.00044297604,0.000034748504,0.0001422903,0.0035949189,0.000548794],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047250098,0.0014567949,0.000018398507,0.008207973,0.001941173,0.00007152089,0.000005269679,3.3711924e-9,0.000015648522,0.00004606629,0.054106094,0.93365854],"study_design_scores_gemma":[0.0061595584,0.0035148496,0.000049654627,0.009927162,0.011613965,0.0001705327,5.223297e-7,5.253166e-7,0.00000910167,0.000027826014,0.96815485,0.0003714332],"about_ca_topic_score_codex":0.0000060766665,"about_ca_topic_score_gemma":0.000010723115,"teacher_disagreement_score":0.93328714,"about_ca_system_score_codex":0.0008961517,"about_ca_system_score_gemma":0.003013171,"threshold_uncertainty_score":0.9997471},"labels":[],"label_agreement":null},{"id":"W2508265039","doi":"10.1038/nrclinonc.2016.120","title":"Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Obesity; Cancer; Diabetes mellitus; Type 2 Diabetes Mellitus; Type 2 diabetes; Intensive care medicine; Bioinformatics; Internal medicine; Endocrinology","score_opus":0.058055389790396275,"score_gpt":0.45216803911155623,"score_spread":0.39411264932115997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508265039","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011888508,0.9936802,0.0000022024744,0.00037967844,0.0030365896,0.0017237194,0.00014814844,0.000018347078,0.00089222373],"genre_scores_gemma":[0.000009267452,0.9818166,0.00010988443,0.011608479,0.0048381854,0.00053188246,0.000084681706,0.00010338617,0.00089762826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99292505,0.0024715974,0.0021112429,0.0014466326,0.00026018653,0.00078529754],"domain_scores_gemma":[0.9956496,0.0008810287,0.001549773,0.001421157,0.00015896886,0.00033949956],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0039746854,0.00080602494,0.0047334367,0.00007166645,0.00016965988,0.00004567325,0.0011608532,0.003942299,0.00022396675],"category_scores_gemma":[0.0015726001,0.00042085213,0.0017447318,0.00025949275,0.0006553045,0.0000072471144,0.0007732356,0.0023514284,0.0001851244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006454074,0.00008698101,0.00015045305,0.0035645799,0.00035027,0.0000015424284,0.0000064181277,3.2063456e-9,0.0000010344054,0.000048264854,0.08576595,0.910018],"study_design_scores_gemma":[0.00051472,0.00031588186,0.000045487446,0.005826762,0.001550693,0.000005613551,0.0000020404389,2.711438e-7,0.000008150526,0.00010120257,0.9910802,0.00054893945],"about_ca_topic_score_codex":0.000004735926,"about_ca_topic_score_gemma":0.000023403487,"teacher_disagreement_score":0.9094691,"about_ca_system_score_codex":0.00008558856,"about_ca_system_score_gemma":0.0009609227,"threshold_uncertainty_score":0.9999502},"labels":[],"label_agreement":null},{"id":"W2524154560","doi":"10.1038/nrclinonc.2016.160","title":"Stage III NSCLC — is it time to centralize care?","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Stage (stratigraphy); Oncology; MEDLINE; Internal medicine; Family medicine","score_opus":0.15045788609815203,"score_gpt":0.5317290995752756,"score_spread":0.38127121347712356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524154560","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.9765888e-7,0.9244898,0.00001805207,0.009185083,0.002361578,0.005899629,0.00010596849,0.00007468009,0.05786499],"genre_scores_gemma":[1.2639286e-7,0.8243667,0.00089907355,0.030997531,0.0027722581,0.00025501996,0.00016356044,0.000087809385,0.14045794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921263,0.0010962628,0.003969085,0.0014084259,0.00052167143,0.0008782826],"domain_scores_gemma":[0.9938596,0.0018531643,0.0016627816,0.0015564229,0.00021495517,0.0008531027],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0025304968,0.0009226192,0.0113481255,0.00024651614,0.00006654333,0.00002477386,0.0008245205,0.0033725079,0.017865606],"category_scores_gemma":[0.0027320958,0.00052451156,0.004060375,0.00074374204,0.00015272424,0.000056156237,0.0004909774,0.0033237366,0.025293712],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048400812,0.00008270749,0.000012823721,0.008773654,0.00026191276,0.000092488764,0.000015610289,1.0544776e-9,1.2951571e-8,0.000040442945,0.42102656,0.5696454],"study_design_scores_gemma":[0.001962603,0.0009980202,0.000025813846,0.0274902,0.0042963945,0.00003235619,0.000006787697,6.578753e-8,3.266465e-8,0.000003057153,0.96471363,0.0004710074],"about_ca_topic_score_codex":0.0000052483865,"about_ca_topic_score_gemma":0.000011127843,"teacher_disagreement_score":0.56917435,"about_ca_system_score_codex":0.0010427107,"about_ca_system_score_gemma":0.0013502234,"threshold_uncertainty_score":0.99972063},"labels":[],"label_agreement":null},{"id":"W2530952499","doi":"10.1038/nrclinonc.2016.162","title":"Imaging biomarker roadmap for cancer studies","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1078,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"Innovative Medicines Initiative; European Commission; Wellbeing of Women; Engineering and Physical Sciences Research Council; National Institute for Health and Care Research; National Cancer Institute; Cancer Research UK; Medical Research Council; European Federation of Pharmaceutical Industries and Associations","keywords":"Medicine; Clinical trial; Medical physics; Drug development; Translational research; Standardization; Biomarker; Internal medicine; Pathology; Drug; Pharmacology; Computer science","score_opus":0.2445465864156629,"score_gpt":0.6209623229717565,"score_spread":0.37641573655609356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530952499","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.8381037e-7,0.97385246,0.00033594068,0.013023231,0.007319489,0.003943298,0.00004303211,0.00008882987,0.0013935227],"genre_scores_gemma":[2.7687162e-7,0.97413045,0.0049856906,0.01033801,0.0057819346,0.0013767179,0.000093840936,0.00014973663,0.0031433492],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99234724,0.0015207942,0.0038064432,0.0012794867,0.00030426733,0.0007417558],"domain_scores_gemma":[0.9875434,0.0083423685,0.0023324094,0.0008551607,0.00039025626,0.0005363784],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.008369708,0.0008030243,0.011417801,0.00025886926,0.00012957102,0.000018791281,0.0005137935,0.002129639,0.00021028062],"category_scores_gemma":[0.029593827,0.0004088861,0.0038131818,0.00035186615,0.0006241163,0.000059539037,0.0002481542,0.004537026,0.00022001383],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037093556,0.00012489044,0.00004827855,0.024139835,0.00091892126,0.00007135363,0.000005707619,3.5737475e-9,1.9467595e-7,0.00013482578,0.17093015,0.80358875],"study_design_scores_gemma":[0.0014639236,0.00021012692,0.0000108970635,0.07425171,0.0054440005,0.00021756128,0.0000030803374,0.0000223732,2.642351e-8,0.00013300643,0.91783834,0.00040493454],"about_ca_topic_score_codex":0.0000029426878,"about_ca_topic_score_gemma":0.0000043855657,"teacher_disagreement_score":0.8031838,"about_ca_system_score_codex":0.00068595575,"about_ca_system_score_gemma":0.0016963608,"threshold_uncertainty_score":0.9998363},"labels":[],"label_agreement":null},{"id":"W2553180822","doi":"10.1038/nrclinonc.2016.184","title":"HPV vaccination in boys — will the UK join the fight?","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University Health Network","keywords":"Join (topology); Medicine; Vaccination; Family medicine; Virology","score_opus":0.2189165276759974,"score_gpt":0.5782711926976772,"score_spread":0.35935466502167984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553180822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.114145e-8,0.91213375,0.000006874733,0.019513674,0.0013148395,0.005946427,0.000021382088,0.000020787102,0.061042193],"genre_scores_gemma":[0.000009030197,0.97970444,0.00005664963,0.0113226725,0.0040336526,0.001315821,0.00007771227,0.000054926186,0.0034251162],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9895103,0.005077167,0.0032786098,0.0008721966,0.0006166071,0.00064513925],"domain_scores_gemma":[0.9850442,0.011684253,0.0011285485,0.0015354794,0.00031254394,0.0002949656],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.012131221,0.00053273933,0.0056923595,0.000174736,0.00012228341,0.000026887112,0.0011132876,0.0034012885,0.019166471],"category_scores_gemma":[0.01425901,0.00017977896,0.0022515315,0.0009746313,0.00024291078,0.00005362605,0.00038396794,0.009879888,0.0010976787],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006853774,0.00016311865,0.000027670034,0.005191173,0.00009100194,0.000040999814,0.000006357611,2.9596399e-9,6.747356e-9,0.00074373576,0.10437397,0.88929343],"study_design_scores_gemma":[0.001176853,0.000649148,0.0021132852,0.0035123555,0.00082849496,0.0000956712,0.0000023834962,9.902861e-7,2.842768e-8,0.0003778413,0.99103487,0.000208089],"about_ca_topic_score_codex":0.000010196398,"about_ca_topic_score_gemma":0.0003297125,"teacher_disagreement_score":0.88908535,"about_ca_system_score_codex":0.00082776824,"about_ca_system_score_gemma":0.002013006,"threshold_uncertainty_score":0.9996801},"labels":[],"label_agreement":null},{"id":"W2555271530","doi":"10.1038/nrclinonc.2016.189","title":"Screening and treatment: where do we go from here?","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Stage (stratigraphy); Internal medicine; Prostate-specific antigen; Randomized controlled trial; Cancer; Gynecology","score_opus":0.18242483890280148,"score_gpt":0.5137869171961926,"score_spread":0.33136207829339115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555271530","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000025045445,0.98855335,0.000006786528,0.0038679421,0.0011728203,0.0038927495,0.00036720026,0.000057940484,0.002078709],"genre_scores_gemma":[9.1896834e-7,0.99041873,0.0029055115,0.00080997794,0.0030376078,0.00097034883,0.00021812944,0.00010533094,0.001533416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937015,0.001381875,0.0027098008,0.0014652908,0.00022272649,0.00051878457],"domain_scores_gemma":[0.991755,0.004840979,0.0016151991,0.001040389,0.00008313168,0.00066528894],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010243739,0.0009570008,0.010429987,0.00011507874,0.00007940928,0.000029701763,0.00023375895,0.0036849012,0.0007280256],"category_scores_gemma":[0.00075188215,0.00046486227,0.0024008928,0.00022337593,0.00026247106,0.00006232031,0.00016397974,0.0020454617,0.0007800889],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074893025,0.00057870726,0.00047304173,0.0044824905,0.0013964117,0.00039364837,0.000009516155,7.5198614e-10,2.1050027e-8,0.00008538409,0.017250385,0.9752555],"study_design_scores_gemma":[0.0031298024,0.002735371,0.00006199367,0.10065246,0.0071553546,0.000112454625,0.000002875156,1.0855163e-7,8.993318e-8,0.00009107159,0.8857035,0.00035492756],"about_ca_topic_score_codex":0.000018316474,"about_ca_topic_score_gemma":0.000069857095,"teacher_disagreement_score":0.97490054,"about_ca_system_score_codex":0.0008450976,"about_ca_system_score_gemma":0.0009257008,"threshold_uncertainty_score":0.9999979},"labels":[],"label_agreement":null},{"id":"W2564174616","doi":"10.1038/nrclinonc.2016.195","title":"RECIST — learning from the past to build the future","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":154,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute; Amgen","keywords":"Medicine; Medical physics; MEDLINE","score_opus":0.06508934699397997,"score_gpt":0.44918318371777877,"score_spread":0.3840938367237988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564174616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004073751,0.9830104,0.000096948286,0.008141156,0.0051681427,0.0017586825,0.00015779308,0.000010902517,0.0016519056],"genre_scores_gemma":[0.0000022839438,0.9529925,0.00044791133,0.013000154,0.031340286,0.00032707822,0.0003930641,0.00007850228,0.0014181958],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99398804,0.0024745523,0.0018347208,0.0010619268,0.00018547008,0.0004552877],"domain_scores_gemma":[0.9928608,0.0039165174,0.0012399064,0.0015935249,0.00014326068,0.00024601637],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0031788265,0.000587971,0.0026589145,0.00002726084,0.00023094175,0.00005404713,0.001739275,0.0032165784,0.00010451372],"category_scores_gemma":[0.006300933,0.00024421618,0.0018178038,0.00024010622,0.00023660762,0.0000018479396,0.0008398347,0.0034578503,0.00066246145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022937675,0.000034062778,0.000025156594,0.00016839466,0.00013369296,0.0000047287513,0.0000035844914,1.5073506e-7,0.0000012168869,0.00010135573,0.26468307,0.7348216],"study_design_scores_gemma":[0.00024661853,0.00053645764,0.000030297999,0.0021772643,0.0006497121,0.000021843625,0.0000063762445,8.438485e-8,3.516581e-7,0.000047970134,0.9959302,0.0003528133],"about_ca_topic_score_codex":0.0000103628245,"about_ca_topic_score_gemma":0.0003062521,"teacher_disagreement_score":0.7344688,"about_ca_system_score_codex":0.00011517122,"about_ca_system_score_gemma":0.0008064874,"threshold_uncertainty_score":0.9988412},"labels":[],"label_agreement":null},{"id":"W2589693917","doi":"10.1038/nrclinonc.2017.18","title":"Approvals in 2016: questioning the clinical benefit of anticancer therapies","year":2017,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick; University of Toronto; Canada Research Chairs; Queen's University","funders":"","keywords":"Medicine; Adverse effect; Intensive care medicine; Oncology; Medical physics; Internal medicine","score_opus":0.40883118857482037,"score_gpt":0.5399416392635282,"score_spread":0.13111045068870786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589693917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014066109,0.96776086,0.000037645343,0.0010353487,0.0047516916,0.0018352431,0.00014032696,0.000014387456,0.024410442],"genre_scores_gemma":[0.00008275354,0.9937231,0.00081144436,0.0012264872,0.0023031377,0.00023042253,0.00002720562,0.000068817324,0.0015266534],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.988112,0.00072875567,0.009387968,0.0011424622,0.000063318716,0.00056552485],"domain_scores_gemma":[0.9827083,0.0037989125,0.011440149,0.0017747786,0.00010536697,0.00017252771],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.021602744,0.000589684,0.011919712,0.00024375082,0.00013432132,0.000066422595,0.0019164965,0.0039080707,0.00025991822],"category_scores_gemma":[0.012566811,0.0004003078,0.002969772,0.00025820523,0.0009835088,0.00023540208,0.00029590057,0.0047795004,0.0007121849],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019368505,0.00019996913,0.0024672723,0.0016191438,0.00020461618,0.000004625184,0.000019970337,2.1456684e-7,9.164169e-10,0.049138207,0.0055247657,0.94080186],"study_design_scores_gemma":[0.0005631923,0.00030743435,0.0029800048,0.006348932,0.00020934465,0.000007094519,0.0000026916082,0.0000038391,6.9102715e-9,0.010632134,0.9785385,0.0004067859],"about_ca_topic_score_codex":0.00012405617,"about_ca_topic_score_gemma":0.00027051792,"teacher_disagreement_score":0.97301376,"about_ca_system_score_codex":0.00031337462,"about_ca_system_score_gemma":0.00095202855,"threshold_uncertainty_score":0.9998449},"labels":[],"label_agreement":null},{"id":"W2606269644","doi":"10.1038/nrclinonc.2017.57","title":"Cancer, obesity, and diabetes: TKIs exert multiple effects on glucose homeostasis","year":2017,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Glucose homeostasis; Diabetes mellitus; Obesity; Cancer; Homeostasis; Oncology; Internal medicine; Bioinformatics; Endocrinology; Insulin resistance","score_opus":0.11735467934617697,"score_gpt":0.48703406104377206,"score_spread":0.36967938169759507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606269644","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025828142,0.99189055,0.000001466158,0.00006554719,0.0046272893,0.002501079,0.00019489105,0.00002265525,0.00043822496],"genre_scores_gemma":[0.00001795323,0.98814285,0.00022683013,0.004098424,0.00554219,0.001111823,0.00041992514,0.000117927666,0.0003220765],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929208,0.0023759014,0.0019185906,0.001745958,0.00026589393,0.0007728463],"domain_scores_gemma":[0.99387574,0.0014884728,0.002113528,0.0018592041,0.00015251906,0.00051055575],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0029125367,0.0010106775,0.0070706457,0.000121987156,0.00021771963,0.00006397112,0.001163049,0.0053810226,0.00004705021],"category_scores_gemma":[0.0076931682,0.00071338675,0.0019859711,0.00015326843,0.00038529042,0.0000086755645,0.00060778984,0.002728552,0.00012149661],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028579485,0.00024586663,0.0001664405,0.011372914,0.00042279196,0.000013494527,0.0000021397768,1.8315855e-8,0.0000023569921,0.000011891699,0.041860387,0.94587314],"study_design_scores_gemma":[0.0010822148,0.0010745343,0.00007932786,0.0084993,0.0019947847,0.0000064077,5.0332415e-7,4.9474386e-7,0.000047917347,0.000020479893,0.98645806,0.0007359701],"about_ca_topic_score_codex":0.0000075446105,"about_ca_topic_score_gemma":0.00013035287,"teacher_disagreement_score":0.94513714,"about_ca_system_score_codex":0.000120320816,"about_ca_system_score_gemma":0.0009121096,"threshold_uncertainty_score":0.9995722},"labels":[],"label_agreement":null},{"id":"W2741665883","doi":"10.1038/nrclinonc.2017.96","title":"HER2-positive breast cancer is lost in translation: time for patient-centered research","year":2017,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Breast cancer; Biomarker; Translational research; Disease; Drug development; Biomarker discovery; Cancer; Translational science; Oncology; Clinical research; Trastuzumab; Internal medicine; Bioinformatics; Drug; Pathology; Proteomics","score_opus":0.5935254299144336,"score_gpt":0.6815331907619722,"score_spread":0.08800776084753859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741665883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000014250015,0.95967877,0.0000024854996,0.013282722,0.0013601846,0.015054855,0.0015591198,0.00002108322,0.009039366],"genre_scores_gemma":[0.0000031003176,0.9869764,0.0008285487,0.00216047,0.0031244208,0.002753942,0.00051761186,0.0001636956,0.0034718004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9855313,0.0059635984,0.0042642606,0.0018427351,0.0010761489,0.0013219981],"domain_scores_gemma":[0.9870272,0.0076692607,0.0015610066,0.00182314,0.0012123839,0.00070699607],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.013857173,0.00075158005,0.009613588,0.0005888638,0.00019812565,0.000059253183,0.0011807092,0.00580609,0.0024183483],"category_scores_gemma":[0.0053632976,0.00053098635,0.0026351486,0.0008534751,0.00084375136,0.00010622105,0.00029652458,0.011922317,0.0017562337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005086616,0.0007986436,0.000079985744,0.022198757,0.00027456685,0.00015926686,0.000053325,6.940489e-9,1.5948466e-7,0.000015357717,0.12501729,0.850894],"study_design_scores_gemma":[0.0021858567,0.0021594518,0.00011267405,0.07580116,0.00086649845,0.00017595403,0.0000037920372,0.000007503453,2.7274965e-7,0.000035717094,0.91827476,0.00037639134],"about_ca_topic_score_codex":0.00008107893,"about_ca_topic_score_gemma":0.00028412888,"teacher_disagreement_score":0.8505176,"about_ca_system_score_codex":0.0023098206,"about_ca_system_score_gemma":0.0077729234,"threshold_uncertainty_score":0.9997142},"labels":[],"label_agreement":null},{"id":"W2762027870","doi":"10.1038/nrclinonc.2017.153","title":"Patient-reported outcomes in cancer care — hearing the patient voice at greater volume","year":2017,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":255,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cambia Health Foundation; Cancer Care Ontario; American Cancer Society","keywords":"Context (archaeology); Health care; Data collection; Workflow; Medicine; Quality (philosophy); MEDLINE; Cancer; Medical physics; Family medicine; Computer science","score_opus":0.2736460353004048,"score_gpt":0.5316970210127823,"score_spread":0.25805098571237745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762027870","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034406423,0.9817393,2.4141795e-7,0.0014528072,0.00826856,0.004918046,0.00008014245,0.0000408836,0.0031559886],"genre_scores_gemma":[0.0002909877,0.9897402,0.000036505273,0.004714243,0.00097645295,0.0015326831,0.00019647424,0.000100923826,0.0024115355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912069,0.002041429,0.0042528333,0.0012767008,0.0005369792,0.00068520004],"domain_scores_gemma":[0.9923991,0.0011761987,0.0034315698,0.0023059861,0.00033407393,0.0003530977],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0017391194,0.0008560958,0.009422173,0.00016706834,0.00020465536,0.00003317349,0.0006105056,0.0035616965,0.00035059295],"category_scores_gemma":[0.0035387562,0.00043852156,0.0032196664,0.00031316897,0.00031048353,0.00005768279,0.00064349076,0.00618375,0.0003049571],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007438172,0.00015027962,0.028752174,0.009568358,0.0003501577,0.00037453714,0.00036117982,5.2073972e-8,8.928589e-9,0.000001956149,0.008239084,0.9521278],"study_design_scores_gemma":[0.00076740194,0.00077665295,0.0046230573,0.019417513,0.0031987485,0.00014042185,0.000044185803,4.0125687e-7,5.779443e-8,0.0000017987112,0.9706068,0.00042296917],"about_ca_topic_score_codex":0.0007922162,"about_ca_topic_score_gemma":0.01159866,"teacher_disagreement_score":0.9623677,"about_ca_system_score_codex":0.0021084014,"about_ca_system_score_gemma":0.0016793028,"threshold_uncertainty_score":0.99980664},"labels":[],"label_agreement":null},{"id":"W2782739600","doi":"10.1038/nrclinonc.2013.17","title":"Tamoxifen—when more might be better","year":2013,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Oestrogen receptor; Oncology; Adverse effect; Internal medicine; Gynecology; Cancer","score_opus":0.09073277744549883,"score_gpt":0.4784138782681507,"score_spread":0.38768110082265184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782739600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028068363,0.9898443,0.000011220386,0.0011588444,0.0023395685,0.002945514,0.000041779123,0.000034513752,0.0035961738],"genre_scores_gemma":[6.9285255e-7,0.97801536,0.003407657,0.008204032,0.0039740526,0.0005648278,0.0013998267,0.00014568461,0.004287891],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918269,0.0028525067,0.002830624,0.0015084031,0.00025529915,0.00072626286],"domain_scores_gemma":[0.995541,0.0005896891,0.0017108764,0.0015093117,0.00014617023,0.00050296314],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0022430944,0.0010247494,0.0055981586,0.00011307105,0.00009913495,0.000033544078,0.0011692742,0.012370112,0.00029520443],"category_scores_gemma":[0.0018779968,0.00063931366,0.003590297,0.00023260142,0.00042109983,0.000006392612,0.000551547,0.0056136833,0.0013737456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012675614,0.00017252016,0.0000054788934,0.002444204,0.00041707364,0.000040622894,0.000003296724,1.1897215e-8,0.000008859779,0.000023481163,0.29434726,0.70252454],"study_design_scores_gemma":[0.00051093585,0.0010122466,0.0000026500563,0.0026101284,0.0018144798,0.00020151597,9.892701e-7,4.92274e-7,0.0000085490565,0.00003511882,0.99311024,0.00069267245],"about_ca_topic_score_codex":0.0000032415612,"about_ca_topic_score_gemma":0.000003794425,"teacher_disagreement_score":0.7018319,"about_ca_system_score_codex":0.00009189912,"about_ca_system_score_gemma":0.0007614201,"threshold_uncertainty_score":0.99960583},"labels":[],"label_agreement":null},{"id":"W2785975065","doi":"10.1038/nrclinonc.2018.14","title":"Bridging the gap: are animal models consistent with clinical cancer cachexia?","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Cancer Foundation","keywords":"Cachexia; Cancer cachexia; Medicine; Cancer; Bridging (networking); Parallels; Cancer treatment; Pace; Bioinformatics; Intensive care medicine; Oncology; Internal medicine; Biology; Computer science","score_opus":0.6230091410809944,"score_gpt":0.6374622087566653,"score_spread":0.014453067675670894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785975065","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000062203057,0.9718442,0.000055341305,0.015570843,0.0030156206,0.005295146,0.000059669354,0.000101087135,0.004051881],"genre_scores_gemma":[0.000016044747,0.9454722,0.0025724333,0.03878723,0.011398387,0.0007295249,0.00009309251,0.00012486191,0.0008062498],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9856839,0.0049302154,0.0063865962,0.0015554465,0.00056947547,0.0008743592],"domain_scores_gemma":[0.9876547,0.004533374,0.004723725,0.0015140612,0.0006617761,0.00091237284],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01228085,0.00087817264,0.011730546,0.0001581639,0.00027620056,0.0000343637,0.0006735201,0.0044424147,0.00031176326],"category_scores_gemma":[0.003284994,0.00042828653,0.0030759964,0.00064273673,0.0013121533,0.000069136586,0.00025426634,0.012399794,0.0003842161],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026755963,0.0005368436,0.00042704502,0.022026256,0.00045303823,0.00019715952,0.00000828744,4.158927e-8,4.313517e-9,0.00034738216,0.13884446,0.8368919],"study_design_scores_gemma":[0.0018454421,0.0016998814,0.00019006248,0.072663195,0.005882874,0.00074865704,0.000008157029,0.00004793439,1.1967278e-8,0.000049925133,0.91644996,0.00041391022],"about_ca_topic_score_codex":0.00001618285,"about_ca_topic_score_gemma":0.00018277694,"teacher_disagreement_score":0.836478,"about_ca_system_score_codex":0.00063708355,"about_ca_system_score_gemma":0.0044571995,"threshold_uncertainty_score":0.9998169},"labels":[],"label_agreement":null},{"id":"W2789017398","doi":"10.1038/nrclinonc.2018.27","title":"Cancer immunotherapy and the value of cure","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Immunotherapy; Oncology; Cancer immunotherapy; Clinical Oncology; Cancer; Internal medicine; Value (mathematics); Immune checkpoint; Intensive care medicine","score_opus":0.12489199908178489,"score_gpt":0.5402313480486471,"score_spread":0.41533934896686225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789017398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000039541746,0.9900198,0.0000037306147,0.0026604487,0.0023390006,0.0036660465,0.000028216204,0.000029059667,0.00124976],"genre_scores_gemma":[0.000001053761,0.989523,0.0004976654,0.0067033293,0.0020814582,0.0003638338,0.000026145924,0.00008348865,0.00072004483],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99270666,0.0026668736,0.003442171,0.000630089,0.00025275725,0.0003014705],"domain_scores_gemma":[0.9927647,0.0032460922,0.0027072036,0.0009819702,0.00017639824,0.0001236407],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.007439287,0.0005249784,0.0085982075,0.00009950478,0.00005728,0.00000949315,0.00046741546,0.003145421,0.00027351166],"category_scores_gemma":[0.0011612155,0.00023067975,0.0031581258,0.00047885612,0.0020324949,0.000026641317,0.00010937343,0.003223932,0.000023365712],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015669735,0.00015330425,0.000016068814,0.010761309,0.0013820442,0.0000061725614,0.000025709858,9.451395e-10,2.749451e-7,0.0003908119,0.032418154,0.9532792],"study_design_scores_gemma":[0.004965538,0.001004092,0.000051206753,0.024186103,0.00369971,0.0001486072,0.0000027487065,6.7858844e-7,2.2270261e-7,0.00006304445,0.96566796,0.00021009438],"about_ca_topic_score_codex":0.00004251171,"about_ca_topic_score_gemma":0.000028958944,"teacher_disagreement_score":0.9530691,"about_ca_system_score_codex":0.00018781798,"about_ca_system_score_gemma":0.001612728,"threshold_uncertainty_score":0.99907565},"labels":[],"label_agreement":null},{"id":"W2789727733","doi":"10.1038/nrclinonc.2018.30","title":"Epigenome-based cancer risk prediction: rationale, opportunities and challenges","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":173,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University and Génome Québec Innovation Centre","funders":"National Institute for Health and Care Research","keywords":"Epigenome; Epigenomics; DNA methylation; Medicine; Risk analysis (engineering); Cancer; Epigenetics; Bioinformatics; Biology; Genetics; Internal medicine","score_opus":0.32373190214194764,"score_gpt":0.48276934153648154,"score_spread":0.1590374393945339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789727733","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000122839665,0.9941322,0.00009413091,0.0006532658,0.0016146416,0.0013843464,0.00030957637,0.000015504267,0.0017840387],"genre_scores_gemma":[0.0000028222073,0.99154305,0.0012095728,0.00050742936,0.00469735,0.0005054321,0.00092308,0.00005787822,0.00055336807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942687,0.0023984585,0.0018903761,0.0009793099,0.000175428,0.00028769753],"domain_scores_gemma":[0.9965189,0.00063373795,0.0016811322,0.0006560902,0.00026132708,0.00024881],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0037285152,0.0004966559,0.0023659358,0.00009962513,0.00013724064,0.000020559093,0.0003158624,0.0035238557,0.000080555255],"category_scores_gemma":[0.0018441203,0.00036991268,0.00081373256,0.00010454104,0.00037983357,0.0000043422483,0.00015470102,0.0011943543,0.000027288486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019202937,0.000095534655,0.0000599917,0.003954759,0.00019227053,0.000003125387,0.00000398483,3.1822233e-7,7.073279e-7,0.00010664915,0.002869621,0.99269384],"study_design_scores_gemma":[0.00035455692,0.0010333842,0.0001025714,0.0017671649,0.0010202802,0.0000032627984,0.0000033072288,0.0000032640512,0.000002424144,0.00006930118,0.9953108,0.0003297246],"about_ca_topic_score_codex":0.0000031994498,"about_ca_topic_score_gemma":0.00010894713,"teacher_disagreement_score":0.9924411,"about_ca_system_score_codex":0.00006454655,"about_ca_system_score_gemma":0.0012931417,"threshold_uncertainty_score":0.9998753},"labels":[],"label_agreement":null},{"id":"W2794419219","doi":"10.1038/nrclinonc.2018.9","title":"Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":673,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Medicine; Immunotherapy; Bevacizumab; Ipilimumab; Modalities; Cancer immunotherapy; Therapeutic modalities; Oncology; Hypoxia (environmental); Angiogenesis; Cancer; Cancer research; Internal medicine; Chemotherapy","score_opus":0.07002965191508446,"score_gpt":0.45947744276645835,"score_spread":0.3894477908513739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794419219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001907354,0.9969509,0.000046494373,0.0000758819,0.0008322561,0.0014049313,0.00005282311,0.000015787247,0.0004301546],"genre_scores_gemma":[0.000017332955,0.9931037,0.0021254672,0.0018630167,0.0013504538,0.00023102002,0.00026239696,0.000105447856,0.0009411681],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957405,0.000894736,0.0015345495,0.001222038,0.00015789819,0.00045032357],"domain_scores_gemma":[0.9969913,0.0003133482,0.0014234668,0.00095062726,0.00012424326,0.00019704446],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013382146,0.0007525696,0.0040874835,0.00007594976,0.00011446781,0.00002658934,0.00050169823,0.0031236215,0.000053284508],"category_scores_gemma":[0.00035122124,0.00043299916,0.0017776389,0.00019769663,0.00035295112,0.00000594625,0.000222392,0.0007712119,0.00008169908],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005606366,0.00016768866,0.00066008244,0.0013382174,0.0014291721,0.0000132786645,0.0000030179203,1.0945298e-8,0.000009887061,0.0000074470386,0.00431353,0.9920016],"study_design_scores_gemma":[0.0010248256,0.0019107627,0.00022980997,0.0013624068,0.0020996367,0.000090606445,0.000002002332,2.6300782e-7,0.000004326882,0.0000020453629,0.9927813,0.0004920359],"about_ca_topic_score_codex":0.000015227608,"about_ca_topic_score_gemma":0.000035623027,"teacher_disagreement_score":0.99150956,"about_ca_system_score_codex":0.0001034359,"about_ca_system_score_gemma":0.0007195841,"threshold_uncertainty_score":0.9998122},"labels":[],"label_agreement":null},{"id":"W2797068438","doi":"10.1038/s41571-018-0006-2","title":"The gut microbiota influences anticancer immunosurveillance and general health","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":504,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Immunosurveillance; Medicine; Gut flora; Cancer; Immunology; Internal medicine","score_opus":0.09779276010841215,"score_gpt":0.5360423370807821,"score_spread":0.43824957697236994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797068438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007463181,0.9943602,0.0000041402936,0.0012609692,0.002226113,0.0016741292,0.00010336434,0.000012302884,0.00028413723],"genre_scores_gemma":[0.0000046556715,0.9881301,0.0010895088,0.006465614,0.0030122197,0.000088892426,0.00028385373,0.000054562443,0.0008705745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918867,0.0033263892,0.0027701922,0.0011571426,0.00011538886,0.000744228],"domain_scores_gemma":[0.99574375,0.0005796631,0.0021218183,0.0011107097,0.00015835368,0.00028572028],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0061731744,0.00060667185,0.0036742582,0.000047151272,0.00042178732,0.000056225457,0.00089000154,0.0028356728,0.000016817638],"category_scores_gemma":[0.0014087143,0.00033998914,0.00094907,0.00023174111,0.001027634,0.0000032640041,0.00048653592,0.0021768748,0.00013655865],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022951594,0.000053796273,0.000054802214,0.0029642077,0.00014879125,0.0000018815684,0.0000031956338,3.8899164e-9,0.000036760994,0.000054374254,0.115425095,0.8812341],"study_design_scores_gemma":[0.0002917508,0.0010241726,0.000459083,0.0022806814,0.00015027332,0.00013658815,0.0000015973543,1.3335192e-7,4.1943218e-7,0.000011821453,0.99529773,0.00034574905],"about_ca_topic_score_codex":0.000019534398,"about_ca_topic_score_gemma":0.0003386239,"teacher_disagreement_score":0.8808884,"about_ca_system_score_codex":0.000115440096,"about_ca_system_score_gemma":0.0025607862,"threshold_uncertainty_score":0.9999052},"labels":[],"label_agreement":null},{"id":"W2800009061","doi":"10.1038/s41571-018-0016-0","title":"The paradox of precision medicine","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University","funders":"Genome Canada","keywords":"Precision medicine; Medicine; Personalized medicine; Medical physics; Intensive care medicine; Bioinformatics; Pathology","score_opus":0.11869901755552532,"score_gpt":0.518780425510443,"score_spread":0.4000814079549177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800009061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000019571291,0.99147165,0.000040857605,0.00030110555,0.0036525228,0.001273677,0.000036977395,0.0000039649585,0.0032172974],"genre_scores_gemma":[0.0000019090478,0.9923153,0.0005341447,0.000768506,0.0053756735,0.00011103911,0.00021613702,0.000043770386,0.00063351134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99451375,0.0013222812,0.002975922,0.00070337317,0.00018109036,0.00030355828],"domain_scores_gemma":[0.9927306,0.003212608,0.0023065184,0.0013450492,0.00023888005,0.00016633069],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005320323,0.00041068337,0.0034633635,0.000043439646,0.00009049292,0.000008107847,0.0010454952,0.0030171755,0.000036073146],"category_scores_gemma":[0.015412168,0.00020575694,0.0013568056,0.00020783184,0.0008485272,0.000001080511,0.00042409103,0.0013162319,0.000083868894],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033070686,0.00005638052,0.0000025398206,0.0010849565,0.000111727546,0.0000018211201,0.0000013887382,1.479607e-8,9.4755364e-7,0.00019735441,0.20364682,0.794863],"study_design_scores_gemma":[0.00032457736,0.0022136278,0.000004565206,0.0038305365,0.00081263174,0.000026927188,0.0000013536022,3.0309386e-7,0.0000017873723,0.00016154755,0.9924224,0.00019975228],"about_ca_topic_score_codex":0.0000031507525,"about_ca_topic_score_gemma":0.00006940374,"teacher_disagreement_score":0.79466325,"about_ca_system_score_codex":0.000054283075,"about_ca_system_score_gemma":0.00091148133,"threshold_uncertainty_score":0.9982771},"labels":[],"label_agreement":null},{"id":"W2801498218","doi":"10.1038/s41571-018-0030-2","title":"Low-value approvals and high prices might incentivize ineffective drug development","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Medicine; Drug development; Drug; Portfolio; Drug approval; Incentive; Pipeline (software); Clinical trial; Value (mathematics); Actuarial science; Risk analysis (engineering); Intensive care medicine; Public economics; Pharmacology; Finance; Business; Internal medicine; Economics; Microeconomics","score_opus":0.0935634486123407,"score_gpt":0.4775639335498192,"score_spread":0.3840004849374785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801498218","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001748353,0.98955005,0.00008904772,0.0003655692,0.005085318,0.003261625,0.000049615992,0.00007020661,0.0015110873],"genre_scores_gemma":[0.000004007436,0.9782373,0.015930401,0.0019461752,0.0008239819,0.0003311719,0.00019264588,0.00006573381,0.0024686027],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98326725,0.009816927,0.004048963,0.0019000235,0.0001110187,0.00085579144],"domain_scores_gemma":[0.98724425,0.0088256495,0.0026716026,0.000839744,0.00022129077,0.00019747092],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01217801,0.001125142,0.009726153,0.00023478086,0.0002568031,0.00003412062,0.0009844571,0.008366371,0.00047248288],"category_scores_gemma":[0.0055465563,0.000654985,0.0015081698,0.0006113517,0.0015716937,0.0000782703,0.00090231077,0.006342596,0.0011269024],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059373164,0.0005939567,0.000012065637,0.008892972,0.0010950171,0.000017135331,0.000022931483,7.78097e-10,0.0000018252115,0.0007596085,0.030616887,0.95792824],"study_design_scores_gemma":[0.0008727359,0.00062592124,0.00007837261,0.01125212,0.0025097425,0.00010075324,0.0000033932474,1.4366125e-7,0.000035656183,0.00017124342,0.9836139,0.00073602545],"about_ca_topic_score_codex":0.000005602184,"about_ca_topic_score_gemma":0.000027366148,"teacher_disagreement_score":0.9571922,"about_ca_system_score_codex":0.0003029978,"about_ca_system_score_gemma":0.0010389726,"threshold_uncertainty_score":0.99965084},"labels":[],"label_agreement":null},{"id":"W2884819844","doi":"10.1038/s41571-018-0071-6","title":"Infant medulloblastoma — learning new lessons from old strata","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"Pediatric Brain Tumor Foundation; American Brain Tumor Association","keywords":"Medulloblastoma; Medicine; DNA methylation; Disease; Risk stratification; Profiling (computer programming); Oncology; Stratification (seeds); Bioinformatics; Computational biology; Internal medicine; Cancer research; Genetics; Biology; Gene","score_opus":0.21576099181374278,"score_gpt":0.5445081010859789,"score_spread":0.32874710927223616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884819844","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002121342,0.9883782,0.000005772973,0.0029242237,0.0026758625,0.003153877,0.00008052236,0.00011439577,0.0026458811],"genre_scores_gemma":[0.000006268504,0.9844998,0.0033454017,0.0025878379,0.0066332845,0.00029296533,0.0011554195,0.00013232698,0.0013466737],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9903116,0.0024719771,0.0042546713,0.0017695598,0.00047513243,0.0007170125],"domain_scores_gemma":[0.9888441,0.0053839255,0.0028410228,0.0015907044,0.0001859783,0.0011542524],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0026155335,0.0010901404,0.01252628,0.0002339966,0.00011974407,0.000041540516,0.0006584709,0.0063043786,0.00152269],"category_scores_gemma":[0.0085929455,0.0006631129,0.0041028126,0.00064632134,0.00029065763,0.00006270865,0.00036309904,0.0077058407,0.0036281738],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038009613,0.0008150817,0.00020142527,0.002832265,0.0010812492,0.00043093396,0.000009456103,1.2871255e-8,1.15251765e-7,0.00020100974,0.138672,0.85571843],"study_design_scores_gemma":[0.0020431424,0.0025214776,0.00022342872,0.035872903,0.011798375,0.00017473043,0.000003375874,0.0000010384998,4.266805e-7,0.000069059395,0.94681025,0.00048178475],"about_ca_topic_score_codex":0.00008691789,"about_ca_topic_score_gemma":0.00027552602,"teacher_disagreement_score":0.85523665,"about_ca_system_score_codex":0.0005091446,"about_ca_system_score_gemma":0.0029036216,"threshold_uncertainty_score":0.9997581},"labels":[],"label_agreement":null},{"id":"W2891861168","doi":"10.1038/s41571-018-0101-4","title":"Why patients receive treatments that are minimally effective?","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network; Queen's University","funders":"","keywords":"Medicine; MEDLINE; Medical physics; Intensive care medicine; General surgery; Family medicine","score_opus":0.17794357545937708,"score_gpt":0.5473828599332276,"score_spread":0.36943928447385044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891861168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046576555,0.97486866,7.3747833e-7,0.00066369754,0.0064684083,0.011469406,0.0001700937,0.00008787696,0.0062245647],"genre_scores_gemma":[0.0000030661795,0.9772383,0.00050816796,0.011401774,0.0037524868,0.002113279,0.0011689715,0.0001433459,0.0036706172],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9900374,0.004141003,0.002891344,0.00175743,0.0004050306,0.000767818],"domain_scores_gemma":[0.9900179,0.0042616995,0.0036155945,0.0010340952,0.00037909113,0.00069163257],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0017635265,0.0012848827,0.012713738,0.00022987758,0.00012380931,0.000017266933,0.00051364006,0.0059504495,0.0010842567],"category_scores_gemma":[0.0023659617,0.0007858454,0.004314402,0.00058697426,0.00048640693,0.0000785286,0.00023961718,0.0042340043,0.002235879],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037732325,0.0033470998,0.0026801005,0.007886485,0.0018973122,0.0001638493,0.000009233375,4.7834836e-10,1.9266656e-8,0.000002918556,0.28658536,0.6970503],"study_design_scores_gemma":[0.0058388235,0.012014478,0.0023269334,0.018553233,0.022756666,0.000098050594,0.0000014295896,1.1055855e-7,3.51481e-7,0.000012052571,0.93788445,0.000513395],"about_ca_topic_score_codex":0.000009682442,"about_ca_topic_score_gemma":0.00006483609,"teacher_disagreement_score":0.6965369,"about_ca_system_score_codex":0.0017593938,"about_ca_system_score_gemma":0.0009921086,"threshold_uncertainty_score":0.9999903},"labels":[],"label_agreement":null},{"id":"W2899892772","doi":"10.1038/s41571-018-0116-x","title":"Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; University of Toronto; American Thyroid Association; American Cancer Society","keywords":"Overdiagnosis; Medicine; Prostate cancer; Thyroid; Intensive care medicine; Watchful waiting; Prostate-specific antigen; Thyroid cancer; Population; Epidemiology; Prostate; Internal medicine; Oncology; Gynecology; Cancer","score_opus":0.22396722444169168,"score_gpt":0.5563381693392888,"score_spread":0.3323709448975971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899892772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000117966185,0.9866063,0.00000912688,0.003090252,0.0012239391,0.008293679,0.00029829575,0.000027349299,0.00033312067],"genre_scores_gemma":[0.00012296143,0.99367905,0.0009328114,0.0010544454,0.0014212062,0.00222711,0.00031667663,0.00006763611,0.00017812446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992227,0.0020734246,0.0033354845,0.0016249105,0.00016871719,0.00057043566],"domain_scores_gemma":[0.9907474,0.006062709,0.0019348009,0.00060655596,0.00019788381,0.000450629],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0060259197,0.00064619846,0.008160124,0.00014808624,0.00008224112,0.000020968766,0.00016897486,0.0028849884,0.000011655387],"category_scores_gemma":[0.005888782,0.0004211438,0.0010774169,0.0003492005,0.00072625227,0.00007440532,0.00014730553,0.002897703,0.000022641],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005266713,0.00045345016,0.0029060282,0.009247161,0.00037490795,0.000040786872,0.000019834195,1.1831671e-8,2.1880703e-8,0.00028130633,0.006197837,0.979952],"study_design_scores_gemma":[0.004142811,0.0068998374,0.006676122,0.0149438,0.0016142357,0.00007310508,0.000007000069,0.000005292621,5.8122357e-8,0.00034728262,0.9649423,0.00034816834],"about_ca_topic_score_codex":0.00003607172,"about_ca_topic_score_gemma":0.0007636638,"teacher_disagreement_score":0.9796038,"about_ca_system_score_codex":0.0012882106,"about_ca_system_score_gemma":0.0025370058,"threshold_uncertainty_score":0.99982405},"labels":[],"label_agreement":null},{"id":"W2905520899","doi":"10.1038/s41571-018-0147-3","title":"Advances in prediction for ovarian cancer treatment stratification","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Modalities; Ovarian cancer; Treatment modality; Intensive care medicine; Risk stratification; Consolidation (business); Oncology; Stratification (seeds); Medical physics; Internal medicine; Cancer","score_opus":0.23252689184304717,"score_gpt":0.5767472291325556,"score_spread":0.3442203372895084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905520899","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.6871344e-7,0.9832073,0.000037884183,0.0012781208,0.0031095755,0.009691815,0.00027845238,0.000035789242,0.0023605933],"genre_scores_gemma":[0.0000029748576,0.979444,0.002806688,0.00051404786,0.004282672,0.011445659,0.0009966338,0.000059149916,0.00044815365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945431,0.0007572542,0.0029941618,0.0011632863,0.00016617157,0.0003760796],"domain_scores_gemma":[0.99575377,0.0015467681,0.0015749383,0.00072154443,0.000166299,0.00023670799],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016524661,0.0005828697,0.005932171,0.0001833811,0.0000584945,0.0000141459495,0.00016837505,0.0026998285,0.00018526403],"category_scores_gemma":[0.0008447377,0.00035057004,0.0017093478,0.00041134824,0.00013134193,0.000088877416,0.000023137865,0.0010662482,0.00009334558],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011213676,0.0015480495,0.00028153212,0.0092552835,0.00028835304,0.000015183704,0.000009592967,6.2734095e-8,1.1644244e-8,0.00039693643,0.006225071,0.9818678],"study_design_scores_gemma":[0.002924736,0.004717539,0.00029485952,0.020573657,0.0054967985,0.0000261841,0.000001878188,0.000004590022,1.8435927e-7,0.00010376706,0.9656397,0.00021611528],"about_ca_topic_score_codex":0.000017213344,"about_ca_topic_score_gemma":0.0005809767,"teacher_disagreement_score":0.98165166,"about_ca_system_score_codex":0.0023589828,"about_ca_system_score_gemma":0.0023710162,"threshold_uncertainty_score":0.9998946},"labels":[],"label_agreement":null},{"id":"W2913253891","doi":"10.1038/s41571-019-0167-7","title":"Real-world data: towards achieving the achievable in cancer care","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":316,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Queen's University","funders":"Canada Research Chairs","keywords":"Medicine; Real world data; Clinical trial; MEDLINE; Quality (philosophy); Clinical Practice; Randomized controlled trial; Health care; Data science; Intensive care medicine; Medical physics; Computer science; Family medicine; Internal medicine","score_opus":0.8509468801012106,"score_gpt":0.6837867345671093,"score_spread":0.1671601455341013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913253891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000512335,0.9529931,0.000010078176,0.016734077,0.006931278,0.005833888,0.001377846,0.000041016352,0.016073572],"genre_scores_gemma":[0.0000035953697,0.9741894,0.0013297695,0.016508726,0.003994563,0.00091552985,0.0008355284,0.00012628955,0.0020966025],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9664023,0.008684132,0.021269716,0.0024844646,0.00019142908,0.0009679842],"domain_scores_gemma":[0.963399,0.014584145,0.017253416,0.0043473872,0.00011109799,0.00030493745],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.09620523,0.0008267393,0.017626008,0.0006059027,0.0001854889,0.00010097573,0.003736104,0.0026384457,0.00047301056],"category_scores_gemma":[0.02674326,0.0006315204,0.0015221196,0.0012262256,0.00029191648,0.00042008463,0.0010347408,0.006968559,0.005890509],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008010108,0.00012506823,0.0014594181,0.02804893,0.00018730127,0.000004013977,0.00010635765,0.0000016401247,3.802085e-10,0.007382763,0.078113295,0.8845632],"study_design_scores_gemma":[0.00044796185,0.00014016923,0.0010099907,0.010446034,0.00034949073,0.00000503924,0.00005891104,0.000029675102,5.621338e-10,0.00016697058,0.9867507,0.0005950112],"about_ca_topic_score_codex":0.0029420352,"about_ca_topic_score_gemma":0.020854743,"teacher_disagreement_score":0.90863746,"about_ca_system_score_codex":0.003696487,"about_ca_system_score_gemma":0.003971163,"threshold_uncertainty_score":0.9996136},"labels":[],"label_agreement":null},{"id":"W2913928134","doi":"10.1038/s41571-019-0177-5","title":"Challenges to curing primary brain tumours","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":972,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University Health Network","funders":"Cancer Research UK; National Institutes of Health; National Cancer Institute; National Institute of Neurological Disorders and Stroke; Medical Research Council; Brain Tumour Charity","keywords":"Brain cancer; Brain research; Medicine; Intensive care medicine; Neuroscience; Cancer; Psychology; Internal medicine","score_opus":0.3081992535077119,"score_gpt":0.5503383396841285,"score_spread":0.2421390861764166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913928134","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000028195855,0.9587301,8.312837e-7,0.013106894,0.002625249,0.00655418,0.00002058348,0.00007103378,0.018888304],"genre_scores_gemma":[0.0000016419264,0.9819912,0.0013246707,0.012505125,0.0023472523,0.0008619503,0.00021799296,0.00012467566,0.0006255199],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99228287,0.0018269251,0.0032696296,0.0015739305,0.0003923637,0.0006543113],"domain_scores_gemma":[0.9904022,0.0057115112,0.0014285872,0.0015613547,0.000133995,0.0007623288],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0041848347,0.00089187856,0.013588969,0.00034017794,0.00004564833,0.000015265345,0.0005207373,0.004042353,0.00014547067],"category_scores_gemma":[0.005418867,0.00054543116,0.0037505107,0.00045692208,0.00008760288,0.000040918836,0.0003646883,0.0044450965,0.0044077],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023706962,0.0011336209,0.000040546915,0.03403682,0.000396322,0.00035037368,0.000008225489,1.365662e-8,6.200967e-8,0.00032455672,0.062278017,0.9014077],"study_design_scores_gemma":[0.0012018457,0.0021034337,0.00044280363,0.0478402,0.005292526,0.0002943751,0.0000020483346,7.086474e-8,8.8843606e-8,0.000013286353,0.94239503,0.00041427792],"about_ca_topic_score_codex":0.0000013410164,"about_ca_topic_score_gemma":0.00001656404,"teacher_disagreement_score":0.90099347,"about_ca_system_score_codex":0.0008332137,"about_ca_system_score_gemma":0.0013210041,"threshold_uncertainty_score":0.9996997},"labels":[],"label_agreement":null},{"id":"W2917677528","doi":"10.1038/s41571-019-0181-9","title":"Vessel co-option in cancer","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":444,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Angiogenesis; Medicine; Blood vessel; Metastasis; Cancer; Disease; Mechanism (biology); Pathology; Bioinformatics; Cancer research; Internal medicine; Biology","score_opus":0.21056619825139275,"score_gpt":0.5653323674891731,"score_spread":0.35476616923778037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917677528","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009573399,0.9933695,0.000017394832,0.00013443563,0.0024916148,0.0015782574,0.00007451652,0.000008185821,0.0023164952],"genre_scores_gemma":[0.0000045474267,0.9914,0.00025322873,0.002337954,0.0029716035,0.00054858084,0.0006223631,0.00007394275,0.0017877507],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946718,0.0014735837,0.002183219,0.0010978157,0.00014955003,0.0004240076],"domain_scores_gemma":[0.9973933,0.00028647418,0.0012805413,0.00081267685,0.00008044164,0.00014657744],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0023283323,0.0005367715,0.00420584,0.00010395589,0.000030552208,0.000011917364,0.0006110519,0.005590058,0.00016827905],"category_scores_gemma":[0.00067646353,0.00038247404,0.0019183335,0.0002601382,0.00013018723,0.0000035858216,0.00016962574,0.0019058535,0.00043103297],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023272001,0.00016167716,0.00012518022,0.004868658,0.00012129191,0.0000066386024,0.0000011656209,3.4380378e-7,0.000003816412,0.000056467714,0.061151035,0.93348044],"study_design_scores_gemma":[0.00041343196,0.00043623836,0.00004955122,0.004493388,0.0005604164,0.000016036562,9.1997424e-7,6.9089225e-7,0.0000018042934,0.000007111828,0.9936034,0.00041698085],"about_ca_topic_score_codex":0.000011895335,"about_ca_topic_score_gemma":0.00007273107,"teacher_disagreement_score":0.93306345,"about_ca_system_score_codex":0.00021180592,"about_ca_system_score_gemma":0.0014852139,"threshold_uncertainty_score":0.99986273},"labels":[],"label_agreement":null},{"id":"W2947012492","doi":"10.1038/s41571-019-0236-y","title":"Reply to ‘Assembling the brain trust: the multidisciplinary imperative in neuro-oncology’","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University Health Network","funders":"National Cancer Institute; Cancer Research UK","keywords":"Multidisciplinary approach; Precision oncology; Medicine; Psychology; Oncology; Internal medicine; Cancer; Political science","score_opus":0.19022848612239612,"score_gpt":0.5445429713486446,"score_spread":0.3543144852262485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947012492","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012836397,0.89718425,0.0000017068703,0.08555251,0.0026414748,0.012848242,0.0000268981,0.00003383899,0.0015827115],"genre_scores_gemma":[0.000041798994,0.9409317,0.00046044795,0.053899463,0.0016607095,0.0024991836,0.000104223094,0.000098094366,0.00030438756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9852017,0.0076140226,0.0043778415,0.0016231304,0.00040832072,0.00077497005],"domain_scores_gemma":[0.959142,0.035851285,0.0020152286,0.0023671242,0.00020410877,0.00042020003],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.010681134,0.0009599202,0.009492765,0.00029381207,0.00020292857,0.000037613365,0.0010588724,0.0030949838,0.000105442654],"category_scores_gemma":[0.020347347,0.00038994427,0.0030681912,0.0014411879,0.00030766238,0.000054539298,0.00073830487,0.008760117,0.00094851805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100949605,0.0011706498,0.0004914811,0.002352325,0.00033156318,0.0005470323,0.00013250245,6.6789767e-7,8.0494897e-7,0.00018073598,0.0757342,0.9189571],"study_design_scores_gemma":[0.0019623353,0.0032272732,0.000969462,0.009624658,0.0031822918,0.00041123223,0.000049613132,0.000010176016,2.5862744e-7,0.000025228965,0.98019737,0.00034009758],"about_ca_topic_score_codex":0.000018621697,"about_ca_topic_score_gemma":0.00015104146,"teacher_disagreement_score":0.918617,"about_ca_system_score_codex":0.0010548313,"about_ca_system_score_gemma":0.0023645966,"threshold_uncertainty_score":0.9998552},"labels":[],"label_agreement":null},{"id":"W2947504704","doi":"10.1038/s41571-019-0235-z","title":"Assembling the brain trust: the multidisciplinary imperative in neuro-oncology","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto","funders":"Cancer Research UK","keywords":"Multidisciplinary approach; Medicine; Psychology; Internal medicine; Oncology; Political science","score_opus":0.21357649914434365,"score_gpt":0.554877179958118,"score_spread":0.3413006808137744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947504704","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010578931,0.9531713,0.0000014354308,0.031208666,0.003032484,0.010055448,0.000024674899,0.000031295876,0.0023689196],"genre_scores_gemma":[0.00007069299,0.9838581,0.00024779874,0.011690417,0.0017820712,0.0018413997,0.00015476432,0.00009755968,0.00025721252],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9838236,0.009443857,0.0042284415,0.0013770369,0.00037961415,0.00074743084],"domain_scores_gemma":[0.9518656,0.04339232,0.002401356,0.0018880793,0.00016872992,0.00028389567],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.009638447,0.00095352606,0.010008685,0.00024613933,0.00019683175,0.00003360337,0.0009805241,0.004423295,0.00015000583],"category_scores_gemma":[0.01345968,0.00037602548,0.0034564838,0.0010993788,0.0004708663,0.000059513415,0.000601532,0.010674183,0.00067965797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006693691,0.0014298396,0.0006186808,0.0030761496,0.00041538462,0.00060456654,0.000081195634,3.9908025e-7,6.363679e-7,0.00034724755,0.02530129,0.9680577],"study_design_scores_gemma":[0.0024974004,0.0024046116,0.00089506886,0.007857996,0.0040720617,0.0005373135,0.000041577674,0.000023499484,1.5403563e-7,0.000040711115,0.9813141,0.00031550322],"about_ca_topic_score_codex":0.00000976439,"about_ca_topic_score_gemma":0.00017297782,"teacher_disagreement_score":0.96774215,"about_ca_system_score_codex":0.0009449662,"about_ca_system_score_gemma":0.0026632117,"threshold_uncertainty_score":0.99986917},"labels":[],"label_agreement":null},{"id":"W2958760191","doi":"10.1038/s41571-019-0254-9","title":"Continuing to improve outcomes of men with metastatic prostate cancer","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Prostate cancer; Medicine; Context (archaeology); Oncology; Disease; Androgen deprivation therapy; Clinical trial; Internal medicine; Androgen receptor; Overall survival; Androgen; Cancer; Hormone; Biology","score_opus":0.17349663504997226,"score_gpt":0.5694412218230142,"score_spread":0.3959445867730419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958760191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021225815,0.98231983,0.000002952274,0.0011004896,0.0007239108,0.01300254,0.00020789892,0.000026640426,0.0025944891],"genre_scores_gemma":[0.000004438131,0.97395563,0.002048439,0.0008680218,0.00030326712,0.0017181743,0.00014165237,0.00009983451,0.020860549],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99366546,0.0011493465,0.0029959783,0.0010382764,0.0005130487,0.00063792226],"domain_scores_gemma":[0.9938364,0.0023135967,0.0019523387,0.0009792094,0.00043029687,0.00048818268],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0030400339,0.0007124691,0.013323363,0.00026966314,0.000027264972,0.000012917111,0.00041013607,0.0012174882,0.00017587857],"category_scores_gemma":[0.001797909,0.0003316109,0.0016794843,0.00065576227,0.00024278418,0.000054045642,0.00021240221,0.0033443004,0.00024909884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004318024,0.0003930276,0.0007890033,0.044640098,0.0019451306,0.00011402372,0.000040233797,4.0014257e-8,6.611271e-7,0.000028435361,0.0051933746,0.9464242],"study_design_scores_gemma":[0.0032972891,0.004097892,0.0001383365,0.03228354,0.009534668,0.000030400017,0.000009875337,6.428083e-7,0.0000016418331,0.0000057122447,0.9502921,0.0003078994],"about_ca_topic_score_codex":0.000024483286,"about_ca_topic_score_gemma":0.000034320434,"teacher_disagreement_score":0.94611627,"about_ca_system_score_codex":0.0005064616,"about_ca_system_score_gemma":0.0027661147,"threshold_uncertainty_score":0.9999136},"labels":[],"label_agreement":null},{"id":"W2964802061","doi":"10.1038/s41571-019-0253-x","title":"Global Consultation on Cancer Staging: promoting consistent understanding and use","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston Health Sciences Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Centers for Disease Control and Prevention; World Health Organization; U.S. Department of Health and Human Services","keywords":"Terminology; Context (archaeology); Medicine; Disease; Cancer; Confusion; Identification (biology); Intensive care medicine; Pathology; Psychology; Internal medicine","score_opus":0.2939129351022284,"score_gpt":0.5190481148766658,"score_spread":0.22513517977443742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964802061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000080057674,0.9947006,0.00006751125,0.00021941995,0.0019349463,0.0019773473,0.00030118413,0.0000096134045,0.00070929865],"genre_scores_gemma":[0.0001116067,0.9957378,0.00042999425,0.0022030699,0.0008115561,0.00012477228,0.00036984537,0.00004256134,0.00016880281],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962952,0.0007618628,0.0014897494,0.0009798568,0.00013541419,0.00033790004],"domain_scores_gemma":[0.9964046,0.0014694148,0.0013141155,0.0004948305,0.00011171478,0.00020532441],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013007225,0.00046981472,0.0025755656,0.00004779082,0.00007526048,0.00006156491,0.00022784724,0.0022132308,0.000012412815],"category_scores_gemma":[0.005190487,0.00036092137,0.0006579565,0.00016677892,0.00019436363,0.000004290379,0.00022783797,0.0010423631,0.000022573837],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045586577,0.00010408451,0.00029777543,0.0043929596,0.00024773975,0.000010344607,0.000005627748,0.0000010961297,9.0373555e-7,0.001120207,0.009019447,0.9847542],"study_design_scores_gemma":[0.00067962316,0.00077445,0.0000316629,0.0051271394,0.0010952648,0.000026051293,0.00000739828,0.000004748637,4.198735e-7,0.0000515349,0.991837,0.00036467443],"about_ca_topic_score_codex":0.000011647319,"about_ca_topic_score_gemma":0.00013686912,"teacher_disagreement_score":0.98438954,"about_ca_system_score_codex":0.0005404032,"about_ca_system_score_gemma":0.0013404636,"threshold_uncertainty_score":0.99988425},"labels":[],"label_agreement":null},{"id":"W2971204478","doi":"10.1038/s41571-019-0264-7","title":"Phase I trials as therapeutic options: (usually) a betrayal of evidence-based medicine","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Betrayal; Alternative medicine; Clinical trial; Phase (matter); Intensive care medicine; Psychotherapist; Internal medicine; Pathology; Psychology; Social psychology","score_opus":0.9696885455836366,"score_gpt":0.8168281786167281,"score_spread":0.15286036696690852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971204478","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000015545837,0.9666783,0.00008995668,0.014451597,0.0037612747,0.012189474,0.000053600244,0.00006809839,0.0027061303],"genre_scores_gemma":[0.0000062722006,0.9755699,0.0026683314,0.01215566,0.0045717163,0.0007337514,0.0002745963,0.00016486991,0.0038549055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.94180906,0.031405162,0.020440027,0.0023817355,0.002952411,0.0010115854],"domain_scores_gemma":[0.2626245,0.7111234,0.015498157,0.0056864494,0.0033561937,0.0017112807],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity","insufficient_payload"],"category_scores_codex":[0.19262819,0.0012296445,0.035572663,0.00087781367,0.00008727596,0.00002002728,0.0020724593,0.01761304,0.0034933493],"category_scores_gemma":[0.686354,0.0006139604,0.009122097,0.0019901223,0.0027151043,0.000110948284,0.00039078775,0.03215679,0.0013229375],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010291263,0.0034321474,0.000008713372,0.09604143,0.0011806025,0.00011340213,0.000008644076,4.336589e-8,0.0000012295069,0.006359909,0.0067619234,0.8850628],"study_design_scores_gemma":[0.006913306,0.023569798,0.000002823322,0.20767543,0.015155922,0.00007098351,0.0000056092986,0.0000037200841,5.7443145e-7,0.0021790136,0.7440594,0.00036341435],"about_ca_topic_score_codex":0.000017286295,"about_ca_topic_score_gemma":0.000021559094,"teacher_disagreement_score":0.8846994,"about_ca_system_score_codex":0.00074485416,"about_ca_system_score_gemma":0.02258648,"threshold_uncertainty_score":0.9999989},"labels":[],"label_agreement":null},{"id":"W2981815608","doi":"10.1038/s41571-019-0287-0","title":"Imatinib and the long tail of targeted drug development","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Imatinib; Medicine; Drug; Drug development; Imatinib mesylate; Anticancer drug; Targeted therapy; Cancer; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.12461724817597737,"score_gpt":0.48656931244882984,"score_spread":0.3619520642728525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981815608","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019185121,0.9882828,0.0000042983734,0.00054307317,0.0011782575,0.0069747106,0.000014280501,0.000026506801,0.0029568993],"genre_scores_gemma":[0.0000071948316,0.98966014,0.004737434,0.0012414833,0.0004919267,0.00038255422,0.00028383077,0.000070409886,0.0031250087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9904787,0.0028774962,0.0049205315,0.00088748446,0.00040484717,0.00043092127],"domain_scores_gemma":[0.9873564,0.0075202263,0.003470275,0.0012162641,0.00017732823,0.00025950043],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0072648046,0.00071782904,0.012687852,0.00013116925,0.000059378737,0.000008626169,0.0004899692,0.0025883145,0.00028447816],"category_scores_gemma":[0.0062346943,0.00033500718,0.0018965605,0.00039975086,0.00064816786,0.00003345837,0.00038089967,0.004606585,0.00051987066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014236501,0.00026905313,0.00006935351,0.039530434,0.0009481597,0.00004553934,0.00004571157,6.7002657e-9,1.30366935e-8,0.00013601854,0.008975205,0.94983816],"study_design_scores_gemma":[0.0062415185,0.00027475812,0.00016083503,0.0258558,0.0065213013,0.00025068343,0.0000038420058,0.0000016658123,2.760873e-7,0.000012080047,0.9604292,0.0002480332],"about_ca_topic_score_codex":0.000006626045,"about_ca_topic_score_gemma":0.0000230939,"teacher_disagreement_score":0.951454,"about_ca_system_score_codex":0.00097631675,"about_ca_system_score_gemma":0.0057811826,"threshold_uncertainty_score":0.9999102},"labels":[],"label_agreement":null},{"id":"W2995032149","doi":"10.1038/s41571-019-0312-3","title":"Reply to ‘Correcting the ASCO position on phase I clinical trials in cancer’","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Clinical trial; Position paper; Cancer; Oncology; Medical physics; Internal medicine; Family medicine; Pathology","score_opus":0.9170537404042044,"score_gpt":0.7532702093287833,"score_spread":0.1637835310754211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995032149","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029328197,0.91012985,0.00010012048,0.058093157,0.017504407,0.0113662705,0.0004420287,0.000039401737,0.0022954128],"genre_scores_gemma":[0.000005945742,0.8285677,0.0007101996,0.16155198,0.0066766664,0.001611362,0.00013766247,0.00009083872,0.00064768735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.87809,0.0578452,0.060178965,0.0027254708,0.00022514146,0.0009351905],"domain_scores_gemma":[0.77025336,0.18054453,0.045323342,0.0029869548,0.00017754901,0.0007142612],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.4905553,0.0008135328,0.029212026,0.0006886358,0.00016950212,0.00009373819,0.0014520157,0.004261626,0.00056795037],"category_scores_gemma":[0.39161605,0.0006097942,0.0046262066,0.0009585907,0.00014766016,0.00017968508,0.00023318439,0.007960076,0.013308787],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006305058,0.0005869889,0.00016328593,0.00503216,0.00018452582,0.0000046047603,0.00004895344,0.0000023268071,1.0297281e-9,0.0027871474,0.1913711,0.7997559],"study_design_scores_gemma":[0.001703657,0.0014779608,0.00009379701,0.01616339,0.00037677377,0.000020339783,0.00002357864,0.00003725829,6.058521e-9,0.0004931714,0.97904456,0.0005655238],"about_ca_topic_score_codex":0.00027132634,"about_ca_topic_score_gemma":0.00032947742,"teacher_disagreement_score":0.79919034,"about_ca_system_score_codex":0.0027713361,"about_ca_system_score_gemma":0.0023487231,"threshold_uncertainty_score":0.99963534},"labels":[],"label_agreement":null},{"id":"W3007679475","doi":"10.1038/s41571-019-0320-3","title":"Current approaches to the management of brain metastases","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":551,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiosurgery; Disease; Brain metastasis; Neuroimaging; Intensive care medicine; Radiation therapy; Lung cancer; Clinical trial; Cancer; Breast cancer; Oncology; Metastasis; Internal medicine; Psychiatry","score_opus":0.5357107495680552,"score_gpt":0.5524210198591318,"score_spread":0.016710270291076634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007679475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.4367615e-7,0.97388357,0.00014037291,0.014744353,0.0012569267,0.008424697,0.00017452787,0.00002761101,0.001347826],"genre_scores_gemma":[8.0829125e-7,0.97838926,0.015198032,0.0037073179,0.0010481719,0.0009800553,0.00040912806,0.000061697014,0.00020552728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99087286,0.0036432305,0.0035591125,0.001068314,0.00044762035,0.00040885096],"domain_scores_gemma":[0.99372745,0.0026578123,0.0016802279,0.0013599871,0.00006006443,0.00051448913],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006162155,0.0007177689,0.009367727,0.00012203149,0.000055121847,0.000011166282,0.0006776357,0.00093711,0.0001546601],"category_scores_gemma":[0.0014173576,0.00033046267,0.0039278334,0.00094024825,0.0001818993,0.000019075633,0.0005091446,0.0032693755,0.0006356211],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050786883,0.0009549116,0.000001956199,0.038882814,0.0022935292,0.00018022319,0.000008872434,6.05685e-8,1.2022431e-9,0.0036366081,0.07174402,0.8822462],"study_design_scores_gemma":[0.0007790206,0.00162463,0.00001412229,0.019592064,0.019751728,0.0001050693,0.000008886724,6.888047e-7,4.1729063e-8,0.000032159798,0.957861,0.00023055618],"about_ca_topic_score_codex":0.0000012782212,"about_ca_topic_score_gemma":0.0000050144795,"teacher_disagreement_score":0.88611704,"about_ca_system_score_codex":0.0002221596,"about_ca_system_score_gemma":0.0005939762,"threshold_uncertainty_score":0.99991477},"labels":[],"label_agreement":null},{"id":"W3008432399","doi":"10.1038/s41571-020-0345-7","title":"Real-world evidence and regulatory drug approval","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Real world evidence; Drug approval; Drug; Cancer drugs; Regulatory science; Drug development; Medicine; Business; Pharmacology; Internal medicine","score_opus":0.24496724960993593,"score_gpt":0.46638844999166723,"score_spread":0.2214212003817313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008432399","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004162741,0.9578884,0.000014888616,0.001508423,0.003145553,0.001851071,0.000120767574,0.000061846666,0.035404857],"genre_scores_gemma":[0.000010008736,0.98804796,0.0016362815,0.0027078062,0.0033421048,0.00021022669,0.000035254496,0.000109166744,0.0039011808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908795,0.00056212506,0.006047226,0.0018392762,0.00006052173,0.00061137695],"domain_scores_gemma":[0.99052006,0.0025245459,0.0052450835,0.0010456793,0.000056234672,0.0006083969],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.006858515,0.0007980156,0.011700077,0.00031328743,0.000109993875,0.00007710007,0.0009807914,0.002575899,0.0003292266],"category_scores_gemma":[0.006408094,0.00071153376,0.0019909216,0.00058703515,0.00046934577,0.00035097147,0.0004307195,0.0046682316,0.002554249],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015325417,0.000069713155,0.00023179835,0.0056667863,0.0001333831,0.000024462643,0.000017165661,2.0174534e-8,2.0915774e-9,0.056908082,0.05054822,0.886385],"study_design_scores_gemma":[0.0003045128,0.00021762872,0.00036641659,0.0061265524,0.0003593016,0.00002032387,0.0000014098905,0.0000043647624,9.9182795e-9,0.003355365,0.9885516,0.0006925252],"about_ca_topic_score_codex":0.00007543943,"about_ca_topic_score_gemma":0.00017773754,"teacher_disagreement_score":0.93800336,"about_ca_system_score_codex":0.0007718096,"about_ca_system_score_gemma":0.0009142945,"threshold_uncertainty_score":0.9995336},"labels":[],"label_agreement":null},{"id":"W3014200667","doi":"10.1038/s41571-020-0362-6","title":"Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":415,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"University of Toronto; King's College London; Queen's University; Ontario Institute for Cancer Research; Government of Canada; Government of Ontario","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); Precautionary principle; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Cancer; Intensive care medicine; Virology; Disease; Infectious disease (medical specialty); Pathology; Internal medicine","score_opus":0.4026145901668752,"score_gpt":0.6490970795603621,"score_spread":0.24648248939348694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014200667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019617195,0.9601295,0.0000057549464,0.02953553,0.00120849,0.0084586665,0.00015956159,0.00013091782,0.0003519402],"genre_scores_gemma":[0.000021327613,0.96998745,0.00028973364,0.024779338,0.0034612291,0.001028024,0.00010367891,0.000049274448,0.00027995656],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907269,0.0036895045,0.0033169354,0.001266479,0.00036002963,0.0006401459],"domain_scores_gemma":[0.98830384,0.0071443184,0.0018864111,0.00081892154,0.00010819503,0.0017382954],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0036136997,0.0008049876,0.009555164,0.00008247375,0.00028320108,0.000023881625,0.00034973604,0.0032416314,0.00008228229],"category_scores_gemma":[0.019842887,0.0004109085,0.0020353445,0.0006617623,0.0005813439,0.00004677467,0.00033124624,0.0042676744,0.00006500514],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0005940365,0.00017677473,0.0011584809,0.048781518,0.0005089864,0.00043315944,0.00005379716,3.3030588e-8,2.2843771e-8,0.00046613172,0.0014290517,0.946398],"study_design_scores_gemma":[0.0059353244,0.0011123403,0.0010149169,0.013294311,0.0056835036,0.001953262,0.0000049100827,0.0000029721916,4.5664263e-9,0.00007516927,0.9706162,0.00030708674],"about_ca_topic_score_codex":0.00017781316,"about_ca_topic_score_gemma":0.00052515103,"teacher_disagreement_score":0.96918714,"about_ca_system_score_codex":0.007219453,"about_ca_system_score_gemma":0.020851642,"threshold_uncertainty_score":0.9998343},"labels":[],"label_agreement":null},{"id":"W3015154527","doi":"10.1038/s41571-020-0352-8","title":"Moving towards personalized treatments of immune-related adverse events","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":345,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Adverse effect; Immune system; Medicine; Intensive care medicine; Cancer; Personalized medicine; Bioinformatics; Immunotherapy; Immunology; Internal medicine; Biology","score_opus":0.1277862675738988,"score_gpt":0.5063780017279471,"score_spread":0.37859173415404834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015154527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013662999,0.98982006,0.0000029141704,0.00060782285,0.0021203286,0.004050903,0.000074758354,0.00005368711,0.0032558725],"genre_scores_gemma":[0.000007732358,0.99412614,0.0011308298,0.0012213378,0.0004759339,0.00020214864,0.0004169897,0.00009402026,0.0023248417],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9894231,0.0022805277,0.00649325,0.00094656856,0.00043134223,0.00042523732],"domain_scores_gemma":[0.9933542,0.0010168089,0.0043068123,0.0008286277,0.00014982586,0.00034371542],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0032008197,0.0008095575,0.012567509,0.00018842428,0.00005283257,0.0000024536287,0.00051206455,0.004354885,0.0011247533],"category_scores_gemma":[0.002901999,0.0005103045,0.008982067,0.000888634,0.00036062,0.00004906243,0.00016928292,0.0038294536,0.00028036043],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009626293,0.000711358,0.000035125937,0.015452555,0.003809897,0.00017383705,0.000034630375,3.7732932e-9,0.0000021625788,0.000025434265,0.0017862421,0.97700614],"study_design_scores_gemma":[0.005895717,0.0022862402,0.00019183102,0.031037489,0.010753207,0.00023718794,0.000007996827,0.000001060509,4.7577717e-7,0.000010517464,0.94923663,0.00034162082],"about_ca_topic_score_codex":0.000018738709,"about_ca_topic_score_gemma":0.0000028642767,"teacher_disagreement_score":0.9766645,"about_ca_system_score_codex":0.0008499513,"about_ca_system_score_gemma":0.0029632873,"threshold_uncertainty_score":0.99978834},"labels":[],"label_agreement":null},{"id":"W3015891597","doi":"10.1038/s41571-020-0368-0","title":"Informative censoring — a neglected cause of bias in oncology trials","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Censoring (clinical trials); Medicine; Clinical trial; Oncology; Internal medicine; Randomized controlled trial; Dropout (neural networks); Clinical endpoint; Disease; Pathology","score_opus":0.9448741470251816,"score_gpt":0.7660528400446187,"score_spread":0.17882130698056287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015891597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000010000907,0.9788648,0.0009221703,0.0005368806,0.0045920936,0.009225198,0.00035055875,0.0001061552,0.0054011843],"genre_scores_gemma":[2.6565928e-7,0.6959756,0.3008322,0.00082886335,0.001593243,0.0005754088,0.000028962655,0.000108317494,0.00005715495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.81599087,0.135065,0.044636954,0.0020258445,0.0009894653,0.0012918811],"domain_scores_gemma":[0.21700656,0.75380206,0.025999,0.0017849146,0.00057816046,0.000829318],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch","metaepi_narrow","research_integrity"],"category_scores_codex":[0.08276943,0.0014290422,0.05556507,0.00061674166,0.00005413397,0.000025640733,0.0019146254,0.012242589,0.00058640726],"category_scores_gemma":[0.9203298,0.0009274833,0.0064742076,0.0026744837,0.0008306735,0.000120832694,0.0008807246,0.01565328,0.00039012288],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029501767,0.00093032344,0.000005272225,0.027207227,0.00092335965,0.0002667699,0.0000828792,3.6313914e-8,9.2394835e-8,0.014050207,0.0107505545,0.9454883],"study_design_scores_gemma":[0.0026990864,0.002368226,0.000006447934,0.025311878,0.0059405896,0.000060316826,0.000014703966,0.0000051508214,4.943585e-7,0.046851825,0.9160787,0.0006625688],"about_ca_topic_score_codex":0.0000068864833,"about_ca_topic_score_gemma":0.000050467395,"teacher_disagreement_score":0.9448257,"about_ca_system_score_codex":0.001147315,"about_ca_system_score_gemma":0.004429026,"threshold_uncertainty_score":0.999846},"labels":[],"label_agreement":null},{"id":"W3022408996","doi":"10.1038/s41571-020-0374-2","title":"Palliative care services at cancer centres — room for improvement","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Palliative care; Referral; Medicine; Nursing; Curative care; Ambulatory care; Family medicine; Quality of life (healthcare); Health care; Political science","score_opus":0.4018971727234965,"score_gpt":0.630122387847158,"score_spread":0.2282252151236615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022408996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000044773296,0.9886644,0.0000089507,0.001246792,0.0020800803,0.006200884,0.0007833981,0.000041178802,0.000969875],"genre_scores_gemma":[0.0000014063863,0.98560506,0.0033213885,0.0047732354,0.0030798318,0.0012628582,0.0013112819,0.000087075845,0.00055786193],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939248,0.0007000024,0.0034028902,0.0011302519,0.0003406905,0.000501393],"domain_scores_gemma":[0.9916871,0.0035965706,0.0030482323,0.00061849447,0.00059007487,0.00045952795],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00077932165,0.0007842175,0.011004031,0.00009611398,0.00007006821,0.000007777304,0.0005139596,0.0030213117,0.00024042011],"category_scores_gemma":[0.0022820192,0.000489427,0.003556835,0.0003686013,0.00013705473,0.000034295324,0.00031715425,0.0023326296,0.00011721071],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017559012,0.0001523695,0.0006974893,0.13301194,0.0009459473,0.000033768505,0.00021189549,2.464906e-8,4.1063984e-7,0.000043118696,0.013048048,0.8516794],"study_design_scores_gemma":[0.0015651673,0.0020582136,0.000031750937,0.07585089,0.007698459,0.0000023614634,0.00007989292,0.0000016173722,0.000004441002,0.000011704464,0.91233814,0.00035738325],"about_ca_topic_score_codex":0.00003189199,"about_ca_topic_score_gemma":0.00044783688,"teacher_disagreement_score":0.8992901,"about_ca_system_score_codex":0.0012130192,"about_ca_system_score_gemma":0.001507859,"threshold_uncertainty_score":0.999969},"labels":[],"label_agreement":null},{"id":"W3025082263","doi":"10.1038/s41571-020-0394-y","title":"COVID-19 and cancer: do we really know what we think we know?","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"Queen's University","keywords":"Coronavirus disease 2019 (COVID-19); Observational study; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Quality (philosophy); Cancer; Limit (mathematics); Need to know; Medicine; Virology; Epistemology; Computer science; Pathology; Philosophy; Internal medicine; Disease","score_opus":0.308748734625815,"score_gpt":0.610603666652903,"score_spread":0.301854932027088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025082263","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.136098e-8,0.679236,0.000007777262,0.31129614,0.0035707527,0.005193902,0.00009456615,0.0001516582,0.0004491362],"genre_scores_gemma":[2.435813e-7,0.88491374,0.0009119515,0.10521086,0.0068584187,0.00040991625,0.00016155132,0.00016705983,0.0013662343],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9845092,0.0052007213,0.0059229666,0.0024574338,0.0007340455,0.0011755893],"domain_scores_gemma":[0.9730638,0.015426313,0.0037125857,0.0018091385,0.000363931,0.0056242263],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.007158727,0.0014923972,0.017567225,0.0004133811,0.00023273937,0.000114450864,0.00091143197,0.009420996,0.0010743825],"category_scores_gemma":[0.037100445,0.00097343576,0.0030221476,0.0013371648,0.0005967966,0.00023380524,0.00062176585,0.014427684,0.00068878394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016872723,0.0002189423,0.000016199238,0.13204385,0.0003296188,0.0006880693,0.00015782959,1.4493447e-8,3.343635e-8,0.0003055419,0.1885155,0.6775557],"study_design_scores_gemma":[0.0017941801,0.0025041592,0.000007959591,0.1323113,0.005117381,0.00061217806,0.00003209218,0.0000016364172,1.4245369e-8,0.0003291699,0.8566244,0.000665498],"about_ca_topic_score_codex":0.000106415995,"about_ca_topic_score_gemma":0.0007567089,"teacher_disagreement_score":0.6768902,"about_ca_system_score_codex":0.0030397428,"about_ca_system_score_gemma":0.037133332,"threshold_uncertainty_score":0.99983877},"labels":[],"label_agreement":null},{"id":"W3027335902","doi":"10.1038/s41571-020-0388-9","title":"Personalized early detection and prevention of breast cancer: ENVISION consensus statement","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":439,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Faculty of Medicine and Health, University of Sydney; NIHR Cambridge Biomedical Research Centre; University of California, San Francisco; Unicancer; Max-Planck-Institut für Bildungsforschung; Centro de Investigación Biomédica en Red de Cáncer; Universiteit Antwerpen; Tartu Ülikool; Institut National Du Cancer; Radboud Universitair Medisch Centrum; Universidad San Pablo - CEU; Leids Universitair Medisch Centrum; Fondation ARC pour la Recherche sur le Cancer; Karolinska Institutet; Universitair Medisch Centrum Utrecht; Lunds Universitet; Queen Mary University of London; National Institute for Health and Care Research; Gentofte Hospital; Universitätsklinikum Köln; Centre International de Recherche sur le Cancer; University of Twente; University of Melbourne; National Cancer Institute; Universität Heidelberg; University of Toronto; World Health Organization; Cancer Research UK; University College London; University of Leicester; Universiteit Leiden; Vanderbilt University Medical Center; Radboud Universiteit; Horizon 2020 Framework Programme; Clalit Health Services; QIMR Berghofer Medical Research Institute; Institut Gustave-Roussy; Vrije Universiteit Amsterdam; Deutsches Krebsforschungszentrum; Université Laval; Cancer Care Ontario; Universidade de Santiago de Compostela; Universitat de Girona; Division of Mathematical Sciences; European Commission","keywords":"Breast cancer; Cancer prevention; Medicine; Psychological intervention; Breast cancer screening; Mammography; Cancer; Family medicine; Nursing; Internal medicine","score_opus":0.2770679094564181,"score_gpt":0.566229596267098,"score_spread":0.2891616868106799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027335902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006896431,0.9951233,0.0000433522,0.0011845956,0.0006437779,0.0025762867,0.00008575305,0.00002377178,0.00025015467],"genre_scores_gemma":[0.000097292876,0.9967559,0.0012891794,0.0007723823,0.00071486586,0.00014828586,0.000043447915,0.00003061046,0.00014804931],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941828,0.0015642295,0.0029198658,0.00071388576,0.000363774,0.00025540023],"domain_scores_gemma":[0.99596775,0.00078753004,0.0023990576,0.0003032878,0.00021336277,0.0003290028],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0025604109,0.00040253004,0.0058191568,0.000098988414,0.00004768527,0.00000866696,0.00014632594,0.0017835521,0.0001654862],"category_scores_gemma":[0.0013022383,0.00027317446,0.0013041134,0.0003729868,0.00025835703,0.000036946174,0.000112674505,0.0024824408,0.00003185758],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039085286,0.0000840047,0.000079682555,0.01262609,0.00028387806,0.000059128422,0.000015049957,1.2436011e-8,0.0000021539558,0.00003228353,0.0015618317,0.984865],"study_design_scores_gemma":[0.0012493953,0.0022132536,0.0005533963,0.028624114,0.0042911293,0.00040200463,0.000009385504,0.00000359727,3.5850906e-7,0.00003069894,0.96243155,0.00019111467],"about_ca_topic_score_codex":0.00005702585,"about_ca_topic_score_gemma":0.00005571271,"teacher_disagreement_score":0.9846739,"about_ca_system_score_codex":0.00042257417,"about_ca_system_score_gemma":0.0012321929,"threshold_uncertainty_score":0.99997205},"labels":[],"label_agreement":null},{"id":"W3033331291","doi":"10.1038/s41571-020-0382-2","title":"The adenosine pathway in immuno-oncology","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":565,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Adenosinergic; Immunotherapy; Immune system; Cancer; Cancer research; Medicine; Cancer immunotherapy; Immunology; Biology; Adenosine receptor; Internal medicine; Receptor","score_opus":0.09757574864050292,"score_gpt":0.4791573120742012,"score_spread":0.3815815634336983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033331291","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000027322944,0.9906471,0.000021866314,0.0015600866,0.0022359358,0.0017616506,0.000024947749,0.000018687217,0.0037270195],"genre_scores_gemma":[0.000008199268,0.99034023,0.0004609791,0.0027578308,0.0046037096,0.000406075,0.000402302,0.000095379335,0.0009252877],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9892745,0.0047026384,0.003871138,0.0012498831,0.00020938583,0.0006924328],"domain_scores_gemma":[0.9944251,0.0021268332,0.001957383,0.0010947373,0.000116798634,0.0002791311],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0047616907,0.00077474286,0.005229671,0.00008304344,0.00014877641,0.00003160646,0.0015665836,0.0059249667,0.000054932512],"category_scores_gemma":[0.0061348137,0.00045591523,0.002059686,0.00055844773,0.00037524846,0.0000044150265,0.00073057,0.004830753,0.000272754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007065667,0.00016955953,0.000005541053,0.0010454421,0.0001796534,0.00014848061,0.0000055128517,1.45236e-7,0.000005267728,0.00017496097,0.10863871,0.88955605],"study_design_scores_gemma":[0.00066058437,0.0015045577,0.0000025387767,0.0018269737,0.00035472537,0.00020138189,0.0000072518774,8.906737e-7,0.00000322778,0.00003965985,0.9949271,0.00047108385],"about_ca_topic_score_codex":0.00000455015,"about_ca_topic_score_gemma":0.000054063887,"teacher_disagreement_score":0.889085,"about_ca_system_score_codex":0.00020627659,"about_ca_system_score_gemma":0.002638046,"threshold_uncertainty_score":0.99978924},"labels":[],"label_agreement":null},{"id":"W3034821185","doi":"10.1038/s41571-020-0401-3","title":"Reply to ‘Personalized treatment of immune-related adverse events — balance is required’","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Microscopic Colitis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Tofacitinib; Medicine; Infliximab; Vedolizumab; Adverse effect; Immune system; Clinical trial; Ulcerative colitis; Internal medicine; Bioinformatics; Immunology; Disease; Rheumatoid arthritis; Biology","score_opus":0.13375682114770235,"score_gpt":0.5219817870157574,"score_spread":0.388224965868055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034821185","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013041615,0.98226583,0.000004470323,0.004972979,0.002135918,0.008152175,0.00017876018,0.00006426167,0.0022125908],"genre_scores_gemma":[0.0000017130154,0.9774496,0.0040987846,0.009999048,0.0007951026,0.00049250684,0.00030772708,0.00010384466,0.0067516947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98781246,0.0021045394,0.0075235977,0.0015427804,0.0004133253,0.00060331076],"domain_scores_gemma":[0.9919818,0.0017653067,0.003522594,0.0017263148,0.0002354096,0.00076856994],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0020445767,0.0009263572,0.016598163,0.00019060067,0.00004888202,0.0000027064912,0.0005605632,0.0034661335,0.0016271839],"category_scores_gemma":[0.0064861057,0.00063094887,0.0059409076,0.0010342543,0.00024009013,0.000035230805,0.00022666599,0.002448703,0.0017617284],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002558146,0.0008480333,0.00008233805,0.013838669,0.0010637436,0.00035269413,0.00010072283,3.0409486e-9,0.0000022866236,0.000068486865,0.023901282,0.95948595],"study_design_scores_gemma":[0.0035095403,0.0053790235,0.00008767417,0.032858513,0.0059243278,0.0003019641,0.0000036417703,5.4902665e-7,0.0000013651672,0.000015997024,0.95153797,0.0003794366],"about_ca_topic_score_codex":0.00002719514,"about_ca_topic_score_gemma":0.000003981894,"teacher_disagreement_score":0.9591065,"about_ca_system_score_codex":0.0014282824,"about_ca_system_score_gemma":0.0027488407,"threshold_uncertainty_score":0.9998527},"labels":[],"label_agreement":null},{"id":"W3037199247","doi":"10.1038/s41571-020-0412-0","title":"Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Cancer Research UK; World Health Organization","keywords":"Statement (logic); Breast cancer; Medical physics; Computer science; Medicine; Political science; Cancer; Law; Internal medicine","score_opus":0.06619570857062869,"score_gpt":0.45438549020357105,"score_spread":0.3881897816329424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037199247","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000095706804,0.99393237,0.00009538311,0.0003489705,0.003624837,0.0015880597,0.00011131307,0.000012181281,0.00019115984],"genre_scores_gemma":[0.00011048712,0.99661165,0.00040257667,0.0003541192,0.0013091102,0.00021347338,0.00031525412,0.000040277635,0.0006430431],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99504125,0.0017664921,0.0019332257,0.00084774906,0.00018844345,0.00022286216],"domain_scores_gemma":[0.99727476,0.00019160322,0.0016066917,0.00036638943,0.00026257127,0.00029796318],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012033248,0.00039646353,0.0023211539,0.00007525603,0.000065749155,0.000023930499,0.00019959341,0.0018922576,0.0000724894],"category_scores_gemma":[0.00092979067,0.0003190442,0.0010259983,0.00020116041,0.00028165503,0.000005658603,0.0001458888,0.00090589933,0.000009435395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027287108,0.00021988995,0.000058441525,0.00397718,0.00021686534,0.000004918285,0.0000051819693,5.2882992e-8,0.00002203125,0.000005879535,0.03231893,0.9628978],"study_design_scores_gemma":[0.0011461929,0.0013280999,0.0002466629,0.0023066155,0.0013627828,0.000078462246,0.0000075981593,0.0000015749492,0.000003509379,0.000056129822,0.9931836,0.000278747],"about_ca_topic_score_codex":0.0000127070825,"about_ca_topic_score_gemma":0.000056358243,"teacher_disagreement_score":0.962619,"about_ca_system_score_codex":0.00009338804,"about_ca_system_score_gemma":0.0008211891,"threshold_uncertainty_score":0.99992615},"labels":[],"label_agreement":null},{"id":"W3040650012","doi":"10.1038/s41571-020-0392-0","title":"ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":365,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Colorectal cancer; Multidisciplinary approach; Task force; Oncology; Internal medicine; Minimal residual disease; Disease; MEDLINE; Cancer; Intensive care medicine","score_opus":0.04859247317157884,"score_gpt":0.4486514804192196,"score_spread":0.40005900724764076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040650012","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004517346,0.99592334,0.00004515977,0.00033786695,0.0003661474,0.002230765,0.00018916582,0.000009001287,0.00044681903],"genre_scores_gemma":[0.00043248484,0.9940232,0.000963399,0.0012430653,0.0012460292,0.0012099342,0.0008065687,0.000044232154,0.000031101445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965195,0.0007115142,0.0014045341,0.0010161788,0.00008738956,0.0002609059],"domain_scores_gemma":[0.99807906,0.0005131894,0.0007564554,0.00029366577,0.000082781306,0.0002748379],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009915034,0.00042542975,0.0023635782,0.0000735611,0.00006739699,0.000036600813,0.00028716997,0.0019789527,0.00001004641],"category_scores_gemma":[0.001178443,0.0003387595,0.0003067682,0.0002441213,0.00023886692,0.0000073561623,0.00023430093,0.0014606792,0.0000064707015],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072277275,0.00012196278,0.00012213494,0.0010329568,0.000060444618,0.0000064362443,0.000011673936,1.5613467e-7,0.00008145852,0.00016889091,0.0024143367,0.99590725],"study_design_scores_gemma":[0.00045126415,0.0017639921,0.00013815572,0.00094548817,0.00050019566,0.000043215754,0.0000070842034,0.000008752689,0.00000397664,0.000081192986,0.99571884,0.00033785217],"about_ca_topic_score_codex":0.000032919554,"about_ca_topic_score_gemma":0.0035370155,"teacher_disagreement_score":0.9955694,"about_ca_system_score_codex":0.00012561532,"about_ca_system_score_gemma":0.0007921853,"threshold_uncertainty_score":0.9999064},"labels":[],"label_agreement":null},{"id":"W3043654181","doi":"10.1038/s41571-020-0415-x","title":"Publisher Correction: The adenosine pathway in immuno-oncology","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Adenosine; Medicine; Psychology; Computer science; Oncology; Internal medicine","score_opus":0.09702945120851257,"score_gpt":0.45902843339692184,"score_spread":0.36199898218840926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043654181","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000012924233,0.973899,0.000036735382,0.002291527,0.010335739,0.0018089672,0.0000093240205,0.000024262106,0.011593131],"genre_scores_gemma":[0.000008477597,0.98324066,0.00027082546,0.0055710617,0.006206653,0.00045945088,0.00054339925,0.00009394703,0.0036055502],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9896995,0.0047653415,0.0034092623,0.0013124689,0.00022569977,0.00058774865],"domain_scores_gemma":[0.99516034,0.0014821499,0.0018673927,0.0010849827,0.00015662843,0.0002485295],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.004275251,0.00077064347,0.004979136,0.00011460446,0.00011194052,0.000048081256,0.0014556076,0.006122747,0.00017410277],"category_scores_gemma":[0.006203703,0.00046033165,0.001973675,0.0008306613,0.00032615344,0.000010291098,0.0006691834,0.0057271575,0.00022601281],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037408478,0.00015152621,0.000008332792,0.0005367742,0.00011837191,0.00007187617,0.0000065299805,2.6218714e-7,0.0000010303914,0.000032117223,0.42462707,0.5744087],"study_design_scores_gemma":[0.0006272786,0.001320707,0.000005536404,0.0016634295,0.0004387485,0.0003970331,0.000012402712,0.000001731012,9.1277974e-7,0.00002940829,0.9950298,0.00047298466],"about_ca_topic_score_codex":0.000010038227,"about_ca_topic_score_gemma":0.00006105585,"teacher_disagreement_score":0.5739357,"about_ca_system_score_codex":0.00022981092,"about_ca_system_score_gemma":0.0025465642,"threshold_uncertainty_score":0.9997848},"labels":[],"label_agreement":null},{"id":"W3081423662","doi":"10.1038/s41571-020-0417-8","title":"Artificial intelligence in radiation oncology","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":401,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Cancer Institute; CARIM School for Cardiovascular Diseases, Universiteit Maastricht; Universiteit Maastricht; National Institutes of Health; Brigham and Women's Hospital","keywords":"Radiation oncology; Medical physics; Medicine; Oncology; Computer science; Radiation therapy; Internal medicine","score_opus":0.1720944463343659,"score_gpt":0.574027760237618,"score_spread":0.40193331390325215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081423662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.392799e-7,0.978197,0.0005101008,0.009845248,0.0030717675,0.002586323,0.0000058737783,0.00006389765,0.0057192505],"genre_scores_gemma":[0.0000035386424,0.9783366,0.007939078,0.0088059,0.004314022,0.0001915654,0.00022247504,0.00008007106,0.00010677787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9886686,0.0038033943,0.005458813,0.0011823494,0.0003300534,0.00055674923],"domain_scores_gemma":[0.99167705,0.0049094944,0.002059899,0.00060692703,0.000080264166,0.00066636526],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0075738765,0.00061394693,0.0103288675,0.0003610957,0.000048614624,0.000018324366,0.00055495364,0.0048805266,0.0003026053],"category_scores_gemma":[0.02993352,0.00043128757,0.0019079476,0.0011104957,0.00034836648,0.00004982791,0.00020116617,0.0160539,0.0011064935],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005972353,0.00049432734,0.00002260378,0.0063391663,0.00011128853,0.0009249211,0.000023866069,2.3202334e-7,7.8863174e-8,0.0011772178,0.0063835564,0.98446304],"study_design_scores_gemma":[0.00026628276,0.0013619721,0.000013661268,0.00868973,0.0015308603,0.00040561412,0.0000049591013,0.00033001657,5.185244e-8,0.00035692385,0.9867149,0.0003250318],"about_ca_topic_score_codex":0.000007599236,"about_ca_topic_score_gemma":0.000016285201,"teacher_disagreement_score":0.984138,"about_ca_system_score_codex":0.0010766281,"about_ca_system_score_gemma":0.003303877,"threshold_uncertainty_score":0.9998139},"labels":[],"label_agreement":null},{"id":"W3083938091","doi":"10.1038/s41571-020-0422-y","title":"Tumour budding in solid cancers","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":366,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Budding; Biology; Medicine; Cancer research; Genetics","score_opus":0.24699227472587224,"score_gpt":0.5821903682922324,"score_spread":0.3351980935663601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083938091","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.7313694e-7,0.9829663,0.000006824025,0.0015444943,0.003097907,0.0030215622,0.00003746449,0.000043580905,0.009281383],"genre_scores_gemma":[0.0000023375276,0.9862351,0.0020359205,0.006838858,0.003845092,0.0003507212,0.00012825728,0.00009963608,0.00046407615],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918557,0.0016232856,0.004368172,0.0012328187,0.0003059351,0.0006140852],"domain_scores_gemma":[0.9950896,0.0016525348,0.0018415725,0.0006568754,0.00009251535,0.0006668993],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0035489528,0.0007174467,0.014751124,0.00024557594,0.000034367404,0.000012828687,0.00044882964,0.0033772746,0.000512154],"category_scores_gemma":[0.00540215,0.00048452205,0.0033231315,0.0011148037,0.0001646033,0.000039229,0.00021101623,0.009133342,0.0006474667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005505793,0.00015443278,0.0000098878445,0.022288844,0.0002032996,0.0007692528,0.000009885516,4.9992018e-8,2.840888e-7,0.00005511813,0.035366826,0.94108707],"study_design_scores_gemma":[0.0010884729,0.000781827,0.000007283816,0.033327144,0.0037265746,0.00024163742,0.0000048736597,0.000001427281,2.4737037e-7,0.000010433302,0.96044266,0.0003674296],"about_ca_topic_score_codex":0.000037730955,"about_ca_topic_score_gemma":0.00025227564,"teacher_disagreement_score":0.9407196,"about_ca_system_score_codex":0.001909276,"about_ca_system_score_gemma":0.0059400536,"threshold_uncertainty_score":0.9998759},"labels":[],"label_agreement":null},{"id":"W3128131226","doi":"10.1038/s41571-021-00473-5","title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1560,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Biomarker; Concordance; Biomarker discovery; Oncology; Companion diagnostic; Immune checkpoint; Clinical trial; PD-L1; Cancer; Disease; Internal medicine; Immunotherapy; Bioinformatics; Biology; Proteomics","score_opus":0.1525086424784524,"score_gpt":0.5349054464247085,"score_spread":0.3823968039462561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128131226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000064849046,0.9856509,0.000004238408,0.0029613574,0.0038299218,0.004520376,0.000047765632,0.000045850473,0.0028747371],"genre_scores_gemma":[0.000011001503,0.98927414,0.001752813,0.004350343,0.00091556896,0.00037797607,0.00017427535,0.000121542755,0.0030223578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9825356,0.006602943,0.008367545,0.0013324285,0.0005515879,0.0006098984],"domain_scores_gemma":[0.98803693,0.005672629,0.003345355,0.0019434643,0.00043410916,0.00056748244],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01688328,0.00090959144,0.013737183,0.0005224074,0.00005970756,0.00001672436,0.0006276474,0.005632502,0.0015354543],"category_scores_gemma":[0.022433473,0.0006032166,0.008643927,0.0019804828,0.0004422641,0.000042077365,0.00039917263,0.004371546,0.00056403317],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067165494,0.00079532,0.0000061013025,0.01255589,0.0012553202,0.00035106734,0.00002621952,2.7508984e-9,0.00012595058,0.00001230668,0.032560438,0.94559485],"study_design_scores_gemma":[0.0021596455,0.0035064504,0.00013835184,0.066103354,0.0032169328,0.00070341845,0.000013062686,9.893824e-8,0.000017810295,0.0000055247137,0.9236523,0.00048307635],"about_ca_topic_score_codex":0.000028234961,"about_ca_topic_score_gemma":0.000015639973,"teacher_disagreement_score":0.94511175,"about_ca_system_score_codex":0.0008330241,"about_ca_system_score_gemma":0.005869745,"threshold_uncertainty_score":0.99976605},"labels":[],"label_agreement":null},{"id":"W3134327013","doi":"10.1038/s41571-021-00491-3","title":"The ten genes for breast (and ovarian) cancer susceptibility","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PALB2; CHEK2; Breast cancer; Ovarian cancer; Gene; Oncology; Biology; Medicine; Cancer; Genetics; Mutation; Germline mutation","score_opus":0.10265145137852312,"score_gpt":0.5104314512757606,"score_spread":0.4077799998972375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134327013","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000029158448,0.9924631,0.00009946801,0.0014380283,0.0029532348,0.0024030048,0.00040758954,0.000009249944,0.00022337043],"genre_scores_gemma":[0.0000017959306,0.98808795,0.0027481676,0.0011635552,0.0041861613,0.0018412531,0.00041248565,0.00006806709,0.001490543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943926,0.0018687084,0.001945141,0.0012440338,0.00012924033,0.00042032456],"domain_scores_gemma":[0.9955555,0.0016037317,0.0011167187,0.0011704814,0.00038312006,0.00017040268],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0042021717,0.00049439364,0.0029094971,0.000029197943,0.00023787325,0.00004623761,0.0006657273,0.0033799165,0.00005265127],"category_scores_gemma":[0.003210546,0.0002924471,0.0015986582,0.00021324136,0.00048002778,0.0000029884636,0.0004133313,0.0014468725,0.000011946169],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024569186,0.0000642007,0.000029487968,0.002406427,0.0003997928,0.0000018792185,0.0000020181335,1.0564564e-7,0.000003019219,0.00013353901,0.038100064,0.9588349],"study_design_scores_gemma":[0.00037096604,0.00022653403,0.00003264596,0.0014051957,0.0013056762,0.00012102376,0.0000048634383,8.898504e-7,0.0000018074154,0.000048706912,0.9961575,0.0003241827],"about_ca_topic_score_codex":0.0000057672955,"about_ca_topic_score_gemma":0.0005581999,"teacher_disagreement_score":0.9585107,"about_ca_system_score_codex":0.00023430478,"about_ca_system_score_gemma":0.003365947,"threshold_uncertainty_score":0.9999528},"labels":[],"label_agreement":null},{"id":"W3136398125","doi":"10.1038/s41571-021-00502-3","title":"First clinical proof-of-concept that FMT can overcome resistance to ICIs","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Fecal bacteriotherapy; Refractory (planetary science); Immunology; Resistance (ecology); Medicine; Transplantation; Intensive care medicine; Biology; Internal medicine; Microbiology; Ecology","score_opus":0.16817183811994693,"score_gpt":0.518229412337673,"score_spread":0.350057574217726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136398125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010768662,0.99044573,0.000076423676,0.001699469,0.0033701146,0.0030780921,0.00028057606,0.000014440302,0.0010243567],"genre_scores_gemma":[0.000017534509,0.981904,0.0046696234,0.0062623927,0.002727513,0.00021319017,0.0010067815,0.00010805291,0.0030909188],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98744863,0.0039669652,0.005491315,0.0020294024,0.00027110215,0.0007925918],"domain_scores_gemma":[0.99255437,0.0013971513,0.0029395388,0.0020771045,0.0003399865,0.0006918278],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0055421665,0.0008701528,0.009220762,0.0001144042,0.0001172111,0.000021872165,0.0013462979,0.00735888,0.00015773572],"category_scores_gemma":[0.00724166,0.0006581751,0.0039503956,0.0005571869,0.00043525232,0.0000041552753,0.0007653752,0.0040571606,0.00006486513],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048851525,0.000495471,0.00006931958,0.009580571,0.0002709889,0.000039058617,0.000009183033,1.2122445e-7,0.0000014834657,0.00011986208,0.1771498,0.81221527],"study_design_scores_gemma":[0.0005556247,0.0013214143,0.000056173896,0.012725666,0.0007876954,0.000048667796,0.0000038163985,5.7093242e-8,0.000010780238,0.0000104906485,0.98387194,0.0006076944],"about_ca_topic_score_codex":0.000008151306,"about_ca_topic_score_gemma":0.0015200801,"teacher_disagreement_score":0.8116076,"about_ca_system_score_codex":0.00019290885,"about_ca_system_score_gemma":0.0035606462,"threshold_uncertainty_score":0.99958694},"labels":[],"label_agreement":null},{"id":"W3138390832","doi":"10.1038/s41571-021-00504-1","title":"FDA approval standards for anticancer agents — lessons from two recent approvals in breast cancer","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Drug approval; Breast cancer; Overall survival; Oncology; Drug; Metastatic breast cancer; Anticancer drug; Cancer; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.30958660989652914,"score_gpt":0.5430798589318376,"score_spread":0.2334932490353085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138390832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000069029293,0.9632976,0.00027853108,0.0037304934,0.0076881815,0.0034396483,0.016313683,0.000029665736,0.005215289],"genre_scores_gemma":[0.000007750554,0.9867615,0.0021497277,0.0037065751,0.0045086397,0.0014963435,0.0006599121,0.00016237269,0.0005471879],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9889593,0.0005868323,0.00693715,0.0023432071,0.00012482906,0.0010486479],"domain_scores_gemma":[0.9912994,0.0017873436,0.0050064363,0.0011797205,0.00031241841,0.0004146828],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.008304187,0.0009609397,0.01389533,0.00032471112,0.000105809035,0.000106967665,0.0011321675,0.0036783244,0.002298329],"category_scores_gemma":[0.0041383454,0.00088244636,0.0028914427,0.0007437922,0.00027344015,0.00024636302,0.00031222042,0.0037736367,0.00024571625],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000623248,0.0003134672,0.00046993172,0.002793463,0.00041766805,0.000018083565,0.000018803672,0.0000015131288,7.0696755e-9,0.012180415,0.046057247,0.9376671],"study_design_scores_gemma":[0.0020983946,0.00012516874,0.00030788,0.007598981,0.00049779454,0.000011707749,0.00000471863,0.000022103079,3.926063e-8,0.002918056,0.9855069,0.0009082393],"about_ca_topic_score_codex":0.00038154778,"about_ca_topic_score_gemma":0.0009266909,"teacher_disagreement_score":0.93944967,"about_ca_system_score_codex":0.0031706037,"about_ca_system_score_gemma":0.003914248,"threshold_uncertainty_score":0.99936265},"labels":[],"label_agreement":null},{"id":"W3163003678","doi":"10.1038/s41571-021-00508-x","title":"Beneficial autoimmunity improves cancer prognosis","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Canadian Institutes of Health Research; Agence Nationale de la Recherche","keywords":"Medicine; Autoimmunity; Oncology; Cancer; Internal medicine; Disease","score_opus":0.20716222520985014,"score_gpt":0.5541318934361366,"score_spread":0.3469696682262864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163003678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000063496996,0.9865846,0.0000014425789,0.0014912154,0.005636055,0.004069158,0.000078254336,0.00008896467,0.0020439757],"genre_scores_gemma":[9.377968e-7,0.9863334,0.000937436,0.0056052087,0.0037206996,0.00126716,0.0004625574,0.00011043514,0.0015622167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99055964,0.0026537091,0.00462388,0.0011687127,0.00037197868,0.0006220795],"domain_scores_gemma":[0.9937536,0.0019100427,0.0025103313,0.0011733541,0.0003212642,0.0003313737],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0045654015,0.0008705152,0.012430123,0.00018397506,0.0001352514,0.000033091288,0.00058885955,0.006614865,0.0012629051],"category_scores_gemma":[0.0030239264,0.000558026,0.0063502737,0.0010519715,0.00041747486,0.000055080967,0.00026610686,0.008026454,0.00013648925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018295486,0.00087497116,0.000027837295,0.021558901,0.0014116496,0.00010068735,0.000008289665,1.9807267e-9,0.0000012270918,0.000039009865,0.028386502,0.94740796],"study_design_scores_gemma":[0.0012662774,0.0011424745,0.00015090943,0.042814765,0.0075671077,0.0001911836,0.000004010586,3.8453155e-7,5.0764174e-7,0.0000049979435,0.9463658,0.00049158285],"about_ca_topic_score_codex":0.00006900549,"about_ca_topic_score_gemma":0.00013225406,"teacher_disagreement_score":0.9469164,"about_ca_system_score_codex":0.0009277944,"about_ca_system_score_gemma":0.006575699,"threshold_uncertainty_score":0.99968714},"labels":[],"label_agreement":null},{"id":"W3185510385","doi":"10.1038/s41571-021-00544-7","title":"Adjuvant olaparib — should all patients with breast cancer have genetic testing?","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Olaparib; Breast cancer; Medicine; Oncology; Genetic testing; Adjuvant; Internal medicine; Mutation; Cancer; Biology; Genetics; Gene","score_opus":0.1445943947971782,"score_gpt":0.487743436468439,"score_spread":0.3431490416712608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185510385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003862063,0.99411863,0.000038255683,0.0002711175,0.00196521,0.0022659933,0.00054074486,0.000022455908,0.000738969],"genre_scores_gemma":[0.000013001797,0.9815311,0.008122205,0.0042716465,0.0026610203,0.0010324141,0.0016869551,0.00017617804,0.0005055245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924411,0.0019219652,0.0026620396,0.0019055724,0.0003880119,0.00068129756],"domain_scores_gemma":[0.99452144,0.0005974278,0.0020960046,0.0015248823,0.00089038373,0.00036986338],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0012160932,0.0009564749,0.0049655773,0.00009429058,0.00009562294,0.000040011488,0.0009556584,0.004657264,0.00022012451],"category_scores_gemma":[0.0021825933,0.00064780406,0.0012960379,0.0004658589,0.00035613048,0.000005838848,0.00051417097,0.0032090042,0.000072801704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000319792,0.00041367568,0.0020441846,0.0024324686,0.0006848968,0.000029867932,0.0000034035152,0.0000026973303,6.79013e-7,0.000003774886,0.039715696,0.9546367],"study_design_scores_gemma":[0.0009427734,0.00079155865,0.0013401342,0.0059274705,0.0029457493,0.00015430198,0.0000018157829,0.0000014471257,8.466427e-7,0.0000036049187,0.9871266,0.0007636874],"about_ca_topic_score_codex":0.00001557902,"about_ca_topic_score_gemma":0.0002431338,"teacher_disagreement_score":0.953873,"about_ca_system_score_codex":0.0005256065,"about_ca_system_score_gemma":0.0047665853,"threshold_uncertainty_score":0.9995973},"labels":[],"label_agreement":null},{"id":"W3191344580","doi":"10.1038/s41571-021-00550-9","title":"Practicing on the edge of oncology: when standard of care feels uncomfortable","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Guideline; Randomized controlled trial; Standard of care; MEDLINE; Alternative medicine; Medical physics; Family medicine; Internal medicine; Pathology","score_opus":0.23076794956579566,"score_gpt":0.4774872909975916,"score_spread":0.2467193414317959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191344580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000081878725,0.89752287,0.00003713307,0.0009242342,0.003051925,0.0016976808,0.0006184273,0.000010320582,0.09612923],"genre_scores_gemma":[0.00006241314,0.99489653,0.0014418367,0.0016533681,0.00093731,0.00014802632,0.00008908121,0.00007213508,0.0006992729],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99066854,0.00093012356,0.006853731,0.0009525136,0.00008907656,0.0005060064],"domain_scores_gemma":[0.9808675,0.0064489166,0.010873563,0.0013541118,0.00027481376,0.00018111769],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.008067059,0.0005842181,0.013776564,0.00023184017,0.00009288712,0.000024434956,0.0010669212,0.0034943633,0.00096039544],"category_scores_gemma":[0.012871267,0.00041320632,0.0028820063,0.00043203073,0.00041486198,0.00014618828,0.000284467,0.0041796532,0.00024403974],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005696167,0.00020202443,0.0000821086,0.0058192597,0.00034472495,0.000009800082,0.00009334639,6.6104866e-7,8.441046e-9,0.089168385,0.031885214,0.8723375],"study_design_scores_gemma":[0.00050559756,0.0023260687,0.000012152251,0.007926925,0.00053389254,0.00001020702,0.000046067544,6.2035025e-7,6.693234e-7,0.0019301531,0.98635334,0.00035429938],"about_ca_topic_score_codex":0.000046332578,"about_ca_topic_score_gemma":0.00015361155,"teacher_disagreement_score":0.95446813,"about_ca_system_score_codex":0.0011119652,"about_ca_system_score_gemma":0.0025277387,"threshold_uncertainty_score":0.99995285},"labels":[],"label_agreement":null},{"id":"W3213271749","doi":"10.1038/s41571-021-00581-2","title":"Daratumumab in newly diagnosed MM — incorporating lessons learnt from CASSIOPEIA, MAIA and beyond","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Daratumumab; Medicine; Multiple myeloma; Oncology; Internal medicine; Intensive care medicine; Bortezomib","score_opus":0.2276479383870076,"score_gpt":0.5494101196842723,"score_spread":0.32176218129726475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213271749","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007837666,0.9899261,0.0000045889437,0.0017184522,0.00084543106,0.0037823897,0.00015558071,0.00003390598,0.0034552019],"genre_scores_gemma":[0.000057706646,0.9866425,0.007408564,0.0013684558,0.0011086786,0.00059099804,0.0019375266,0.00010020605,0.00078541087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98812723,0.005119283,0.003757374,0.001733512,0.00050968636,0.00075291854],"domain_scores_gemma":[0.9871443,0.0089089265,0.0016462874,0.0011692973,0.00018461376,0.000946601],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00352613,0.00087771827,0.0114801815,0.0003098401,0.00012741495,0.000056106914,0.00039856212,0.004487783,0.00028703804],"category_scores_gemma":[0.016757028,0.0005801553,0.0015033274,0.0008743506,0.0003682159,0.00007233983,0.00057976076,0.009434083,0.00026377136],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007613151,0.0009814701,0.0015979818,0.0052127372,0.00046231798,0.008429874,0.000017546601,1.7354601e-8,3.4211462e-7,0.00015405499,0.004648356,0.9784192],"study_design_scores_gemma":[0.004729626,0.00092946633,0.002140632,0.026762707,0.0017519916,0.00026576652,0.000018839997,0.000006881211,1.2468374e-7,0.000073699055,0.9629204,0.00039983666],"about_ca_topic_score_codex":0.00020989143,"about_ca_topic_score_gemma":0.0018739686,"teacher_disagreement_score":0.97801936,"about_ca_system_score_codex":0.0007313381,"about_ca_system_score_gemma":0.0034176994,"threshold_uncertainty_score":0.99966496},"labels":[],"label_agreement":null},{"id":"W4221033081","doi":"10.1038/s41571-022-00624-2","title":"Should the control arms of randomized trials have an expiry date?","year":2022,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Randomized controlled trial; Chemotherapy; Clinical trial; Clinical equipoise; Lung cancer; MEDLINE; Intensive care medicine; Oncology; Surgery; Internal medicine","score_opus":0.46518099347242153,"score_gpt":0.64827772807525,"score_spread":0.18309673460282844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221033081","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.4583599e-7,0.97250855,0.000047157686,0.0026603458,0.0026673512,0.01629565,0.00023074482,0.00003044872,0.00555943],"genre_scores_gemma":[0.000005622357,0.98494875,0.0008156714,0.0060456116,0.0019319672,0.004354937,0.0009476562,0.000068380454,0.0008813692],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9630847,0.027024856,0.008245968,0.0008160345,0.00048412816,0.00034429488],"domain_scores_gemma":[0.9404246,0.050017513,0.007372969,0.0016520338,0.00019799403,0.0003348602],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.03904313,0.0006178999,0.02929894,0.00015737345,0.000110922294,0.000013713596,0.00060058886,0.0021553405,0.0021883703],"category_scores_gemma":[0.045890488,0.00025592474,0.008436251,0.00032844846,0.00050839956,0.000049464197,0.00011316421,0.0045852917,0.000047262096],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048145205,0.000892039,0.000004480227,0.004338932,0.0038623067,0.000052014828,0.000053672644,9.110279e-8,2.7651481e-8,0.00047859864,0.010999156,0.9745042],"study_design_scores_gemma":[0.07230501,0.0011508209,0.0000020876619,0.003199987,0.061660096,0.00008252248,0.000024062765,0.0000023132213,3.0138647e-8,0.00007467686,0.8613202,0.00017818004],"about_ca_topic_score_codex":0.000018186065,"about_ca_topic_score_gemma":0.000018511015,"teacher_disagreement_score":0.97432595,"about_ca_system_score_codex":0.0002879062,"about_ca_system_score_gemma":0.0028356009,"threshold_uncertainty_score":0.9999893},"labels":[],"label_agreement":null},{"id":"W4243737142","doi":"10.1038/s41571-018-0120-1","title":"Addendum: Low-value approvals and high prices might incentivize ineffective drug development","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Revenue; Hindsight bias; Profit (economics); Actuarial science; Finance; Economics; Business; Microeconomics","score_opus":0.18648345030762592,"score_gpt":0.46972368995637276,"score_spread":0.28324023964874684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243737142","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059192287,0.9801551,0.00003904147,0.0005837398,0.0037157186,0.0028130685,0.00023167538,0.000043152864,0.012359327],"genre_scores_gemma":[0.000023796469,0.98736024,0.0037532959,0.004286945,0.0030307893,0.0005087626,0.00015651391,0.00010043604,0.00077924354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9904404,0.00089445664,0.0058834017,0.0019171571,0.00006654724,0.00079800707],"domain_scores_gemma":[0.99085534,0.0030588345,0.0046426947,0.0007988199,0.00007484609,0.0005694432],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.009595575,0.000933531,0.009418636,0.00039166494,0.00017517296,0.00009795895,0.0010200599,0.0030322727,0.00045448446],"category_scores_gemma":[0.002824406,0.00077013846,0.0013352312,0.0005095702,0.00049870356,0.00018765172,0.0007297791,0.0037421887,0.004435952],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001702269,0.0003586101,0.00005806608,0.008337315,0.0005108477,0.000010266283,0.000045952977,2.4445804e-8,6.500835e-9,0.037982505,0.03258297,0.9200964],"study_design_scores_gemma":[0.0007468043,0.00017633129,0.00010010836,0.0033969039,0.00031762663,0.00001648375,0.0000011144489,0.000012802863,3.5648833e-7,0.0036708848,0.9907381,0.00082246953],"about_ca_topic_score_codex":0.000019885174,"about_ca_topic_score_gemma":0.00003581387,"teacher_disagreement_score":0.95815516,"about_ca_system_score_codex":0.00069071376,"about_ca_system_score_gemma":0.00065649947,"threshold_uncertainty_score":0.99947494},"labels":[],"label_agreement":null},{"id":"W4288052966","doi":"10.1038/s41571-022-00667-5","title":"Defining clinically important overall survival thresholds: lessons from quality of life","year":2022,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Quality of life (healthcare); MEDLINE; Oncology; Intensive care medicine; Gerontology; Internal medicine; Nursing","score_opus":0.4457884125422678,"score_gpt":0.6182712969811195,"score_spread":0.17248288443885168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288052966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014071468,0.97590005,0.00001628694,0.0013131719,0.0026085644,0.0035556774,0.0005196648,0.00006864549,0.015877215],"genre_scores_gemma":[0.000017864599,0.98587704,0.0061791623,0.0036183437,0.0016605824,0.0005450594,0.0013472014,0.00012934869,0.00062541786],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.96238166,0.014928552,0.018355152,0.0019763354,0.0013672323,0.0009910497],"domain_scores_gemma":[0.8990045,0.081190534,0.0141698,0.0034961444,0.0004489972,0.0016899793],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.04111456,0.0010061744,0.029511381,0.00028118203,0.00016948386,0.000015097501,0.0013837415,0.0069615925,0.0061610932],"category_scores_gemma":[0.103486575,0.00068783766,0.006330793,0.0007373433,0.0009740959,0.000059277532,0.0011002151,0.015556422,0.0003472745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085693155,0.0021879785,0.03314108,0.013066048,0.0023405564,0.0002432315,0.000022022316,1.4168313e-8,1.2858311e-7,0.0032394794,0.011095803,0.9338067],"study_design_scores_gemma":[0.0031936986,0.0029733644,0.0030181678,0.008013887,0.0072408314,0.00005005213,0.000021020216,0.0000028654706,1.0034166e-8,0.00048712178,0.9744728,0.0005261895],"about_ca_topic_score_codex":0.00018154172,"about_ca_topic_score_gemma":0.00015228445,"teacher_disagreement_score":0.963377,"about_ca_system_score_codex":0.00067456183,"about_ca_system_score_gemma":0.015106678,"threshold_uncertainty_score":0.99955726},"labels":[],"label_agreement":null},{"id":"W4376642614","doi":"10.1038/s41571-023-00770-1","title":"Cholangiocarcinoma — novel biological insights and therapeutic strategies","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona; European Commission","keywords":"Immune system; Immunotherapy; Tumor microenvironment; Biology; Cancer; Disease; Malignancy; Cancer research; Chimeric antigen receptor; Computational biology; Bioinformatics; Medicine; Immunology; Internal medicine","score_opus":0.38899566087997883,"score_gpt":0.5322932829363055,"score_spread":0.14329762205632668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376642614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048203427,0.99121195,0.000007333975,0.00054710644,0.0015552304,0.002837486,0.000027614324,0.00017690359,0.003588177],"genre_scores_gemma":[0.00009490859,0.99323434,0.0004012249,0.0026477394,0.0024441944,0.00043078366,0.00015710053,0.000099452416,0.0004902407],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940462,0.0009745483,0.0027438807,0.001376001,0.00027599436,0.0005833776],"domain_scores_gemma":[0.99448204,0.0030821261,0.0010726489,0.0008151116,0.00014193152,0.00040612026],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0017984621,0.0009085109,0.0095831845,0.00027716174,0.00013194779,0.000046697285,0.00039706533,0.0043382426,0.000043953427],"category_scores_gemma":[0.0014698175,0.0005038669,0.002282804,0.0007488099,0.0006261808,0.00005414947,0.00039918377,0.0051384256,0.00040631805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004763,0.0002797722,0.00023621034,0.011374601,0.0009836024,0.00021866127,0.000043632997,3.1660643e-9,4.0924334e-7,0.0013387433,0.0044417307,0.981035],"study_design_scores_gemma":[0.0011043232,0.0015723688,0.0044858814,0.008724564,0.0038067517,0.00044831593,0.000042280357,6.847998e-7,2.6614645e-8,0.00016907605,0.97917724,0.0004684946],"about_ca_topic_score_codex":0.0000073874803,"about_ca_topic_score_gemma":0.00003963971,"teacher_disagreement_score":0.9805665,"about_ca_system_score_codex":0.00021852074,"about_ca_system_score_gemma":0.0012005835,"threshold_uncertainty_score":0.9997413},"labels":[],"label_agreement":null},{"id":"W4382020994","doi":"10.1038/s41571-023-00785-8","title":"Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Fondation pour la Recherche Médicale; Horizon 2020 Framework Programme; Institut Universitaire de France; Stand Up To Cancer; Genentech; Labex Immuno-Oncology; National Institutes of Health; PharmaMar; University of Texas MD Anderson Cancer Center; Ligue Contre le Cancer; AstraZeneca; Institut National Du Cancer; Fonds de Recherche du Québec - Santé; Institut National de la Santé et de la Recherche Médicale; Exelixis; Sanofi; European Commission; Daiichi Sankyo Europe; National Cancer Institute; HORIZON EUROPE Framework Programme; Gilead Sciences; Melanoma Research Alliance; GlaxoSmithKline; Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche; Bristol-Myers Squibb; American Association for Cancer Research; Seerave Foundation","keywords":"Dysbiosis; Medicine; Gut flora; Clinical trial; Cancer; Biomarker; Metagenomics; Bioinformatics; Oncology; Computational biology; Immunology; Internal medicine; Biology","score_opus":0.3343139125727195,"score_gpt":0.5517493436111188,"score_spread":0.21743543103839935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382020994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001030342,0.97596675,0.00002144018,0.002523079,0.009851483,0.01067423,0.00024874392,0.00031447713,0.00038950652],"genre_scores_gemma":[0.000001289729,0.9723742,0.0015096073,0.010982922,0.0064138235,0.0032121225,0.0015904108,0.00043823785,0.003477375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898286,0.0017967011,0.0053530703,0.0017221074,0.00040455276,0.0008949585],"domain_scores_gemma":[0.99117285,0.0035390025,0.0032471195,0.0013277457,0.0003484614,0.00036484216],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0065846746,0.0012507904,0.009873694,0.00057872996,0.0001876686,0.00008234564,0.0008406623,0.007869433,0.00048953807],"category_scores_gemma":[0.0021762538,0.0008422002,0.0068510706,0.0014208636,0.00047668905,0.00012248188,0.00012495618,0.003965267,0.00033567395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011636986,0.00033189234,0.0000017082378,0.0131217,0.0034385673,0.00003775466,0.000012950235,4.623721e-8,0.00040467049,0.00005471548,0.17592287,0.80550945],"study_design_scores_gemma":[0.004057735,0.0022012433,0.000012352618,0.0195727,0.004171091,0.00011628948,0.0000060187353,0.0000076191636,0.000004301308,0.0000348534,0.9690072,0.00080858695],"about_ca_topic_score_codex":0.000053104974,"about_ca_topic_score_gemma":0.00017874804,"teacher_disagreement_score":0.80470085,"about_ca_system_score_codex":0.0015531568,"about_ca_system_score_gemma":0.004583801,"threshold_uncertainty_score":0.9994029},"labels":[],"label_agreement":null},{"id":"W4384560337","doi":"10.1038/s41571-023-00805-7","title":"Problematic crossovers in cancer drug trials","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Context (archaeology); Randomized controlled trial; Clinical trial; Cancer drugs; Drug trial; Crossover; Medical physics; Drug; Cancer; Skew; Oncology; Intensive care medicine; Internal medicine; Pharmacology; Artificial intelligence; Computer science","score_opus":0.31368035781239245,"score_gpt":0.589727256611743,"score_spread":0.2760468987993505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384560337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000115957055,0.9911388,0.000004550823,0.0003637175,0.0036009555,0.0039128773,0.00024549762,0.000017381306,0.0007046144],"genre_scores_gemma":[0.0000014860067,0.991367,0.00043817135,0.0014634554,0.0029723693,0.0016750237,0.00051814923,0.00011763843,0.0014467018],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98929477,0.0032986035,0.0054599694,0.0011943948,0.00018445725,0.0005678248],"domain_scores_gemma":[0.9922104,0.0035717315,0.0029539107,0.00092548697,0.00010107182,0.0002374134],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.012536725,0.0006520041,0.008605408,0.00016529625,0.00004740104,0.000036753492,0.0007982531,0.0037825897,0.00008092225],"category_scores_gemma":[0.022285426,0.00046605666,0.0026651225,0.0005352391,0.00018023694,0.000002917695,0.00043922875,0.0024825928,0.00030643778],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031768068,0.00017011778,0.00001899575,0.011670261,0.0002503788,0.000026159907,0.0000058695405,0.0000018566178,0.0000011299164,0.000084856074,0.09401148,0.8937271],"study_design_scores_gemma":[0.00084956374,0.00028194074,0.000010293557,0.010765634,0.001098676,0.00001023829,0.0000028093225,9.668154e-7,7.0691465e-7,0.0001823051,0.98633134,0.00046554772],"about_ca_topic_score_codex":0.000042482654,"about_ca_topic_score_gemma":0.0013807502,"teacher_disagreement_score":0.89326155,"about_ca_system_score_codex":0.0002960144,"about_ca_system_score_gemma":0.0027929924,"threshold_uncertainty_score":0.99981874},"labels":[],"label_agreement":null},{"id":"W4385213278","doi":"10.1038/s41571-023-00802-w","title":"Improving quality and quantity of life for childhood cancer survivors globally in the twenty-first century","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Survivorship curve; Quality of life (healthcare); Childhood cancer; Cancer; Population; Disease; Clinical trial; Cohort; Cancer survivorship; Health care; Gerontology; Intensive care medicine; Environmental health; Nursing; Pathology; Internal medicine","score_opus":0.23963492726775487,"score_gpt":0.5419280595400113,"score_spread":0.30229313227225646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385213278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022092694,0.9800408,0.000015426325,0.006273376,0.0032381315,0.009460856,0.00050713983,0.000064737345,0.00017863367],"genre_scores_gemma":[0.00004111151,0.9859618,0.00076872983,0.009581462,0.0023621435,0.00090260606,0.00023957972,0.000109174085,0.000033408225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9819635,0.006442386,0.008347675,0.0015475546,0.0009160194,0.0007828693],"domain_scores_gemma":[0.97135955,0.02021241,0.0059799594,0.0016249979,0.00032321637,0.0004998378],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.03538452,0.0008935201,0.013094925,0.00025386724,0.00012990394,0.000034883466,0.0012557111,0.00370222,0.00003301339],"category_scores_gemma":[0.046047747,0.00055353757,0.0030165964,0.0012665626,0.0005061966,0.000083560684,0.00046976915,0.0052723037,0.00002534383],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016738934,0.0010218576,0.00299097,0.11559753,0.00053565734,0.0000111162535,0.00019761965,6.428844e-8,2.3113767e-8,0.00088508904,0.005120723,0.873472],"study_design_scores_gemma":[0.00208627,0.00081795483,0.013676328,0.026294049,0.0026330494,0.000021827249,0.000090347385,0.0000014097824,1.4716389e-8,0.00007999204,0.9538351,0.0004636262],"about_ca_topic_score_codex":0.0030148602,"about_ca_topic_score_gemma":0.041629273,"teacher_disagreement_score":0.94871444,"about_ca_system_score_codex":0.000417652,"about_ca_system_score_gemma":0.0038978118,"threshold_uncertainty_score":0.9996916},"labels":[],"label_agreement":null},{"id":"W4387253827","doi":"10.1038/s41571-023-00819-1","title":"Heterogeneity and treatment landscape of ovarian carcinoma","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian carcinoma; Malignancy; Ovarian cancer; Medicine; Carcinoma; Targeted therapy; Disease; Genetic heterogeneity; Tumor microenvironment; Cancer research; Oncology; Cancer; Bioinformatics; Internal medicine; Biology; Gene; Genetics; Phenotype","score_opus":0.27561281465262794,"score_gpt":0.5323425707244082,"score_spread":0.2567297560717802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387253827","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053251686,0.99350935,6.163838e-7,0.00059816707,0.000982009,0.0034216414,0.00012727374,0.000039057748,0.0012686484],"genre_scores_gemma":[0.000034836274,0.9964943,0.0007794192,0.0003300772,0.001114443,0.0006097639,0.00023038538,0.00007614773,0.00033062705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946122,0.0010815341,0.0027866862,0.00097653456,0.00019414954,0.00034889055],"domain_scores_gemma":[0.9948998,0.0022119153,0.0014679267,0.0009220928,0.00008873896,0.00040952495],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015174765,0.0006325307,0.010108457,0.00018902427,0.000040935476,0.0000085882375,0.0001656518,0.002650639,0.000093157054],"category_scores_gemma":[0.0007900005,0.00035814682,0.0023336967,0.00042844546,0.00017139775,0.00002016685,0.00012944278,0.0012854212,0.00018897699],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049690385,0.00093204685,0.0032806806,0.016184226,0.0012607191,0.00030662402,0.000006575929,4.4317217e-9,1.0839292e-8,0.00014756556,0.003669336,0.9741625],"study_design_scores_gemma":[0.0023030443,0.004016319,0.003603918,0.012639025,0.010727521,0.00020020001,0.0000016277219,6.518103e-7,2.1993775e-7,0.000010639628,0.9662778,0.00021907486],"about_ca_topic_score_codex":0.000021777954,"about_ca_topic_score_gemma":0.00014076676,"teacher_disagreement_score":0.9739435,"about_ca_system_score_codex":0.00040579448,"about_ca_system_score_gemma":0.0012958483,"threshold_uncertainty_score":0.99988705},"labels":[],"label_agreement":null},{"id":"W4390616641","doi":"10.1038/s41571-023-00857-9","title":"‘Contribution of component’ and the perioperative immune-checkpoint inhibitor precedent","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Pembrolizumab; Perioperative; Medicine; Adjuvant; Oncology; Stage (stratigraphy); Lung cancer; Internal medicine; Population; Neoadjuvant therapy; Immunotherapy; Intensive care medicine; Surgery; Cancer; Biology","score_opus":0.08469361818736132,"score_gpt":0.4895845095704079,"score_spread":0.40489089138304657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390616641","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015722499,0.9879288,0.0000041197563,0.0032383515,0.002631835,0.005296514,0.000038438488,0.000023900357,0.0008223239],"genre_scores_gemma":[0.00004932653,0.99654466,0.00016160232,0.000990815,0.0010704427,0.00038490878,0.0001565861,0.00003998355,0.0006016694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918375,0.0027215348,0.0042994157,0.000630622,0.00025088913,0.00026005445],"domain_scores_gemma":[0.995234,0.0020775925,0.0017374596,0.0006080879,0.00021669155,0.00012615256],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.007987066,0.000517587,0.007897921,0.00011188375,0.00006816693,0.000021969468,0.00024994952,0.0022892246,0.00010336255],"category_scores_gemma":[0.0028621492,0.00022525626,0.0034565562,0.00039385055,0.0011497485,0.00003140388,0.00021519916,0.0040977877,0.000072974646],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001413047,0.00022024596,0.0000022321585,0.015260815,0.001228962,0.000019377207,0.000057976285,1.8059921e-9,0.000006898552,0.00066392525,0.0035132302,0.9776133],"study_design_scores_gemma":[0.003989459,0.0011129716,0.000029307968,0.031707145,0.0074891043,0.0002908604,0.00000950709,0.0000018721562,0.0000033216531,0.000024781213,0.95514953,0.0001921514],"about_ca_topic_score_codex":0.000014117026,"about_ca_topic_score_gemma":0.000019234676,"teacher_disagreement_score":0.97742116,"about_ca_system_score_codex":0.00037431333,"about_ca_system_score_gemma":0.0009240698,"threshold_uncertainty_score":0.99900603},"labels":[],"label_agreement":null},{"id":"W4391248735","doi":"10.1038/s41571-024-00861-7","title":"Combination strategies for advanced-stage urothelial carcinoma: a paradigm shift","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of Calgary","funders":"","keywords":"Chemoimmunotherapy; Urothelial carcinoma; Context (archaeology); Metastatic Urothelial Carcinoma; Stage (stratigraphy); Medicine; Oncology; Paradigm shift; First line; Chemotherapy; Internal medicine; Bladder cancer; Cancer; Cyclophosphamide","score_opus":0.1680158617999199,"score_gpt":0.528506426900634,"score_spread":0.3604905651007141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391248735","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000018372143,0.9774552,0.00013120404,0.0013609106,0.005059264,0.010267941,0.0004695082,0.00013309106,0.0051210322],"genre_scores_gemma":[0.000062331375,0.98771274,0.0010062467,0.0018238698,0.002746555,0.003151761,0.0008206986,0.00017665901,0.002499148],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99369407,0.0008886445,0.0031340064,0.0013672414,0.00031828694,0.0005977256],"domain_scores_gemma":[0.995876,0.0016054828,0.0011659072,0.00087506836,0.00009458135,0.00038293964],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0018641462,0.00096112373,0.0083366325,0.0002379954,0.0000926298,0.00005838805,0.00040631753,0.0037341116,0.00015861775],"category_scores_gemma":[0.000829729,0.0005959118,0.0038662262,0.00047018554,0.00023116455,0.00011892626,0.00010881921,0.004020441,0.0005826508],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021426188,0.0006703614,0.000006964631,0.050018158,0.00055370404,0.00016036749,0.000025632633,2.2740586e-8,3.5663234e-8,0.016625362,0.013031671,0.9186935],"study_design_scores_gemma":[0.003355966,0.0044742594,0.000014979953,0.0124996845,0.013341077,0.00009967141,0.000007359024,0.0000021177452,8.737132e-8,0.0033892568,0.96237206,0.00044348318],"about_ca_topic_score_codex":0.000009823745,"about_ca_topic_score_gemma":0.000047336736,"teacher_disagreement_score":0.9493404,"about_ca_system_score_codex":0.000713409,"about_ca_system_score_gemma":0.005692896,"threshold_uncertainty_score":0.9999439},"labels":[],"label_agreement":null},{"id":"W4391954183","doi":"10.1038/s41571-024-00863-5","title":"Targeting ATR in patients with cancer","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Telesta Therapeutics (Canada)","funders":"","keywords":"Medicine; DNA damage; Biomarker; Kinase; DNA repair; Cancer; Computational biology; Bioinformatics; Cancer research; Biology; DNA; Genetics","score_opus":0.053497314054840095,"score_gpt":0.4625624470275212,"score_spread":0.4090651329726811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391954183","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033339988,0.99471915,0.0000068218765,0.00006619793,0.002378663,0.0021850402,0.000063640255,0.000023429902,0.0005237107],"genre_scores_gemma":[0.000006147354,0.99385166,0.0015371045,0.0008338356,0.0014362214,0.00052687293,0.00075822545,0.0001235349,0.0009264226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99437475,0.0013880403,0.0022037942,0.0013381994,0.00021278707,0.00048245463],"domain_scores_gemma":[0.99783874,0.00017409878,0.0009932815,0.0007039055,0.000112788344,0.00017721197],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0022720455,0.00065901875,0.003914513,0.00011569828,0.000027977501,0.000017642085,0.00061057083,0.0041686287,0.00006832615],"category_scores_gemma":[0.0013646607,0.00039597752,0.0011045694,0.00040581173,0.00011095716,0.000003523938,0.0004042563,0.0033365875,0.00021796543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003934248,0.00021471696,0.00021662014,0.0068025924,0.00022088496,0.000024786215,0.0000017820565,1.8065667e-7,6.12865e-7,0.000026325197,0.030488849,0.9619633],"study_design_scores_gemma":[0.0005127532,0.0009986346,0.000020803174,0.009189528,0.0011859101,0.0000048833986,6.8737086e-7,5.9123005e-7,4.5741078e-7,0.000010626025,0.9876269,0.00044823904],"about_ca_topic_score_codex":0.000004143667,"about_ca_topic_score_gemma":0.000083408995,"teacher_disagreement_score":0.96151507,"about_ca_system_score_codex":0.00019750127,"about_ca_system_score_gemma":0.001085456,"threshold_uncertainty_score":0.9998492},"labels":[],"label_agreement":null},{"id":"W4392982551","doi":"10.1038/s41571-024-00882-2","title":"Identification of dynamic microbiota signatures in patients with melanoma receiving ICIs: opportunities and challenges","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Microbiome; Melanoma; Computational biology; Gut flora; Gut microbiome; Identification (biology); Immunology; Biology; Medicine; Bioinformatics; Ecology; Cancer research","score_opus":0.13806588119189953,"score_gpt":0.4500587480147986,"score_spread":0.31199286682289906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392982551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015263508,0.9953792,6.0871866e-7,0.00095255807,0.00080343796,0.0024067953,0.00005979338,0.000020804306,0.00022413766],"genre_scores_gemma":[0.00013630641,0.9986867,0.00016777456,0.00028229918,0.00012453187,0.000111022164,0.00017569741,0.000057754252,0.00025795077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99499077,0.0008102747,0.003050167,0.00071940676,0.00019476884,0.0002346049],"domain_scores_gemma":[0.996712,0.0008490441,0.001682379,0.00053025567,0.00012867406,0.00009760507],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0030428832,0.00046401512,0.0046432163,0.00038133326,0.000021978223,0.000012985359,0.00022450855,0.0023306564,0.000036960486],"category_scores_gemma":[0.00058873766,0.00027035133,0.00070783944,0.00034598674,0.00033752937,0.0000482934,0.00008679689,0.0023739631,0.000008382706],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035459115,0.00030001954,0.000049794653,0.04988186,0.00047935545,0.00002725114,0.000026650985,2.5863498e-9,8.223335e-7,0.000040095278,0.0008444229,0.9479951],"study_design_scores_gemma":[0.0011249569,0.0013616286,0.0036168452,0.05333071,0.002660584,0.000024093815,0.000014026096,9.1702054e-7,8.142905e-8,0.00001110934,0.9376214,0.00023360846],"about_ca_topic_score_codex":0.0000039690394,"about_ca_topic_score_gemma":0.00017903974,"teacher_disagreement_score":0.94776154,"about_ca_system_score_codex":0.0002813013,"about_ca_system_score_gemma":0.0006454368,"threshold_uncertainty_score":0.99997485},"labels":[],"label_agreement":null},{"id":"W4394689596","doi":"10.1038/s41571-024-00886-y","title":"Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clinical trial; Immune system; Blockade; Vascular endothelial growth factor; Aflibercept; Cancer research; Angiogenesis; Pharmacology; Bevacizumab; Oncology; Immunology; VEGF receptors; Internal medicine; Chemotherapy; Receptor","score_opus":0.2805150098880188,"score_gpt":0.5924041186574771,"score_spread":0.3118891087694583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394689596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002336411,0.9774843,0.00014970859,0.0011097158,0.014823316,0.003561051,0.0020681736,0.000044535842,0.00073584216],"genre_scores_gemma":[0.000024330397,0.9752054,0.0014746239,0.0018142882,0.012729572,0.0005624973,0.007296721,0.00017886386,0.0007136712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97641265,0.008199383,0.01218429,0.0022646075,0.0002951043,0.000643987],"domain_scores_gemma":[0.98525536,0.00710924,0.004772335,0.0020068379,0.00027684128,0.0005793593],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.022814073,0.0011219331,0.012396083,0.00019684098,0.00012799764,0.000113256276,0.0012807234,0.008872905,0.0001970716],"category_scores_gemma":[0.038325205,0.00080930314,0.01142099,0.00047387756,0.0004911602,0.0000069273087,0.0010562243,0.0051028337,0.00092166394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012044773,0.0014952507,0.0000015678605,0.0016272056,0.0015125115,0.0000624704,0.000003868866,4.1770296e-8,0.000013779521,0.00035245367,0.15733397,0.83747643],"study_design_scores_gemma":[0.0046733674,0.001795259,0.0000018590647,0.006181819,0.010780887,0.00003909135,0.0000048742627,0.0000038075443,0.000010751829,0.00036364212,0.97533756,0.0008070781],"about_ca_topic_score_codex":0.000022065327,"about_ca_topic_score_gemma":0.00010946539,"teacher_disagreement_score":0.8366693,"about_ca_system_score_codex":0.00020641988,"about_ca_system_score_gemma":0.0035644777,"threshold_uncertainty_score":0.99985623},"labels":[],"label_agreement":null},{"id":"W4397023159","doi":"10.1038/s41571-024-00904-z","title":"Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"World Health Organization","keywords":"Epidemiology; Medicine; Cervical cancer; Cancer prevention; HPV infection; HPV vaccines; Cancer; Psychological intervention; Incidence (geometry); Epidemiology of cancer; Vaccination; Disease; Causes of cancer; Oncology; Immunology; Gynecology; Internal medicine; Breast cancer","score_opus":0.2954926588836861,"score_gpt":0.6092025723175984,"score_spread":0.31370991343391236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397023159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000023671646,0.98379,0.0000060827824,0.007163827,0.0013766723,0.0029438252,0.000048402333,0.000028699042,0.0046401517],"genre_scores_gemma":[0.000017455732,0.9916722,0.00039220712,0.00070083415,0.005745156,0.00032089173,0.00029118313,0.000047685247,0.00081235054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99132127,0.0037127684,0.0032406063,0.0009775251,0.00030885867,0.00043898128],"domain_scores_gemma":[0.9944093,0.0030536863,0.0013510252,0.00043647544,0.00032797508,0.00042152344],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.009046432,0.00047215464,0.0078087416,0.00024073829,0.000042654145,0.0000048984034,0.00019527622,0.0039207027,0.00063343684],"category_scores_gemma":[0.004161516,0.00028967793,0.0012937975,0.000537271,0.00046066535,0.0000407895,0.0003003086,0.004608546,0.000027339785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009214853,0.00017081155,0.00009829687,0.04294999,0.00048532526,0.000019577794,0.000011936957,5.9413527e-9,8.639195e-9,0.0004210542,0.02096775,0.9347831],"study_design_scores_gemma":[0.0008412735,0.0022082347,0.007281048,0.004490888,0.005984466,0.00007558071,0.0000063394173,0.000009537829,2.9225525e-8,0.00034740704,0.97855556,0.00019964762],"about_ca_topic_score_codex":0.000035869933,"about_ca_topic_score_gemma":0.00006124948,"teacher_disagreement_score":0.9575878,"about_ca_system_score_codex":0.00070990296,"about_ca_system_score_gemma":0.0019488009,"threshold_uncertainty_score":0.99995553},"labels":[],"label_agreement":null},{"id":"W4400279736","doi":"10.1038/s41571-024-00913-y","title":"Just scratching the surface: novel treatment approaches for multiple myeloma targeting cell membrane proteins","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Scratching; Multiple myeloma; Cell; Membrane protein; Cancer research; Membrane; Chemistry; Medicine; Cell biology; Biology; Immunology; Materials science; Biochemistry","score_opus":0.2146654647075981,"score_gpt":0.45244591242351617,"score_spread":0.23778044771591808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400279736","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020315374,0.9870733,0.00050157733,0.00072431867,0.0019859697,0.008736833,0.00021339206,0.000037208814,0.0007070625],"genre_scores_gemma":[0.000044832675,0.9788669,0.010272158,0.00064415,0.003747041,0.0018941541,0.0017706198,0.00013227954,0.0026278906],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99413884,0.0012845445,0.0024663708,0.0013865533,0.00019060393,0.00053311035],"domain_scores_gemma":[0.99656904,0.0008395058,0.001374688,0.000913046,0.000105001505,0.00019870284],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003936711,0.0008569224,0.0031964872,0.000057178626,0.00023347045,0.000069344234,0.0007675844,0.0034595614,0.0000143279585],"category_scores_gemma":[0.0028277014,0.00044457053,0.002852452,0.00027547718,0.00020592326,0.0000069361854,0.00031063386,0.0020328644,0.00009859575],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000458037,0.0004957216,0.0000014818187,0.011750961,0.00034106345,0.0000037464656,0.000014713829,0.0000022030822,0.0001998895,0.00008708993,0.020472497,0.9665848],"study_design_scores_gemma":[0.00079323316,0.001055544,2.2220846e-7,0.0019351119,0.0016786727,0.00001975064,0.000017171526,0.000051825395,0.0003539253,0.0000082877405,0.993606,0.00048027877],"about_ca_topic_score_codex":0.0000053568333,"about_ca_topic_score_gemma":0.000036672573,"teacher_disagreement_score":0.9731335,"about_ca_system_score_codex":0.00018615188,"about_ca_system_score_gemma":0.0011358135,"threshold_uncertainty_score":0.9998006},"labels":[],"label_agreement":null},{"id":"W4403032713","doi":"10.1038/s41571-024-00945-4","title":"Two decades of advances in clinical oncology — lessons learned and future directions","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; University of Texas MD Anderson Cancer Center; Labex Immuno-Oncology; National Institutes of Health; Universitätsklinikum Heidelberg; Medac; Institut Gustave-Roussy; European Organisation for Research and Treatment of Cancer; Fondation pour la Recherche Médicale; European Commission; Ministerio de Ciencia e Innovación; Ligue Contre le Cancer; Generalitat de Catalunya; Fundación Científica Asociación Española Contra el Cáncer; National Cancer Institute; HORIZON EUROPE Framework Programme; Servier; Agència de Gestió d'Ajuts Universitaris i de Recerca; Novocure; Institut National Du Cancer; Prostate Cancer Foundation; Memorial Sloan-Kettering Cancer Center; Institut National de la Santé et de la Recherche Médicale; Ministère des Solidarités et de la Santé; Agence Nationale de la Recherche; Direction Générale de l’offre de Soins; U.S. Department of Defense; Associazione Italiana per la Ricerca sul Cancro; Seerave Foundation; Institut Universitaire de France; Pfizer; Cancer Research UK","keywords":"Medicine; Clinical Oncology; Oncology; MEDLINE; Internal medicine; Medical physics; Cancer","score_opus":0.13743282181576305,"score_gpt":0.5681612698389262,"score_spread":0.4307284480231632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403032713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026307722,0.9884901,0.0000062679833,0.0016347304,0.005176913,0.0011660366,0.00016785235,0.000013209337,0.0033185687],"genre_scores_gemma":[0.000012162596,0.9904246,0.0020006378,0.0008777942,0.0058995704,0.00022052588,0.00026117516,0.0000738022,0.00022976736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99148524,0.0023445175,0.0041835927,0.0014245346,0.0001348731,0.00042724097],"domain_scores_gemma":[0.99480027,0.002265261,0.0017406408,0.00077297527,0.00012960308,0.00029124808],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0048892437,0.00060225104,0.0057939906,0.00020201676,0.000050672723,0.000018495439,0.0005450793,0.005256798,0.000022877834],"category_scores_gemma":[0.004630823,0.0004383597,0.0018186423,0.0004891758,0.00060715596,0.0000071246927,0.000548228,0.004267774,0.000040167477],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006544637,0.0004042843,0.00007045713,0.0038225665,0.0002101755,0.000034073557,0.0000070009723,1.687725e-7,0.0000010483158,0.0015134581,0.0064932513,0.98737806],"study_design_scores_gemma":[0.0008116983,0.0016991807,0.000036899677,0.0026061013,0.0017246626,0.00007989374,0.000013907146,9.945734e-7,6.2571985e-7,0.00035660403,0.9922735,0.00039591457],"about_ca_topic_score_codex":0.000010123628,"about_ca_topic_score_gemma":0.0013960864,"teacher_disagreement_score":0.98698217,"about_ca_system_score_codex":0.00014316043,"about_ca_system_score_gemma":0.002315193,"threshold_uncertainty_score":0.9998068},"labels":[],"label_agreement":null},{"id":"W4404058850","doi":"10.1038/s41571-024-00964-1","title":"On the cusp of targeted therapy for cancer cachexia — what clinical benefits might we promise our patients?","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cancer cachexia; Cachexia; Cancer therapy; Oncology; Targeted therapy; Internal medicine; MEDLINE; Cancer; Intensive care medicine","score_opus":0.42064440673630255,"score_gpt":0.6163134491502561,"score_spread":0.19566904241395355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404058850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016116941,0.9373166,0.0000010864671,0.03875212,0.010206744,0.013251703,0.00020241489,0.000051362254,0.00020186533],"genre_scores_gemma":[0.0000049790233,0.96785575,0.0006735814,0.023212425,0.004058901,0.0026165089,0.000342276,0.00013372657,0.0011018547],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9880214,0.0030736777,0.0066252495,0.0012329415,0.00045322237,0.0005935235],"domain_scores_gemma":[0.98757887,0.007077716,0.003158458,0.0010799987,0.0006046015,0.0005003856],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.008915571,0.00078298996,0.009664294,0.00021475689,0.00010795192,0.00003095222,0.00060890784,0.00454295,0.00022895957],"category_scores_gemma":[0.0064391675,0.00033567092,0.0045875846,0.00061994285,0.00020447592,0.00006415391,0.00011715982,0.007941772,0.0002303012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003434616,0.0013146986,0.00005554156,0.030200668,0.0003990454,0.000006480777,0.000012487025,9.016401e-9,1.683067e-8,0.0006836722,0.23117179,0.7358121],"study_design_scores_gemma":[0.0027432756,0.0033564537,0.000052630607,0.09977581,0.003047351,0.000007169487,0.000008473907,0.0000028880556,1.8097042e-7,0.00024997068,0.89047307,0.00028273306],"about_ca_topic_score_codex":0.0000032825228,"about_ca_topic_score_gemma":0.000025683565,"teacher_disagreement_score":0.7355294,"about_ca_system_score_codex":0.00036766313,"about_ca_system_score_gemma":0.0024208731,"threshold_uncertainty_score":0.9999095},"labels":[],"label_agreement":null},{"id":"W4404940657","doi":"10.1038/s41571-024-00966-z","title":"Synthetic lethal strategies for the development of cancer therapeutics","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Telesta Therapeutics (Canada)","funders":"","keywords":"Synthetic lethality; CRISPR; Medicine; Computational biology; Epigenetics; Drug discovery; Bioinformatics; DNA repair; Biology; Genetics; DNA; Gene","score_opus":0.15958765689535367,"score_gpt":0.5725352650957538,"score_spread":0.4129476082004001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404940657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003209929,0.9928209,0.0031163536,0.000119828415,0.0021334894,0.001514783,0.000042483054,0.000008781993,0.00024013747],"genre_scores_gemma":[0.000032920027,0.9936628,0.0037649756,0.00019197754,0.0011474632,0.00075220765,0.00006984577,0.000059684637,0.00031813956],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970336,0.00026820725,0.0017808947,0.0005448999,0.00010808176,0.00026429238],"domain_scores_gemma":[0.99812925,0.000647129,0.0005263576,0.0005466334,0.0000902684,0.000060375387],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019691868,0.0004023265,0.0020542399,0.000040998435,0.000049645834,0.00001620349,0.00057016924,0.0018683689,0.000013584824],"category_scores_gemma":[0.00029564538,0.00021034447,0.0013128782,0.00013524268,0.00014790692,0.0000011556382,0.00017040287,0.001139734,0.000014045434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010071219,0.00004633551,4.9148724e-7,0.010536035,0.0007075755,7.814794e-7,0.00001842613,0.0000021548644,0.00001765606,0.00012698282,0.0023287262,0.98620474],"study_design_scores_gemma":[0.00011773163,0.00021561934,0.0000015690164,0.0031902115,0.0029544532,0.000009766292,0.0000150900905,0.000006112459,0.000024739524,0.000027997246,0.9932065,0.00023022252],"about_ca_topic_score_codex":9.044335e-7,"about_ca_topic_score_gemma":0.0000886082,"teacher_disagreement_score":0.99087775,"about_ca_system_score_codex":0.000042552216,"about_ca_system_score_gemma":0.0018936375,"threshold_uncertainty_score":0.99942744},"labels":[],"label_agreement":null},{"id":"W4405250040","doi":"10.1038/s41571-024-00970-3","title":"Leptomeningeal metastatic disease: new frontiers and future directions","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Clinical trial; Disease; Cancer; Intensive care medicine; Leptomeninges; Oncology; Pathology; Internal medicine; Central nervous system","score_opus":0.1472500419084576,"score_gpt":0.5315277315165922,"score_spread":0.3842776896081346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405250040","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.04332e-7,0.98156816,0.000024332634,0.007189241,0.006763217,0.0033838258,0.00014859128,0.0001061622,0.0008162701],"genre_scores_gemma":[6.776408e-8,0.96904343,0.016075227,0.0017892558,0.006136822,0.0003447082,0.0005824694,0.000107687716,0.005920346],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.993854,0.0017157668,0.002420716,0.0012571275,0.00029519442,0.0004572053],"domain_scores_gemma":[0.995979,0.0009667867,0.0008162995,0.0007944393,0.00006113354,0.0013823461],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0021416973,0.0008479379,0.008518748,0.0002935261,0.00009026303,0.000040705218,0.0001972166,0.0012986073,0.0002724336],"category_scores_gemma":[0.001225376,0.00047119008,0.0031512517,0.0007239069,0.0002176457,0.0000493986,0.00016343307,0.00487076,0.000430243],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036268942,0.00025428398,0.000007608948,0.015903423,0.0016315263,0.0007070423,0.0000065863273,1.4489585e-9,6.284089e-10,0.0003084102,0.2536017,0.7275431],"study_design_scores_gemma":[0.0008221802,0.0008035152,0.000026473144,0.010510677,0.059452914,0.00054594607,0.0000066780917,0.0000010742344,1.1960628e-9,0.00017777982,0.9273342,0.0003185877],"about_ca_topic_score_codex":0.0000043343653,"about_ca_topic_score_gemma":0.000009327294,"teacher_disagreement_score":0.7272245,"about_ca_system_score_codex":0.00038538696,"about_ca_system_score_gemma":0.0024381618,"threshold_uncertainty_score":0.9999979},"labels":[],"label_agreement":null},{"id":"W4408654141","doi":"10.1038/s41571-025-01013-1","title":"Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Radiosurgery; Medicine; Context (archaeology); Systemic therapy; Clinical trial; Multidisciplinary approach; Brain tumor; Medical physics; Intensive care medicine; Radiation therapy; Internal medicine; Cancer; Pathology","score_opus":0.268919922275821,"score_gpt":0.523161701804245,"score_spread":0.25424177952842403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408654141","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000149150965,0.9786569,0.00033574438,0.0010133998,0.0011043176,0.016408198,0.0023412819,0.000036515965,0.00008871643],"genre_scores_gemma":[0.000007676278,0.96988726,0.012503471,0.0007591519,0.00045639178,0.0062526856,0.009730531,0.00007490142,0.00032795337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99401134,0.001479122,0.0027119825,0.0010887831,0.00023314875,0.0004756078],"domain_scores_gemma":[0.9803886,0.015855802,0.00216144,0.00077694585,0.00038186266,0.00043535957],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029355302,0.0007578423,0.006906879,0.00039204693,0.00024639297,0.000028971497,0.00021591857,0.0011385705,0.000015036414],"category_scores_gemma":[0.005611535,0.00044843895,0.0018387384,0.00026182865,0.00023959881,0.00007915273,0.00018678769,0.0015059495,0.000002657429],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002076369,0.0012060622,0.00030474117,0.089086585,0.0010549612,0.000020416646,0.00002848798,1.3839617e-8,7.8550594e-10,0.00065950054,0.006854152,0.9005774],"study_design_scores_gemma":[0.0043890057,0.0031792105,0.00013999226,0.03537467,0.016152672,0.00003163059,0.000050518414,9.1662366e-7,1.1962293e-8,0.000022629962,0.9403024,0.000356368],"about_ca_topic_score_codex":7.687143e-7,"about_ca_topic_score_gemma":0.000011700181,"teacher_disagreement_score":0.9334482,"about_ca_system_score_codex":0.00046696,"about_ca_system_score_gemma":0.002783052,"threshold_uncertainty_score":0.99979675},"labels":[],"label_agreement":null},{"id":"W4411094243","doi":"10.1038/s41571-025-01031-z","title":"Surrogate end points in oncology: aligning drug development incentives and patient needs","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Surrogate endpoint; Drug development; Incentive; Oncology; Drug; Internal medicine; Intensive care medicine; Medical physics; Pharmacology","score_opus":0.1841165872883653,"score_gpt":0.47868406450756495,"score_spread":0.2945674772191996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411094243","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006754356,0.96260065,0.000005028256,0.0020377846,0.0023465976,0.0017981913,0.00013149052,0.000022385306,0.030990304],"genre_scores_gemma":[0.000051245406,0.98829144,0.001724522,0.008706672,0.00027433774,0.00033011902,0.0000948128,0.000045840196,0.00048101548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99030447,0.0011194152,0.0065978006,0.0011984984,0.000046072306,0.0007337361],"domain_scores_gemma":[0.99188834,0.0041133445,0.0030585579,0.0005099093,0.000038906895,0.0003909402],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0071969978,0.000701266,0.00846018,0.0009329194,0.00010044161,0.00004934788,0.0006578033,0.0025927227,0.00023762869],"category_scores_gemma":[0.0030275716,0.0006418506,0.0009385559,0.0007788568,0.00029665543,0.00012772241,0.0007374032,0.0039716535,0.0007082347],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014989864,0.000351096,0.00030160957,0.0044131936,0.0001791259,0.000024548159,0.00019421057,7.948804e-8,3.5278795e-9,0.016063655,0.005791952,0.97266555],"study_design_scores_gemma":[0.00080837164,0.00013872962,0.00008327067,0.004859928,0.000128959,0.000011647262,0.000012661575,0.000006713018,1.2254833e-7,0.0020867938,0.9913021,0.00056071463],"about_ca_topic_score_codex":0.000018300745,"about_ca_topic_score_gemma":0.00011498427,"teacher_disagreement_score":0.9855101,"about_ca_system_score_codex":0.0012150885,"about_ca_system_score_gemma":0.0012064698,"threshold_uncertainty_score":0.9996033},"labels":[],"label_agreement":null},{"id":"W4412699285","doi":"10.1038/s41571-025-01063-5","title":"Clarifying the role of SONIA: supporting academic evidence on CDK4/6 inhibitor timing","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; MEDLINE; Internal medicine; Oncology","score_opus":0.24823529704736547,"score_gpt":0.5942362198508672,"score_spread":0.3460009228035017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412699285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002998051,0.99009746,0.000040487983,0.002254125,0.0016892784,0.0039466606,0.00001747857,0.00006139496,0.0018901395],"genre_scores_gemma":[0.00003059286,0.9884299,0.0020186575,0.0054813656,0.0029457563,0.00042780107,0.000029948134,0.00007873822,0.00055724266],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9893053,0.0027622108,0.0055809557,0.0011383856,0.0005369283,0.0006762009],"domain_scores_gemma":[0.9736441,0.01920831,0.00523229,0.0013926899,0.0002770946,0.00024556604],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0090224035,0.0007805129,0.009203607,0.00025047467,0.00013338895,0.000009346255,0.0010151706,0.005537551,0.00012317853],"category_scores_gemma":[0.03140457,0.0004302277,0.0027125436,0.00094799994,0.00048654518,0.00010179363,0.00040993094,0.017862253,0.000119587545],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014478162,0.00011902988,0.000072415976,0.027641615,0.0002592756,0.000025874768,0.000030852025,1.4607514e-7,0.0000032566843,0.0003456526,0.0011802389,0.9701769],"study_design_scores_gemma":[0.00039318908,0.0006190074,0.000014963137,0.18533225,0.0027654022,0.00008889385,0.000020899386,0.0000015401176,0.0000050067147,0.00027043946,0.810247,0.00024140326],"about_ca_topic_score_codex":0.0000026682906,"about_ca_topic_score_gemma":0.0000040101204,"teacher_disagreement_score":0.9699355,"about_ca_system_score_codex":0.00066598016,"about_ca_system_score_gemma":0.0033920233,"threshold_uncertainty_score":0.9998149},"labels":[],"label_agreement":null},{"id":"W4413954889","doi":"10.1038/s41571-025-01073-3","title":"Non-financial conflicts of interest","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia, Okanagan Campus; Kelowna General Hospital","funders":"","keywords":"Medicine; Conflict of interest; Finance; Economics","score_opus":0.8569446025520843,"score_gpt":0.740936353755192,"score_spread":0.11600824879689231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413954889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000069325706,0.9598154,0.0000075426633,0.0011024273,0.012511044,0.0040048696,0.0003593211,0.0000649692,0.022127513],"genre_scores_gemma":[0.00002522795,0.97889876,0.00019192252,0.013932613,0.0029941853,0.00044559606,0.00024670849,0.0000549329,0.0032100345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9817662,0.00901175,0.006696546,0.0012808213,0.0001917836,0.0010528914],"domain_scores_gemma":[0.9818488,0.012109699,0.0034529762,0.0009448289,0.00040759915,0.0012361009],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.011304594,0.0010660675,0.011323933,0.00037297074,0.00019043933,0.000011529112,0.001787796,0.024944322,0.0018395595],"category_scores_gemma":[0.01309762,0.00080246007,0.0032288644,0.0011351263,0.0010481449,0.000080463615,0.0006613824,0.035318032,0.0008413184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016025102,0.0009364004,0.000044960634,0.053128812,0.00036181975,0.000119526034,0.000016492113,7.3304356e-8,5.2650716e-7,0.0039319345,0.08658662,0.8547126],"study_design_scores_gemma":[0.0012731447,0.0007078512,0.000013858719,0.01917882,0.0044927406,0.000051440347,0.0000028517845,0.000003921035,0.0000058168107,0.00020744436,0.97349864,0.0005634957],"about_ca_topic_score_codex":0.0000055736605,"about_ca_topic_score_gemma":0.000040558425,"teacher_disagreement_score":0.886912,"about_ca_system_score_codex":0.00036830097,"about_ca_system_score_gemma":0.0047756736,"threshold_uncertainty_score":0.99993664},"labels":[],"label_agreement":null},{"id":"W4414782587","doi":"10.1038/s41571-025-01083-1","title":"Author Correction: Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Radiosurgery; Multidisciplinary approach; Current (fluid); MEDLINE; Multidisciplinary team","score_opus":0.271412466987298,"score_gpt":0.5238763999248607,"score_spread":0.2524639329375627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414782587","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009885674,0.9770549,0.0006581894,0.0014427989,0.0038259728,0.0153576555,0.0015159666,0.000047633497,0.00008700753],"genre_scores_gemma":[0.00000814462,0.9734415,0.009039318,0.00058498833,0.00063416065,0.00663441,0.008263099,0.000073905896,0.0013205009],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939024,0.0016039396,0.0026894202,0.0011090924,0.0002423487,0.00045283808],"domain_scores_gemma":[0.9802736,0.015860988,0.0022392303,0.00073566026,0.00044586393,0.00044467056],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030691924,0.0007489655,0.006351694,0.0004136515,0.0003164146,0.000033440472,0.00019062452,0.001205863,0.000020038515],"category_scores_gemma":[0.0066970726,0.00045686134,0.0017671899,0.00031947438,0.00023035327,0.000085807456,0.00016075485,0.0016707855,0.0000029324888],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025278007,0.0011757909,0.0002938287,0.059597954,0.0009254431,0.000018080902,0.000038220358,2.994385e-8,6.7937045e-10,0.00032029807,0.025508394,0.91186917],"study_design_scores_gemma":[0.0035024069,0.0035469364,0.00016518348,0.03387094,0.015278945,0.000057533387,0.00007883167,0.0000029081625,1.5522623e-8,0.000013548669,0.94312,0.00036274877],"about_ca_topic_score_codex":0.000001009693,"about_ca_topic_score_gemma":0.00001636553,"teacher_disagreement_score":0.9176116,"about_ca_system_score_codex":0.0005649761,"about_ca_system_score_gemma":0.002949133,"threshold_uncertainty_score":0.9997883},"labels":[],"label_agreement":null},{"id":"W4414976681","doi":"10.1038/s41571-025-01080-4","title":"Unresectable stage III non-small-cell lung cancer: state of the art and challenges","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chemoimmunotherapy; Durvalumab; Stage (stratigraphy); Radiation therapy; Chemoradiotherapy; Immunotherapy; Clinical trial; Lung cancer","score_opus":0.10519094712061199,"score_gpt":0.48397862658316976,"score_spread":0.37878767946255776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414976681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008223415,0.97795874,0.0000014144999,0.0030612624,0.0017533433,0.005937541,0.000121468336,0.00001599701,0.011141989],"genre_scores_gemma":[0.0000037965578,0.9851749,0.00023466581,0.0013580295,0.0004296512,0.0011869909,0.000040647326,0.000043493954,0.011527838],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947306,0.0012267049,0.0024510645,0.00092863577,0.0002527146,0.00041029943],"domain_scores_gemma":[0.99321693,0.0033864325,0.0018740763,0.0011137575,0.00017258505,0.00023619644],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0022619986,0.0005992746,0.007906237,0.00011470066,0.00006616881,0.000009089184,0.00042085274,0.0016377361,0.000116651936],"category_scores_gemma":[0.00075718644,0.00030059746,0.0017054247,0.000411393,0.00021406978,0.000024810204,0.00039118956,0.0029588991,0.000015946871],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037829253,0.00056495104,0.0003119545,0.1550855,0.00065862364,0.000029195218,0.00001805874,8.568829e-8,2.4044947e-8,0.000056992973,0.022828074,0.8204087],"study_design_scores_gemma":[0.001822195,0.0006175462,0.00019898909,0.08063005,0.008032061,0.0000108325385,0.0000030127192,0.0000014303894,0.000001068972,0.000008008795,0.9084785,0.00019629329],"about_ca_topic_score_codex":0.00003752864,"about_ca_topic_score_gemma":0.00065417215,"teacher_disagreement_score":0.88565046,"about_ca_system_score_codex":0.000680684,"about_ca_system_score_gemma":0.0035379948,"threshold_uncertainty_score":0.9999446},"labels":[],"label_agreement":null}]}